HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
112508.0,247400,2176-04-15 07:12:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2176-4-14**] 08:07 AM
   MRSA admit swab
 BLOOD CULTURED - At [**2176-4-14**] 02:01 PM
   central line
 URINE CULTURE - At [**2176-4-14**] 02:01 PM
 INVASIVE VENTILATION - START [**2176-4-15**] 01:53 AM
 FEVER - 102.6
F - [**2176-4-14**] 08:00 PM
   - d/w son her current disposition
   - ABG still respiratory alkalosis
   - CSF from shunt:  263 WBC, 94% PMN
   - IVIg x 1 per BMT
   - continuing meropenem, changed gent to cipro for better CSF
   penetration, increased dose of dapto for better CSF penetration
   - nasopharyngeal aspirate negative viral screen
   - induced sputum not done
   - has contrast allergy, got non-contrast CT chest with infiltrate vs
   atelectasis LLL
   - 10-15 beat NSVT, having lots of ectopy, lytes repleted
   - 2400:  SVT to the 170s, given fluid, metoprolol 5 mg IV x 2 followed
   by diltiazem 15 mg IV-->HR fell to 60s, but BP also dropped from SBP
   110 to SBP 60s-70s
   - 0030-0130:  attempting to place radial arterial line unsuccessfully,
   BP on the cuff mostly 60s-80s
   - 0130:  asystole, code blue, regained perfusing rhythm after epi x 2
   mg, atropine x 2mg, 2 amps calcium chloride
   - received 4 grams calcium gluconate + 2 amps calcium chloride for
   presumed calcium channel blocker toxicity, also gave glucagon 5 mg x 1
   for possible component of beta blocker toxicity
   - sedating with fentanyl/midazolam to try to improve vent synchrony
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-14**] 06:30 PM
   Acyclovir - [**2176-4-14**] 06:54 PM
   Micafungin - [**2176-4-14**] 08:17 PM
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Meropenem - [**2176-4-15**] 04:00 AM
   Infusions:
   Phenylephrine - 2 mcg/Kg/min
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 0.5 mg/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-14**] 09:39 AM
   Fentanyl - [**2176-4-15**] 03:08 AM
   Midazolam (Versed) - [**2176-4-15**] 03:09 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-15**] 06:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.2
C (102.6
   Tcurrent: 35.7
C (96.3
   HR: 101 (68 - 139) bpm
   BP: 114/79(87) {76/35(52) - 199/118(122)} mmHg
   RR: 30 (18 - 41) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  5,009 mL
                                                                  3,141 mL
   PO:
             TF:
   IVF:
                                                                  3,456 mL
                                                                  3,128 mL
   Blood products:
                                                                     74 mL
   Total out:
                                                                  3,050 mL
                                                                  1,685 mL
   Urine:
                                                                  3,050 mL
                                                                  1,685 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,959 mL
                                                                  1,456 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   RR (Set): 24
   PEEP: 10 cmH2O
   FiO2: 50%
   RSBI Deferred: PEEP > 10, FiO2 > 60%
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.28/26/269/13/-12
   Ve: 15.9 L/min
   PaO2 / FiO2: 538
   Physical Examination
   General:  intubated, sedated but flickers eyes in reponse to voice
   HEENT:  dry mucous membranes
   Heart:  regular, no audible murmur
   Lungs:  clear anteriorly
   Abdomen:  soft
   Extremities:  cool, distal pulses palpable but thready
   Labs / Radiology
   37 K/uL
   9.8 g/dL
   40 mg/dL
   0.8 mg/dL
   13 mEq/L
   5.0 mEq/L
   23 mg/dL
   117 mEq/L
   142 mEq/L
   30.6 %
   0.9 K/uL
        [image002.jpg]
                             [**2176-4-14**]  04:42 PM
                             [**2176-4-14**]  06:50 PM
                             [**2176-4-14**]  10:44 PM
                             [**2176-4-15**]  01:30 AM
                             [**2176-4-15**]  01:43 AM
                             [**2176-4-15**]  02:47 AM
                             [**2176-4-15**]  03:15 AM
                             [**2176-4-15**]  04:32 AM
                             [**2176-4-15**]  04:50 AM
   WBC
   0.9
   Hct
   26.6
   30.6
   Plt
   37
   Cr
   0.6
   0.3
   0.8
   0.8
   TCO2
   23
   22
   7
   9
   13
   Glucose
   118
   99
   83
   40
   Other labs: PT / PTT / INR:22.5/102.0/2.2, ALT / AST:[**Telephone/Fax (1) 6012**], Alk Phos
   / T Bili:336/1.6, Fibrinogen:784 mg/dL, Lactic Acid:4.7 mmol/L,
   Albumin:2.0 g/dL, LDH:341 IU/L, Ca++:13.4 mg/dL, Mg++:2.1 mg/dL,
   PO4:6.0 mg/dL
   CSF:  263 WBC, 94% PMN, 6 lymphs, 33 RBC, 123 protein, 73 glucose.
   HSV, toxo, CMV, EBV pending
   Non-contrast chest CT:
   1. Peripheral wedge-shaped left upper lobe consolidation, previously
   seen as
   an area of bronchiectasis ([**2169-12-30**]), ground-glass ([**2172-4-8**]), and
   consolidation ([**2172-3-31**]) - findings suggest recurrent infection in a
   region
   of focal bronchiectasis.
   2. New small left and tiny right pleural effusions.
   3. Scattered tree-in-[**Male First Name (un) **] opacities which may represent inflammation or
   infection.
   4. Extensive chest wall and mediastinal collateral vascularization and
   prominence of the azygos vein, likely due to known occlusion of the SVC
   and
   brachiocephalic veins.
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   #) s/p asystolic arrest:  Likely cause was toxicity from calcium
   channel blockade.  Her tachyarthymia may have been secondary to
   sympathetic output from fevers in the setting of a heart compromised by
   prior anthracycline toxicity.  Currently her pupils are reactive and
   she responds to stimulation.
   - monitor electrolytes q6h and replete PRN
   - trend lactate
   - no further nodal agents
   - head CT to evaluate for severe neurologic damage
   .
   #) respiratory failure:  intubated in the peri-code setting.  ABGs
   during the day yesterday indicated primary metabolic alkalosis.
   Possibilities for etiology include intracranial process, drug effect,
   PE.  Could not evaluate for PE yesterday because of reported allergy to
   contrast (patient was unable to define further.)  No obvious drug
   offenders on her list.
   - CT head to evaluate for intracranial process
   - LENIs to evaluate for source of PE
   - wean FiO2 and PEEP as tolerated
   .
   #) hypotension:  blood pressures were very labile prior to the code.
   She is currently requiring a small dose of neo.
   - wean neo as tolerated
   .
   #) fevers:  On ciprofloxacin+dapto+meropenem.  Recent cultures with VRE
   but none since [**4-11**]. CSF findings concerning for infection seeding her
   CSF.  It is possible that her Ommaya is confaminated.  Also would be
   concerned for infected clots given her known upper extremity DVTs
   and/or for cardiac vegetations.  No evidence of septic emboli on lung
   CT yesterday.  Nasopharyngeal aspirate negative, induced sputum to be
   done today.
   - continue antibiotics, changed to improve CSF penetration
   - discuss with ID antibiotic coverage
   - discuss with oncology the possibility of an infected Ommaya
   - TTE to evaluate valves for vegetation
   - f/u CSF studies
   - induced sputum
   .
   #) ALL:  with recent recurrent CNS disease.   This hospitalization she
   was treated with intrathecal chemotherapy and DLI with resolution of
   CSF blasts as of [**2176-4-1**].    Her CSF picture currently
   - f/u cytology of spinal fluid
   - TTE today to evaluate for endocarditis
   - s/p IVIg yesterday
   - continue filgastrim
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis)
   - discuss with
   .
   #) increased LFTs:  appears to be shock liver
   - continue to monitor
   .
   #)  increased urin output:  concerning for DI in the setting of a
   possible intra-cranial process
   - check serum/urine osms
   .
   #) Coagulopathy:  concerning for DIC
   - follow DIC labs q4h today
   - transfuse blood and products PRN
   .
   #)  Hypoglycemia:  noted on morning labs, s/p
 amp d50.  Possibly
   secondary to insulin in TPN, which was stopped overnight.
   - follow FSBG
   - D5
   ICU Care
   Nutrition: nutrition consult for TF recs
   Glycemic Control:
   Lines:   contact IR for arterial line placement today given difficulty
   placing at bedside
   Indwelling Port (PortaCath) - [**2176-4-14**] 06:30 AM
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:  full code (confirmed last night with her healthcare
   proxy)
   Disposition: ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2176-4-14**] 08:07 AM
   MRSA admit swab
 BLOOD CULTURED - At [**2176-4-14**] 02:01 PM
   central line
 URINE CULTURE - At [**2176-4-14**] 02:01 PM
 INVASIVE VENTILATION - START [**2176-4-15**] 01:53 AM
 FEVER - 102.6
F - [**2176-4-14**] 08:00 PM
   - d/w son her current disposition
   - ABG still respiratory alkalosis
   - CSF from shunt:  263 WBC, 94% PMN
   - IVIg x 1 per BMT
   - continuing meropenem, changed gent to cipro for better CSF
   penetration, increased dose of dapto for better CSF penetration
   - nasopharyngeal aspirate negative viral screen
   - induced sputum not done
   - has contrast allergy, got non-contrast CT chest with infiltrate vs
   atelectasis LLL
   - 10-15 beat NSVT, having lots of ectopy, lytes repleted
   - 2400:  SVT to the 170s, given fluid, metoprolol 5 mg IV x 2 followed
   by diltiazem 15 mg IV-->HR fell to 60s, but BP also dropped from SBP
   110 to SBP 60s-70s
   - 0030-0130:  attempting to place radial arterial line unsuccessfully,
   BP on the cuff mostly 60s-80s
   - 0130:  asystole, code blue, regained perfusing rhythm after epi x 2
   mg, atropine x 2mg, 2 amps calcium chloride
   - received 4 grams calcium gluconate + 2 amps calcium chloride for
   presumed calcium channel blocker toxicity, also gave glucagon 5 mg x 1
   for possible component of beta blocker toxicity
   - sedating with fentanyl/midazolam to try to improve vent synchrony
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-14**] 06:30 PM
   Acyclovir - [**2176-4-14**] 06:54 PM
   Micafungin - [**2176-4-14**] 08:17 PM
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Meropenem - [**2176-4-15**] 04:00 AM
   Infusions:
   Phenylephrine - 2 mcg/Kg/min
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 0.5 mg/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-14**] 09:39 AM
   Fentanyl - [**2176-4-15**] 03:08 AM
   Midazolam (Versed) - [**2176-4-15**] 03:09 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-15**] 06:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.2
C (102.6
   Tcurrent: 35.7
C (96.3
   HR: 101 (68 - 139) bpm
   BP: 114/79(87) {76/35(52) - 199/118(122)} mmHg
   RR: 30 (18 - 41) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  5,009 mL
                                                                  3,141 mL
   PO:
             TF:
   IVF:
                                                                  3,456 mL
                                                                  3,128 mL
   Blood products:
                                                                     74 mL
   Total out:
                                                                  3,050 mL
                                                                  1,685 mL
   Urine:
                                                                  3,050 mL
                                                                  1,685 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,959 mL
                                                                  1,456 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   RR (Set): 24
   PEEP: 10 cmH2O
   FiO2: 50%
   RSBI Deferred: PEEP > 10, FiO2 > 60%
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.28/26/269/13/-12
   Ve: 15.9 L/min
   PaO2 / FiO2: 538
   Physical Examination
   General:  intubated, sedated but flickers eyes in reponse to voice
   HEENT:  dry mucous membranes
   Heart:  regular, no audible murmur
   Lungs:  clear anteriorly
   Abdomen:  soft
   Extremities:  cool, distal pulses palpable but thready
   Labs / Radiology
   37 K/uL
   9.8 g/dL
   40 mg/dL
   0.8 mg/dL
   13 mEq/L
   5.0 mEq/L
   23 mg/dL
   117 mEq/L
   142 mEq/L
   30.6 %
   0.9 K/uL
        [image002.jpg]
                             [**2176-4-14**]  04:42 PM
                             [**2176-4-14**]  06:50 PM
                             [**2176-4-14**]  10:44 PM
                             [**2176-4-15**]  01:30 AM
                             [**2176-4-15**]  01:43 AM
                             [**2176-4-15**]  02:47 AM
                             [**2176-4-15**]  03:15 AM
                             [**2176-4-15**]  04:32 AM
                             [**2176-4-15**]  04:50 AM
   WBC
   0.9
   Hct
   26.6
   30.6
   Plt
   37
   Cr
   0.6
   0.3
   0.8
   0.8
   TCO2
   23
   22
   7
   9
   13
   Glucose
   118
   99
   83
   40
   Other labs: PT / PTT / INR:22.5/102.0/2.2, ALT / AST:[**Telephone/Fax (1) 6012**], Alk Phos
   / T Bili:336/1.6, Fibrinogen:784 mg/dL, Lactic Acid:4.7 mmol/L,
   Albumin:2.0 g/dL, LDH:341 IU/L, Ca++:13.4 mg/dL, Mg++:2.1 mg/dL,
   PO4:6.0 mg/dL
   CSF:  263 WBC, 94% PMN, 6 lymphs, 33 RBC, 123 protein, 73 glucose.
   HSV, toxo, CMV, EBV pending
   Non-contrast chest CT:
   1. Peripheral wedge-shaped left upper lobe consolidation, previously
   seen as
   an area of bronchiectasis ([**2169-12-30**]), ground-glass ([**2172-4-8**]), and
   consolidation ([**2172-3-31**]) - findings suggest recurrent infection in a
   region
   of focal bronchiectasis.
   2. New small left and tiny right pleural effusions.
   3. Scattered tree-in-[**Male First Name (un) **] opacities which may represent inflammation or
   infection.
   4. Extensive chest wall and mediastinal collateral vascularization and
   prominence of the azygos vein, likely due to known occlusion of the SVC
   and
   brachiocephalic veins.
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   #) s/p asystolic arrest:  Likely cause was toxicity from calcium
   channel blockade.  Her tachyarthymia may have been secondary to
   sympathetic output from fevers in the setting of a heart compromised by
   prior anthracycline toxicity.  Currently her pupils are reactive and
   she responds to stimulation.
   - monitor electrolytes q6h and replete PRN
   - trend lactate
   - no further nodal agents
   - head CT to evaluate for severe neurologic damage
   .
   #) respiratory failure:  intubated in the peri-code setting.  ABGs
   during the day yesterday indicated primary metabolic alkalosis.
   Possibilities for etiology include intracranial process, drug effect,
   PE.  Could not evaluate for PE yesterday because of reported allergy to
   contrast (patient was unable to define further.)  No obvious drug
   offenders on her list.
   - CT head to evaluate for intracranial process
   - LENIs to evaluate for source of PE
   - wean FiO2 and PEEP as tolerated
   .
   #) hypotension:  blood pressures were very labile prior to the code.
   She is currently requiring a small dose of neo.
   - wean neo as tolerated
   .
   #) fevers:  On ciprofloxacin+dapto+meropenem.  Recent cultures with VRE
   but none since [**4-11**]. CSF findings concerning for infection seeding her
   CSF.  It is possible that her Ommaya is confaminated.  Also would be
   concerned for infected clots given her known upper extremity DVTs
   and/or for cardiac vegetations.  No evidence of septic emboli on lung
   CT yesterday.  Nasopharyngeal aspirate negative, induced sputum to be
   done today.
   - continue antibiotics, changed to improve CSF penetration
   - discuss with ID antibiotic coverage
   - discuss with oncology the possibility of an infected Ommaya
   - TTE to evaluate valves for vegetation
   - f/u CSF studies
   - induced sputum
   .
   #) ALL:  with recent recurrent CNS disease.   This hospitalization she
   was treated with intrathecal chemotherapy and DLI with resolution of
   CSF blasts as of [**2176-4-1**].    Her CSF picture currently
   - f/u cytology of spinal fluid
   - TTE today to evaluate for endocarditis
   - s/p IVIg yesterday
   - continue filgastrim
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis)
   - discuss with
   .
   #) increased LFTs:  appears to be shock liver
   - continue to monitor
   .
   #)  increased urin output:  concerning for DI in the setting of a
   possible intra-cranial process
   - check serum/urine osms
   .
   #) Coagulopathy:  concerning for DIC
   - follow DIC labs q4h today
   - transfuse blood and products PRN
   .
   #)  Hypoglycemia:  noted on morning labs, s/p
 amp d50.  Possibly
   secondary to insulin in TPN, which was stopped overnight.
   - follow FSBG
   - D5
   ICU Care
   Nutrition: nutrition consult for TF recs
   Glycemic Control:
   Lines:   contact IR for arterial line placement today given difficulty
   placing at bedside
   Indwelling Port (PortaCath) - [**2176-4-14**] 06:30 AM
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:  full code (confirmed last night with her healthcare
   proxy)
   Disposition: ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with acute lymphoblastic leukemia (ALL) and recent VRE bacteremia. She was admitted to the ICU due to acute-on-chronic poor medical status, increasing tachypnea, tachycardia, and temperature. She had a code blue event due to suspected calcium channel blockade toxicity, and was successfully resuscitated. The patient is currently intubated and on ventilatory support.

Potential Medical Complications:

1. Respiratory failure: The patient's primary metabolic alkalosis may be due to an intracranial process, drug effect, or pulmonary embolism (PE). A CT head is recommended to evaluate for intracranial process, and LENIs to evaluate for source of PE.
2. Hypotension: The patient's blood pressures were labile prior to the code, and she is currently requiring a small dose of neosynephrine (neo). Weaning of neo as tolerated is recommended.
3. Fevers: The patient's fevers may be due to VRE bacteremia, infected clots, or cardiac vegetations. Antibiotics have been changed to improve CSF penetration, and further evaluation is needed to determine the source of the infection.
4. ALL: The patient's recent recurrent CNS disease requires close monitoring of CSF cytology and TTE to evaluate for endocarditis.
5. Increased LFTs: The patient's increased liver function tests (LFTs) may be due to shock liver. Close monitoring is recommended.
6. Increased urin output: The patient's increased urin output may be due to diabetes insipidus (DI) in the setting of a possible intra-cranial process. Serum and urine osmolality checks are recommended.
7. Coagulopathy: The patient's coagulopathy may be due to disseminated intravascular coagulation (DIC). Close monitoring of DIC labs and transfusion of blood and products as needed are recommended.
8. Hypoglycemia: The patient's hypoglycemia may be due to insulin in TPN, which was stopped overnight. Close monitoring of FSBG and D5 administration are recommended.

Recommendations:

1. Continue antibiotics changed to improve CSF penetration.
2. Discuss antibiotic coverage with ID and oncology.
3. Evaluate for infected Ommaya with oncology.
4. Perform TTE to evaluate for cardiac vegetations.
5. Continue filgastrim and acyclovir.
6. Monitor LFTs and urin output closely.
7. Monitor coagulopathy and transfuse blood and products as needed.
8. Follow FSBG and D5 administration closely.
9. Consider stress ulcer prophylaxis with PPI.
10. Monitor for VAP and take measures to prevent it."
112508.0,247400,2176-04-15 07:12:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2176-4-14**] 08:07 AM
   MRSA admit swab
 BLOOD CULTURED - At [**2176-4-14**] 02:01 PM
   central line
 URINE CULTURE - At [**2176-4-14**] 02:01 PM
 INVASIVE VENTILATION - START [**2176-4-15**] 01:53 AM
 FEVER - 102.6
F - [**2176-4-14**] 08:00 PM
   - d/w son her current disposition
   - ABG still respiratory alkalosis
   - CSF from shunt:  263 WBC, 94% PMN
   - IVIg x 1 per BMT
   - continuing meropenem, changed gent to cipro for better CSF
   penetration, increased dose of dapto for better CSF penetration
   - nasopharyngeal aspirate negative viral screen
   - induced sputum not done
   - has contrast allergy, got non-contrast CT chest with infiltrate vs
   atelectasis LLL
   - 10-15 beat NSVT, having lots of ectopy, lytes repleted
   - 2400:  SVT to the 170s, given fluid, metoprolol 5 mg IV x 2 followed
   by diltiazem 15 mg IV-->HR fell to 60s, but BP also dropped from SBP
   110 to SBP 60s-70s
   - 0030-0130:  attempting to place radial arterial line unsuccessfully,
   BP on the cuff mostly 60s-80s
   - 0130:  asystole, code blue, regained perfusing rhythm after epi x 2
   mg, atropine x 2mg, 2 amps calcium chloride
   - received 4 grams calcium gluconate + 2 amps calcium chloride for
   presumed calcium channel blocker toxicity, also gave glucagon 5 mg x 1
   for possible component of beta blocker toxicity
   - sedating with fentanyl/midazolam to try to improve vent synchrony
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-14**] 06:30 PM
   Acyclovir - [**2176-4-14**] 06:54 PM
   Micafungin - [**2176-4-14**] 08:17 PM
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Meropenem - [**2176-4-15**] 04:00 AM
   Infusions:
   Phenylephrine - 2 mcg/Kg/min
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 0.5 mg/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-14**] 09:39 AM
   Fentanyl - [**2176-4-15**] 03:08 AM
   Midazolam (Versed) - [**2176-4-15**] 03:09 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-15**] 06:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.2
C (102.6
   Tcurrent: 35.7
C (96.3
   HR: 101 (68 - 139) bpm
   BP: 114/79(87) {76/35(52) - 199/118(122)} mmHg
   RR: 30 (18 - 41) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  5,009 mL
                                                                  3,141 mL
   PO:
             TF:
   IVF:
                                                                  3,456 mL
                                                                  3,128 mL
   Blood products:
                                                                     74 mL
   Total out:
                                                                  3,050 mL
                                                                  1,685 mL
   Urine:
                                                                  3,050 mL
                                                                  1,685 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,959 mL
                                                                  1,456 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   RR (Set): 24
   PEEP: 10 cmH2O
   FiO2: 50%
   RSBI Deferred: PEEP > 10, FiO2 > 60%
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.28/26/269/13/-12
   Ve: 15.9 L/min
   PaO2 / FiO2: 538
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   37 K/uL
   9.8 g/dL
   40 mg/dL
   0.8 mg/dL
   13 mEq/L
   5.0 mEq/L
   23 mg/dL
   117 mEq/L
   142 mEq/L
   30.6 %
   0.9 K/uL
        [image002.jpg]
                             [**2176-4-14**]  04:42 PM
                             [**2176-4-14**]  06:50 PM
                             [**2176-4-14**]  10:44 PM
                             [**2176-4-15**]  01:30 AM
                             [**2176-4-15**]  01:43 AM
                             [**2176-4-15**]  02:47 AM
                             [**2176-4-15**]  03:15 AM
                             [**2176-4-15**]  04:32 AM
                             [**2176-4-15**]  04:50 AM
   WBC
   0.9
   Hct
   26.6
   30.6
   Plt
   37
   Cr
   0.6
   0.3
   0.8
   0.8
   TCO2
   23
   22
   7
   9
   13
   Glucose
   118
   99
   83
   40
   Other labs: PT / PTT / INR:22.5/102.0/2.2, ALT / AST:[**Telephone/Fax (1) 6012**], Alk Phos
   / T Bili:336/1.6, Fibrinogen:784 mg/dL, Lactic Acid:4.7 mmol/L,
   Albumin:2.0 g/dL, LDH:341 IU/L, Ca++:13.4 mg/dL, Mg++:2.1 mg/dL,
   PO4:6.0 mg/dL
   CSF:  263 WBC, 94% PMN, 6 lymphs, 33 RBC, 123 protein, 73 glucose.
   HSV, toxo, CMV, EBV pending
   Non-contrast chest CT:
   1. Peripheral wedge-shaped left upper lobe consolidation, previously
   seen as
   an area of bronchiectasis ([**2169-12-30**]), ground-glass ([**2172-4-8**]), and
   consolidation ([**2172-3-31**]) - findings suggest recurrent infection in a
   region
   of focal bronchiectasis.
   2. New small left and tiny right pleural effusions.
   3. Scattered tree-in-[**Male First Name (un) **] opacities which may represent inflammation or
   infection.
   4. Extensive chest wall and mediastinal collateral vascularization and
   prominence of the azygos vein, likely due to known occlusion of the SVC
   and
   brachiocephalic veins.
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   #) s/p asystolic arrest:  Likely cause was toxicity from calcium
   channel blockade.  Her tachyarthymia may have been secondary to
   sympathetic output from fevers.
   - monitor electrolytes and replete PRN
   - no further nodal agents
   #) respiratory failure:  intubated for hypoxic respiratory failure.
   ABGs prior indicated primary metabolic alkalosis. Possibly secondary to
   intracranial process.  Could not evaluate for PE yesterday because of
   reported allergy to contrast (patient was unable to define further.)
   #) fevers:  On ciprofloxacin+dapto+meropenem.  Recent cultures with VRE
   but none since [**4-11**]. Nasopharyngeal aspirate negative, induced sputum
   to be done today.  CSF findings concerning for infection seeding her
   CSF
   - continue antibiotics, changed to improve CSF penetration
   - discuss with ID
   #) ALL:  with recent recurrent CNS disease.   Her hospital course thus
   far has been characterized by:
   The patient was found to have recurrent bone marrow as well as CNS
   disease after presenting with dizziness. After C/T/L spine imaging, the
   patient's CSF was sampled and she was given IT MTX through an Ommaya
   biweekly for 2 weeks after her CSF cleared on [**2176-4-1**].  The was then
   treated on a weekly basis starting on XXXX.  The patient was unable to
   tolerate AraC due to severe nausea and vomiting. After one treatment
   with Ara-C, the patient instead recevied intra-thecal methotrexate
   approximately twice per week. Her CSF remained positive for blasts
   until tap on [**2176-4-1**].  She also received a cycle of HyperCVAD. She
   received part A as well as dexamethasone on D11-14 but vincristine was
   not given on D11 due to poor ostomy output and concern for further
   ileus. Peripheral blood smears showed resolution of peripheral blasts
   after 1-2 days of systemic chemotherapy. Her course was complicated by
   mucositis, poorly healing aphthous ulcers and poor po intake secondary
   to pain, which complicated healing and cause electrolyte abnormalities
   requiring significant repletion.  She was changed from oral pain
   medication to a low dose morphine PCA with good effect. She was also
   started on TPN for nutrition and her electrolytes abnormalities
   resolved.
   - f/u cytology of spinal fluid
   - TTE today to evaluate for endocarditis
   - s/p IVIg yesterday
   - continue filgastrim
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis)
   WORSENING FUNCTIONAL STATUS
   Likely secondary to worsening bacteremia. She has been on daptomycin as
   well as micafungin and meropenem. She has not been growing VRE
   recently, but it is possible that she is continuing to have
   complications of VRE through dapto. Gentamicin was added shortly before
   her transfer. Lisinopril was d/c
ed yesterday, suggesting continued
   decline in BP is masked somewhat by d/c
ing antihypertensive, adds to
   this slow-moving but potentially serious likely infectious picture. No
   clear source currently. Still neutropenic but large number of
   metas/myelos/etc may suggest imminent recovery.
   - consider CT torso
 w CTA for PE rule-out
   - aggressive fluid resuscitation, continue to evaluate if this either
   brings down O2 sat (consider fluid overload) and/or brings down tachy,
   brings up BP (c/w sepsis); would expect the latter effect to
   predominate
   - continue dapto/gent
   - additional blood cultures, continue surveillance cultures, CIS
   - UA/Ucx
   - follow blood counts closely
   - continue filgrastim
   - has been getting morphine PCA for pain; would emphasize to only have
   pt trigger PCA given increasingly sedated picture
   - MRA/MRV was c/w clot in SVC but appeared to show collateral
   circulation, no indication of SVC syndrome clinically
   - viral assays
   - sputum cultures
induced sputum
   - echocardiogram tomorrow
   ALL
   Has been getting methotrexate evidently, held [**4-12**] for bacteremia.
   Getting neupogen.
   - continue filgrastim
   - check in w heme/onc re recommendations; in particular, discuss
   question of whether IVIG would be indicated now or in future
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis),
   - CNS tap to evaluate for blasts, new process
   - 4 days ago DLI
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   ICU Care
   Nutrition: nutrition consult for TF recs
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2176-4-14**] 06:30 AM
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2176-4-14**] 08:07 AM
   MRSA admit swab
 BLOOD CULTURED - At [**2176-4-14**] 02:01 PM
   central line
 URINE CULTURE - At [**2176-4-14**] 02:01 PM
 INVASIVE VENTILATION - START [**2176-4-15**] 01:53 AM
 FEVER - 102.6
F - [**2176-4-14**] 08:00 PM
   - d/w son her current disposition
   - ABG still respiratory alkalosis
   - CSF from shunt:  263 WBC, 94% PMN
   - IVIg x 1 per BMT
   - continuing meropenem, changed gent to cipro for better CSF
   penetration, increased dose of dapto for better CSF penetration
   - nasopharyngeal aspirate negative viral screen
   - induced sputum not done
   - has contrast allergy, got non-contrast CT chest with infiltrate vs
   atelectasis LLL
   - 10-15 beat NSVT, having lots of ectopy, lytes repleted
   - 2400:  SVT to the 170s, given fluid, metoprolol 5 mg IV x 2 followed
   by diltiazem 15 mg IV-->HR fell to 60s, but BP also dropped from SBP
   110 to SBP 60s-70s
   - 0030-0130:  attempting to place radial arterial line unsuccessfully,
   BP on the cuff mostly 60s-80s
   - 0130:  asystole, code blue, regained perfusing rhythm after epi x 2
   mg, atropine x 2mg, 2 amps calcium chloride
   - received 4 grams calcium gluconate + 2 amps calcium chloride for
   presumed calcium channel blocker toxicity, also gave glucagon 5 mg x 1
   for possible component of beta blocker toxicity
   - sedating with fentanyl/midazolam to try to improve vent synchrony
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-14**] 06:30 PM
   Acyclovir - [**2176-4-14**] 06:54 PM
   Micafungin - [**2176-4-14**] 08:17 PM
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Meropenem - [**2176-4-15**] 04:00 AM
   Infusions:
   Phenylephrine - 2 mcg/Kg/min
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 0.5 mg/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-14**] 09:39 AM
   Fentanyl - [**2176-4-15**] 03:08 AM
   Midazolam (Versed) - [**2176-4-15**] 03:09 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-15**] 06:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.2
C (102.6
   Tcurrent: 35.7
C (96.3
   HR: 101 (68 - 139) bpm
   BP: 114/79(87) {76/35(52) - 199/118(122)} mmHg
   RR: 30 (18 - 41) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  5,009 mL
                                                                  3,141 mL
   PO:
             TF:
   IVF:
                                                                  3,456 mL
                                                                  3,128 mL
   Blood products:
                                                                     74 mL
   Total out:
                                                                  3,050 mL
                                                                  1,685 mL
   Urine:
                                                                  3,050 mL
                                                                  1,685 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,959 mL
                                                                  1,456 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   RR (Set): 24
   PEEP: 10 cmH2O
   FiO2: 50%
   RSBI Deferred: PEEP > 10, FiO2 > 60%
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.28/26/269/13/-12
   Ve: 15.9 L/min
   PaO2 / FiO2: 538
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   37 K/uL
   9.8 g/dL
   40 mg/dL
   0.8 mg/dL
   13 mEq/L
   5.0 mEq/L
   23 mg/dL
   117 mEq/L
   142 mEq/L
   30.6 %
   0.9 K/uL
        [image002.jpg]
                             [**2176-4-14**]  04:42 PM
                             [**2176-4-14**]  06:50 PM
                             [**2176-4-14**]  10:44 PM
                             [**2176-4-15**]  01:30 AM
                             [**2176-4-15**]  01:43 AM
                             [**2176-4-15**]  02:47 AM
                             [**2176-4-15**]  03:15 AM
                             [**2176-4-15**]  04:32 AM
                             [**2176-4-15**]  04:50 AM
   WBC
   0.9
   Hct
   26.6
   30.6
   Plt
   37
   Cr
   0.6
   0.3
   0.8
   0.8
   TCO2
   23
   22
   7
   9
   13
   Glucose
   118
   99
   83
   40
   Other labs: PT / PTT / INR:22.5/102.0/2.2, ALT / AST:[**Telephone/Fax (1) 6012**], Alk Phos
   / T Bili:336/1.6, Fibrinogen:784 mg/dL, Lactic Acid:4.7 mmol/L,
   Albumin:2.0 g/dL, LDH:341 IU/L, Ca++:13.4 mg/dL, Mg++:2.1 mg/dL,
   PO4:6.0 mg/dL
   CSF:  263 WBC, 94% PMN, 6 lymphs, 33 RBC, 123 protein, 73 glucose.
   HSV, toxo, CMV, EBV pending
   Non-contrast chest CT:
   1. Peripheral wedge-shaped left upper lobe consolidation, previously
   seen as
   an area of bronchiectasis ([**2169-12-30**]), ground-glass ([**2172-4-8**]), and
   consolidation ([**2172-3-31**]) - findings suggest recurrent infection in a
   region
   of focal bronchiectasis.
   2. New small left and tiny right pleural effusions.
   3. Scattered tree-in-[**Male First Name (un) **] opacities which may represent inflammation or
   infection.
   4. Extensive chest wall and mediastinal collateral vascularization and
   prominence of the azygos vein, likely due to known occlusion of the SVC
   and
   brachiocephalic veins.
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   #) s/p asystolic arrest:  Likely cause was toxicity from calcium
   channel blockade.  Her tachyarthymia may have been secondary to
   sympathetic output from fevers.
   - monitor electrolytes and replete PRN
   - no further nodal agents
   #) respiratory failure:  intubated for hypoxic respiratory failure.
   ABGs prior indicated primary metabolic alkalosis. Possibly secondary to
   intracranial process.  Could not evaluate for PE yesterday because of
   reported allergy to contrast (patient was unable to define further.)
   #) fevers:  On ciprofloxacin+dapto+meropenem.  Recent cultures with VRE
   but none since [**4-11**]. Nasopharyngeal aspirate negative, induced sputum
   to be done today.  CSF findings concerning for infection seeding her
   CSF
   - continue antibiotics, changed to improve CSF penetration
   - discuss with ID
   #) ALL:  with recent recurrent CNS disease.   Her hospital course thus
   far has been characterized by:
   The patient was found to have recurrent bone marrow as well as CNS
   disease after presenting with dizziness. After C/T/L spine imaging, the
   patient's CSF was sampled and she was given IT MTX through an Ommaya
   biweekly for 2 weeks after her CSF cleared on [**2176-4-1**].  The was then
   treated on a weekly basis starting on XXXX.  The patient was unable to
   tolerate AraC due to severe nausea and vomiting. After one treatment
   with Ara-C, the patient instead recevied intra-thecal methotrexate
   approximately twice per week. Her CSF remained positive for blasts
   until tap on [**2176-4-1**].  She also received a cycle of HyperCVAD. She
   received part A as well as dexamethasone on D11-14 but vincristine was
   not given on D11 due to poor ostomy output and concern for further
   ileus. Peripheral blood smears showed resolution of peripheral blasts
   after 1-2 days of systemic chemotherapy. Her course was complicated by
   mucositis, poorly healing aphthous ulcers and poor po intake secondary
   to pain, which complicated healing and cause electrolyte abnormalities
   requiring significant repletion.  She was changed from oral pain
   medication to a low dose morphine PCA with good effect. She was also
   started on TPN for nutrition and her electrolytes abnormalities
   resolved.
   - f/u cytology of spinal fluid
   - TTE today to evaluate for endocarditis
   - s/p IVIg yesterday
   - continue filgastrim
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis)
   WORSENING FUNCTIONAL STATUS
   Likely secondary to worsening bacteremia. She has been on daptomycin as
   well as micafungin and meropenem. She has not been growing VRE
   recently, but it is possible that she is continuing to have
   complications of VRE through dapto. Gentamicin was added shortly before
   her transfer. Lisinopril was d/c
ed yesterday, suggesting continued
   decline in BP is masked somewhat by d/c
ing antihypertensive, adds to
   this slow-moving but potentially serious likely infectious picture. No
   clear source currently. Still neutropenic but large number of
   metas/myelos/etc may suggest imminent recovery.
   - consider CT torso
 w CTA for PE rule-out
   - aggressive fluid resuscitation, continue to evaluate if this either
   brings down O2 sat (consider fluid overload) and/or brings down tachy,
   brings up BP (c/w sepsis); would expect the latter effect to
   predominate
   - continue dapto/gent
   - additional blood cultures, continue surveillance cultures, CIS
   - UA/Ucx
   - follow blood counts closely
   - continue filgrastim
   - has been getting morphine PCA for pain; would emphasize to only have
   pt trigger PCA given increasingly sedated picture
   - MRA/MRV was c/w clot in SVC but appeared to show collateral
   circulation, no indication of SVC syndrome clinically
   - viral assays
   - sputum cultures
induced sputum
   - echocardiogram tomorrow
   ALL
   Has been getting methotrexate evidently, held [**4-12**] for bacteremia.
   Getting neupogen.
   - continue filgrastim
   - check in w heme/onc re recommendations; in particular, discuss
   question of whether IVIG would be indicated now or in future
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis),
   - CNS tap to evaluate for blasts, new process
   - 4 days ago DLI
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   ICU Care
   Nutrition: nutrition consult for TF recs
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2176-4-14**] 06:30 AM
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with acute lymphoblastic leukemia (ALL) who has been admitted to the ICU with acute-on-chronic poor medical status. She has a history of VRE bacteremia and has been treated with antibiotics, but her condition has continued to deteriorate. She has developed tachypnea, tachycardia, and fever, and has had an asystolic arrest, which was likely caused by calcium channel blockade toxicity. She is currently intubated for hypoxic respiratory failure and is receiving antibiotics to treat her infection.

The patient has a complex medical history, including recurrent bone marrow and CNS disease, and has undergone multiple treatments, including chemotherapy, steroids, and blood transfusions. She has also had a recent episode of mucositis, which has complicated her recovery.

The patient's current condition is characterized by:

* Fever, unknown origin
* Tachypnea and tachycardia
* Asystolic arrest, likely caused by calcium channel blockade toxicity
* Intubation for hypoxic respiratory failure
* Antibiotic treatment for VRE bacteremia
* CSF findings concerning for infection seeding
* Recurrent bone marrow and CNS disease
* History of mucositis

Potential medical complications that can arise from this patient's condition include:

* Sepsis and septic shock
* Respiratory failure
* Cardiac arrhythmias
* Neurological complications, such as seizures or stroke
* Infection seeding of the CSF
* Recurrent bone marrow and CNS disease
* Mucositis and other gastrointestinal complications
* Hypertension and hypotension
* Electrolyte imbalances
* Renal and liver dysfunction

The patient's treatment plan includes:

* Antibiotic therapy for VRE bacteremia
* CSF drainage and culture
* Induced sputum for diagnosis
* TTE for evaluation of endocarditis
* IVIg for immune modulation
* Filgrastim for neutropenia
* Acyclovir, micafungin, and nystatin for prophylaxis against mucositis
* Aggressive fluid resuscitation and hemodynamic monitoring
* Close monitoring of blood counts and electrolyte levels
* Consideration of CT torso and CTA for PE rule-out
* MRA/MRV for evaluation of SVC syndrome
* Echocardiogram for evaluation of cardiac function
* Viral assays for diagnosis of viral infections
* Sputum cultures for diagnosis of respiratory infections
* CNS tap for evaluation of blasts and new process."
112508.0,247400,2176-04-15 07:12:00,Physician ,Physician Attending Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2176-4-14**] 08:07 AM
   MRSA admit swab
 BLOOD CULTURED - At [**2176-4-14**] 02:01 PM
   central line
 URINE CULTURE - At [**2176-4-14**] 02:01 PM
 INVASIVE VENTILATION - START [**2176-4-15**] 01:53 AM
 FEVER - 102.6
F - [**2176-4-14**] 08:00 PM
   - d/w son her current disposition
   - ABG still respiratory alkalosis
   - CSF from shunt:  263 WBC, 94% PMN
   - IVIg x 1 per BMT
   - continuing meropenem, changed gent to cipro for better CSF
   penetration, increased dose of dapto for better CSF penetration
   - nasopharyngeal aspirate negative viral screen
   - induced sputum not done
   - has contrast allergy, got non-contrast CT chest with infiltrate vs
   atelectasis LLL
   - 10-15 beat NSVT, having lots of ectopy, lytes repleted
   - 2400:  SVT to the 170s, given fluid, metoprolol 5 mg IV x 2 followed
   by diltiazem 15 mg IV-->HR fell to 60s, but BP also dropped from SBP
   110 to SBP 60s-70s
   - 0030-0130:  attempting to place radial arterial line unsuccessfully,
   BP on the cuff mostly 60s-80s
   - 0130:  asystole, code blue, regained perfusing rhythm after epi x 2
   mg, atropine x 2mg, 2 amps calcium chloride
   - received 4 grams calcium gluconate + 2 amps calcium chloride for
   presumed calcium channel blocker toxicity, also gave glucagon 5 mg x 1
   for possible component of beta blocker toxicity
   - sedating with fentanyl/midazolam to try to improve vent synchrony
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-14**] 06:30 PM
   Acyclovir - [**2176-4-14**] 06:54 PM
   Micafungin - [**2176-4-14**] 08:17 PM
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Meropenem - [**2176-4-15**] 04:00 AM
   Infusions:
   Phenylephrine - 2 mcg/Kg/min
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 0.5 mg/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-14**] 09:39 AM
   Fentanyl - [**2176-4-15**] 03:08 AM
   Midazolam (Versed) - [**2176-4-15**] 03:09 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-15**] 06:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.2
C (102.6
   Tcurrent: 35.7
C (96.3
   HR: 101 (68 - 139) bpm
   BP: 114/79(87) {76/35(52) - 199/118(122)} mmHg
   RR: 30 (18 - 41) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  5,009 mL
                                                                  3,141 mL
   PO:
             TF:
   IVF:
                                                                  3,456 mL
                                                                  3,128 mL
   Blood products:
                                                                     74 mL
   Total out:
                                                                  3,050 mL
                                                                  1,685 mL
   Urine:
                                                                  3,050 mL
                                                                  1,685 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,959 mL
                                                                  1,456 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   RR (Set): 24
   PEEP: 10 cmH2O
   FiO2: 50%
   RSBI Deferred: PEEP > 10, FiO2 > 60%
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.28/26/269/13/-12
   Ve: 15.9 L/min
   PaO2 / FiO2: 538
   Physical Examination
   General:  intubated, sedated but flickers eyes in reponse to voice
   HEENT:  dry mucous membranes
   Heart:  regular, no audible murmur
   Lungs:  clear anteriorly
   Abdomen:  soft
   Extremities:  cool, distal pulses palpable but thready
   Labs / Radiology
   37 K/uL
   9.8 g/dL
   40 mg/dL
   0.8 mg/dL
   13 mEq/L
   5.0 mEq/L
   23 mg/dL
   117 mEq/L
   142 mEq/L
   30.6 %
   0.9 K/uL
        [image002.jpg]
                             [**2176-4-14**]  04:42 PM
                             [**2176-4-14**]  06:50 PM
                             [**2176-4-14**]  10:44 PM
                             [**2176-4-15**]  01:30 AM
                             [**2176-4-15**]  01:43 AM
                             [**2176-4-15**]  02:47 AM
                             [**2176-4-15**]  03:15 AM
                             [**2176-4-15**]  04:32 AM
                             [**2176-4-15**]  04:50 AM
   WBC
   0.9
   Hct
   26.6
   30.6
   Plt
   37
   Cr
   0.6
   0.3
   0.8
   0.8
   TCO2
   23
   22
   7
   9
   13
   Glucose
   118
   99
   83
   40
   Other labs: PT / PTT / INR:22.5/102.0/2.2, ALT / AST:[**Telephone/Fax (1) 6012**], Alk Phos
   / T Bili:336/1.6, Fibrinogen:784 mg/dL, Lactic Acid:4.7 mmol/L,
   Albumin:2.0 g/dL, LDH:341 IU/L, Ca++:13.4 mg/dL, Mg++:2.1 mg/dL,
   PO4:6.0 mg/dL
   CSF:  263 WBC, 94% PMN, 6 lymphs, 33 RBC, 123 protein, 73 glucose.
   HSV, toxo, CMV, EBV pending
   Non-contrast chest CT:
   1. Peripheral wedge-shaped left upper lobe consolidation, previously
   seen as
   an area of bronchiectasis ([**2169-12-30**]), ground-glass ([**2172-4-8**]), and
   consolidation ([**2172-3-31**]) - findings suggest recurrent infection in a
   region
   of focal bronchiectasis.
   2. New small left and tiny right pleural effusions.
   3. Scattered tree-in-[**Male First Name (un) **] opacities which may represent inflammation or
   infection.
   4. Extensive chest wall and mediastinal collateral vascularization and
   prominence of the azygos vein, likely due to known occlusion of the SVC
   and
   brachiocephalic veins.
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   #) s/p asystolic arrest:  Likely cause was toxicity from calcium
   channel blockade.  Her tachyarthymia may have been secondary to
   sympathetic output from fevers in the setting of a heart compromised by
   prior anthracycline toxicity.  Currently her pupils are reactive and
   she responds to stimulation.
   - monitor electrolytes q6h and replete PRN
   - trend lactate
   - no further nodal agents
   - head CT to evaluate for severe neurologic damage
   .
   #) respiratory failure:  intubated in the peri-code setting.  ABGs
   during the day yesterday indicated primary metabolic alkalosis.
   Possibilities for etiology include intracranial process, drug effect,
   PE.  Could not evaluate for PE yesterday because of reported allergy to
   contrast (patient was unable to define further.)  No obvious drug
   offenders on her list.
   - CT head to evaluate for intracranial process
   - LENIs to evaluate for source of PE
   - wean FiO2 and PEEP as tolerated
   .
   #) hypotension:  blood pressures were very labile prior to the code.
   She is currently requiring a small dose of neo.
   - wean neo as tolerated
   .
   #) fevers:  On ciprofloxacin+dapto+meropenem.  Recent cultures with VRE
   but none since [**4-11**]. CSF findings concerning for infection seeding her
   CSF.  It is possible that her Ommaya is confaminated.  Also would be
   concerned for infected clots given her known upper extremity DVTs
   and/or for cardiac vegetations.  No evidence of septic emboli on lung
   CT yesterday.  Nasopharyngeal aspirate negative, induced sputum to be
   done today.
   - continue antibiotics, changed to improve CSF penetration
   - discuss with ID antibiotic coverage
   - discuss with oncology the possibility of an infected Ommaya
   - TTE to evaluate valves for vegetation
   - f/u CSF studies
   - induced sputum
   .
   #) ALL:  with recent recurrent CNS disease.   This hospitalization she
   was treated with intrathecal chemotherapy and DLI with resolution of
   CSF blasts as of [**2176-4-1**].    Her CSF picture currently
   - f/u cytology of spinal fluid
   - TTE today to evaluate for endocarditis
   - s/p IVIg yesterday
   - continue filgastrim
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis)
   - discuss with
   .
   #) increased LFTs:  appears to be shock liver
   - continue to monitor
   .
   #)  increased urin output:  concerning for DI in the setting of a
   possible intra-cranial process
   - check serum/urine osms
   .
   #) Coagulopathy:  concerning for DIC
   - follow DIC labs q4h today
   - transfuse blood and products PRN
   .
   #)  Hypoglycemia:  noted on morning labs, s/p
 amp d50.  Possibly
   secondary to insulin in TPN, which was stopped overnight.
   - follow FSBG
   - D5
   ICU Care
   Nutrition: nutrition consult for TF recs
   Glycemic Control:
   Lines:   contact IR for arterial line placement today given difficulty
   placing at bedside
   Indwelling Port (PortaCath) - [**2176-4-14**] 06:30 AM
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:  full code (confirmed last night with her healthcare
   proxy)
   Disposition: ICU
   ------ Protected Section ------
   I saw and examined the patient, and was physically present with the ICU
   team for the key portions of the services provided. I agree with Dr
   [**Last Name (STitle) **]
s note, including the assessment and plan. I would emphasize and
   add the following points:
   60 yo F with ALL relapse, transferred to with tachypnea, tachycardia,
   fevers. She received IT methotrexate recently and has an Ommaya shunt.
   VRE bacteremia..  She has a h/o svt/atrial tach with chemo related
   cardiotoxicity. Yesterday had continued resp alkalosis. Ommaya shunt
   tapped
new leukocytosis, neg gram stain, cx pending.  Noncontrast
   chest CT showed LLL infiltrate/atelectasis.  Increased ectopy/svt with
   HR to 160's--without hypotension.  Was given 5 Lopressor IV X 2, 15 IV
   dilt with initial improved rate control then developed hypotension and
   asystolic arrest. Intubated.  Started on Neo. Suspected calcium channel
   blocker toxicity.  Received calcium chloride/gluconate/glucagon.
   102.6-->96.3  68-139  118/60  acv 500/24/10/50%
   perrla, withdraws to touch, but minimally responsive on small amt
   sedated, intubated, coarse, rr tachy, + BS soft, L fem line
   Labs reviewed and noted above
   cxr with diffuse patchy airspace ds r > l, l effusion/atelectasis
   Agree with plan to evaluate with head CT given persistent resp
   alkalosis yesterday, CSF findings, and increased urine output
   concerning for central process (?DI). Awaiting lenis given some concern
   for possible pe contributing to this prior alkalotic picture as has
   contrast allergy and unable to tolerate CTA. Consult neurosurgery about
   whether Ommaya may be contaminated given leukocytosis on tap.  Continue
   broad antibx coverage including csf coverage following id recs and f/u
   all cx data.  Check TTE to reeval for vegetations/sbe.  Potential
   infectious nedis includes also port and known UE DVT as well as pna.
   Continue ACV support and wean neo for maps > 65.  Increased lfts appear
   most c/w shock liver given cardiac arrest
continue to trend.  Given
   elevated INR
follow coags and dic labs.  Hypoglycemia felt [**1-1**] to
   TPN/insulin
now without dedicated port. Continue D5 and follow. Check
   serum/urine osms given increased urine output.  Maintain adequate fluid
   support.   Access is an issue given multiple clotted vessels.   Has IR
   placed fem line 1 PIV, port.  Continue boots, PPI.  Remains full code.
   Remainder as above.
   Critically ill
   Time spent: 50 min
   ------ Protected Section Addendum Entered By:[**Name (NI) 209**] [**Last Name (NamePattern1) 210**], MD
   on:[**2176-4-15**] 06:21 PM ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2176-4-14**] 08:07 AM
   MRSA admit swab
 BLOOD CULTURED - At [**2176-4-14**] 02:01 PM
   central line
 URINE CULTURE - At [**2176-4-14**] 02:01 PM
 INVASIVE VENTILATION - START [**2176-4-15**] 01:53 AM
 FEVER - 102.6
F - [**2176-4-14**] 08:00 PM
   - d/w son her current disposition
   - ABG still respiratory alkalosis
   - CSF from shunt:  263 WBC, 94% PMN
   - IVIg x 1 per BMT
   - continuing meropenem, changed gent to cipro for better CSF
   penetration, increased dose of dapto for better CSF penetration
   - nasopharyngeal aspirate negative viral screen
   - induced sputum not done
   - has contrast allergy, got non-contrast CT chest with infiltrate vs
   atelectasis LLL
   - 10-15 beat NSVT, having lots of ectopy, lytes repleted
   - 2400:  SVT to the 170s, given fluid, metoprolol 5 mg IV x 2 followed
   by diltiazem 15 mg IV-->HR fell to 60s, but BP also dropped from SBP
   110 to SBP 60s-70s
   - 0030-0130:  attempting to place radial arterial line unsuccessfully,
   BP on the cuff mostly 60s-80s
   - 0130:  asystole, code blue, regained perfusing rhythm after epi x 2
   mg, atropine x 2mg, 2 amps calcium chloride
   - received 4 grams calcium gluconate + 2 amps calcium chloride for
   presumed calcium channel blocker toxicity, also gave glucagon 5 mg x 1
   for possible component of beta blocker toxicity
   - sedating with fentanyl/midazolam to try to improve vent synchrony
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-14**] 06:30 PM
   Acyclovir - [**2176-4-14**] 06:54 PM
   Micafungin - [**2176-4-14**] 08:17 PM
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Meropenem - [**2176-4-15**] 04:00 AM
   Infusions:
   Phenylephrine - 2 mcg/Kg/min
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 0.5 mg/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-14**] 09:39 AM
   Fentanyl - [**2176-4-15**] 03:08 AM
   Midazolam (Versed) - [**2176-4-15**] 03:09 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-15**] 06:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.2
C (102.6
   Tcurrent: 35.7
C (96.3
   HR: 101 (68 - 139) bpm
   BP: 114/79(87) {76/35(52) - 199/118(122)} mmHg
   RR: 30 (18 - 41) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  5,009 mL
                                                                  3,141 mL
   PO:
             TF:
   IVF:
                                                                  3,456 mL
                                                                  3,128 mL
   Blood products:
                                                                     74 mL
   Total out:
                                                                  3,050 mL
                                                                  1,685 mL
   Urine:
                                                                  3,050 mL
                                                                  1,685 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,959 mL
                                                                  1,456 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   RR (Set): 24
   PEEP: 10 cmH2O
   FiO2: 50%
   RSBI Deferred: PEEP > 10, FiO2 > 60%
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.28/26/269/13/-12
   Ve: 15.9 L/min
   PaO2 / FiO2: 538
   Physical Examination
   General:  intubated, sedated but flickers eyes in reponse to voice
   HEENT:  dry mucous membranes
   Heart:  regular, no audible murmur
   Lungs:  clear anteriorly
   Abdomen:  soft
   Extremities:  cool, distal pulses palpable but thready
   Labs / Radiology
   37 K/uL
   9.8 g/dL
   40 mg/dL
   0.8 mg/dL
   13 mEq/L
   5.0 mEq/L
   23 mg/dL
   117 mEq/L
   142 mEq/L
   30.6 %
   0.9 K/uL
        [image002.jpg]
                             [**2176-4-14**]  04:42 PM
                             [**2176-4-14**]  06:50 PM
                             [**2176-4-14**]  10:44 PM
                             [**2176-4-15**]  01:30 AM
                             [**2176-4-15**]  01:43 AM
                             [**2176-4-15**]  02:47 AM
                             [**2176-4-15**]  03:15 AM
                             [**2176-4-15**]  04:32 AM
                             [**2176-4-15**]  04:50 AM
   WBC
   0.9
   Hct
   26.6
   30.6
   Plt
   37
   Cr
   0.6
   0.3
   0.8
   0.8
   TCO2
   23
   22
   7
   9
   13
   Glucose
   118
   99
   83
   40
   Other labs: PT / PTT / INR:22.5/102.0/2.2, ALT / AST:[**Telephone/Fax (1) 6012**], Alk Phos
   / T Bili:336/1.6, Fibrinogen:784 mg/dL, Lactic Acid:4.7 mmol/L,
   Albumin:2.0 g/dL, LDH:341 IU/L, Ca++:13.4 mg/dL, Mg++:2.1 mg/dL,
   PO4:6.0 mg/dL
   CSF:  263 WBC, 94% PMN, 6 lymphs, 33 RBC, 123 protein, 73 glucose.
   HSV, toxo, CMV, EBV pending
   Non-contrast chest CT:
   1. Peripheral wedge-shaped left upper lobe consolidation, previously
   seen as
   an area of bronchiectasis ([**2169-12-30**]), ground-glass ([**2172-4-8**]), and
   consolidation ([**2172-3-31**]) - findings suggest recurrent infection in a
   region
   of focal bronchiectasis.
   2. New small left and tiny right pleural effusions.
   3. Scattered tree-in-[**Male First Name (un) **] opacities which may represent inflammation or
   infection.
   4. Extensive chest wall and mediastinal collateral vascularization and
   prominence of the azygos vein, likely due to known occlusion of the SVC
   and
   brachiocephalic veins.
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   #) s/p asystolic arrest:  Likely cause was toxicity from calcium
   channel blockade.  Her tachyarthymia may have been secondary to
   sympathetic output from fevers in the setting of a heart compromised by
   prior anthracycline toxicity.  Currently her pupils are reactive and
   she responds to stimulation.
   - monitor electrolytes q6h and replete PRN
   - trend lactate
   - no further nodal agents
   - head CT to evaluate for severe neurologic damage
   .
   #) respiratory failure:  intubated in the peri-code setting.  ABGs
   during the day yesterday indicated primary metabolic alkalosis.
   Possibilities for etiology include intracranial process, drug effect,
   PE.  Could not evaluate for PE yesterday because of reported allergy to
   contrast (patient was unable to define further.)  No obvious drug
   offenders on her list.
   - CT head to evaluate for intracranial process
   - LENIs to evaluate for source of PE
   - wean FiO2 and PEEP as tolerated
   .
   #) hypotension:  blood pressures were very labile prior to the code.
   She is currently requiring a small dose of neo.
   - wean neo as tolerated
   .
   #) fevers:  On ciprofloxacin+dapto+meropenem.  Recent cultures with VRE
   but none since [**4-11**]. CSF findings concerning for infection seeding her
   CSF.  It is possible that her Ommaya is confaminated.  Also would be
   concerned for infected clots given her known upper extremity DVTs
   and/or for cardiac vegetations.  No evidence of septic emboli on lung
   CT yesterday.  Nasopharyngeal aspirate negative, induced sputum to be
   done today.
   - continue antibiotics, changed to improve CSF penetration
   - discuss with ID antibiotic coverage
   - discuss with oncology the possibility of an infected Ommaya
   - TTE to evaluate valves for vegetation
   - f/u CSF studies
   - induced sputum
   .
   #) ALL:  with recent recurrent CNS disease.   This hospitalization she
   was treated with intrathecal chemotherapy and DLI with resolution of
   CSF blasts as of [**2176-4-1**].    Her CSF picture currently
   - f/u cytology of spinal fluid
   - TTE today to evaluate for endocarditis
   - s/p IVIg yesterday
   - continue filgastrim
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis)
   - discuss with
   .
   #) increased LFTs:  appears to be shock liver
   - continue to monitor
   .
   #)  increased urin output:  concerning for DI in the setting of a
   possible intra-cranial process
   - check serum/urine osms
   .
   #) Coagulopathy:  concerning for DIC
   - follow DIC labs q4h today
   - transfuse blood and products PRN
   .
   #)  Hypoglycemia:  noted on morning labs, s/p
 amp d50.  Possibly
   secondary to insulin in TPN, which was stopped overnight.
   - follow FSBG
   - D5
   ICU Care
   Nutrition: nutrition consult for TF recs
   Glycemic Control:
   Lines:   contact IR for arterial line placement today given difficulty
   placing at bedside
   Indwelling Port (PortaCath) - [**2176-4-14**] 06:30 AM
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:  full code (confirmed last night with her healthcare
   proxy)
   Disposition: ICU
   ------ Protected Section ------
   I saw and examined the patient, and was physically present with the ICU
   team for the key portions of the services provided. I agree with Dr
   [**Last Name (STitle) **]
s note, including the assessment and plan. I would emphasize and
   add the following points:
   60 yo F with ALL relapse, transferred to with tachypnea, tachycardia,
   fevers. She received IT methotrexate recently and has an Ommaya shunt.
   VRE bacteremia..  She has a h/o svt/atrial tach with chemo related
   cardiotoxicity. Yesterday had continued resp alkalosis. Ommaya shunt
   tapped
new leukocytosis, neg gram stain, cx pending.  Noncontrast
   chest CT showed LLL infiltrate/atelectasis.  Increased ectopy/svt with
   HR to 160's--without hypotension.  Was given 5 Lopressor IV X 2, 15 IV
   dilt with initial improved rate control then developed hypotension and
   asystolic arrest. Intubated.  Started on Neo. Suspected calcium channel
   blocker toxicity.  Received calcium chloride/gluconate/glucagon.
   102.6-->96.3  68-139  118/60  acv 500/24/10/50%
   perrla, withdraws to touch, but minimally responsive on small amt
   sedated, intubated, coarse, rr tachy, + BS soft, L fem line
   Labs reviewed and noted above
   cxr with diffuse patchy airspace ds r > l, l effusion/atelectasis
   Agree with plan to evaluate with head CT given persistent resp
   alkalosis yesterday, CSF findings, and increased urine output
   concerning for central process (?DI). Awaiting lenis given some concern
   for possible pe contributing to this prior alkalotic picture as has
   contrast allergy and unable to tolerate CTA. Consult neurosurgery about
   whether Ommaya may be contaminated given leukocytosis on tap.  Continue
   broad antibx coverage including csf coverage following id recs and f/u
   all cx data.  Check TTE to reeval for vegetations/sbe.  Potential
   infectious nedis includes also port and known UE DVT as well as pna.
   Continue ACV support and wean neo for maps > 65.  Increased lfts appear
   most c/w shock liver given cardiac arrest
continue to trend.  Given
   elevated INR
follow coags and dic labs.  Hypoglycemia felt [**1-1**] to
   TPN/insulin
now without dedicated port. Continue D5 and follow. Check
   serum/urine osms given increased urine output.  Maintain adequate fluid
   support.   Access is an issue given multiple clotted vessels.   Has IR
   placed fem line 1 PIV, port.  Continue boots, PPI.  Remains full code.
   Remainder as above.
   Critically ill
   Time spent: 50 min
   ------ Protected Section Addendum Entered By:[**Name (NI) 209**] [**Last Name (NamePattern1) 210**], MD
   on:[**2176-4-15**] 06:21 PM ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

**Summary:**

The patient is a 60-year-old woman with acute lymphoblastic leukemia (ALL) who was admitted to the ICU with acute-on-chronic poor medical status, increasing tachypnea, tachycardia, and temperature. She has a history of VRE bacteremia and recent recurrent CNS disease. She was treated with intrathecal chemotherapy and DLI, resulting in resolution of CSF blasts. She has an Ommaya shunt, which was tapped with new leukocytosis, negative gram stain, and pending cultures.

**Potential Medical Complications:**

1. **Central Nervous System (CNS) Infection:** The patient's CSF findings are concerning for infection seeding her CSF. The possibility of an infected Ommaya shunt, cardiac vegetations, and septic emboli should be considered.
2. **Respiratory Failure:** The patient's respiratory status is compromised, with persistent respiratory alkalosis, and she is intubated. The etiology of her respiratory failure is unclear, and a head CT to evaluate for intracranial process is recommended.
3. **Hypotension:** The patient's blood pressure was labile prior to the code, and she is currently requiring a small dose of neosynephrine. Weaning of neosynephrine should be done carefully.
4. **Fever:** The patient's fever is unknown in origin and is being treated with antibiotics. The possibility of infected clots, cardiac vegetations, or septic emboli should be considered.
5. **Coagulopathy:** The patient's INR is elevated, and she has a history of shock liver. Monitoring of coagulation studies and transfusion of blood products as needed is recommended.
6. **Hypoglycemia:** The patient's hypoglycemia may be related to insulin in her TPN, which was stopped overnight. Monitoring of blood glucose levels and provision of D5 as needed is recommended.
7. **Increased Urine Output:** The patient's increased urine output may be related to a central process, such as diabetes insipidus, or a nephrotoxic medication. Serum and urine osmolarities should be checked to evaluate for diabetes insipidus.
8. **Port Infection:** The patient's port is a potential source of infection, and consultation with ID and oncology is recommended to evaluate the possibility of port infection.

**Recommendations:**

1. Continue broad antibiotic coverage, including CSF coverage, following ID recommendations.
2. Evaluate the patient's Ommaya shunt for contamination.
3. Perform a head CT to evaluate for intracranial process.
4. Monitor the patient's coagulation studies and transfuse blood products as needed.
5. Wean neosynephrine carefully to avoid hypotension.
6. Monitor the patient's blood glucose levels and provide D5 as needed.
7. Check serum and urine osmolarities to evaluate for diabetes insipidus.
8. Maintain adequate fluid support to prevent dehydration.
9. Consult with ID and oncology to evaluate the possibility of port infection.
10. Consider performing a TTE to evaluate for vegetations or septic emboli."
112508.0,247400,2176-04-16 11:59:00,Physician ,Physician Resident Progress Note,"Chief Complaint: VRE infection associated with Omaya port, s/p
   neurosurgical procedure to remove port
   24 Hour Events:
 TRANS ESOPHAGEAL ECHO - At [**2176-4-15**] 12:49 PM
   Read: ""The left atrium is normal in size. No atrial septal defect is
   seen by 2D or color Doppler. Left ventricular wall thicknesses and
   cavity size are normal. There is severe global left ventricular
   hypokinesis (LVEF = 20 %). No masses or thrombi are seen in the left
   ventricle. There is no ventricular septal defect. Right ventricular
   chamber size is normal. with mild global free wall hypokinesis. The
   aortic valve leaflets (3) are mildly thickened but aortic stenosis is
   not present. No masses or vegetations are seen on the aortic valve. No
   aortic regurgitation is seen. The mitral valve leaflets are mildly
   thickened. No mass or vegetation is seen on the mitral valve. Mild (1+)
   mitral regurgitation is seen. The pulmonary artery systolic pressure
   could not be determined. There is a small pericardial effusion. There
   are no echocardiographic signs of tamponade.  IMPRESSION:
   Cardiomyopathy. No valvular vegetations seen.""
 ULTRASOUND - At [**2176-4-15**] 01:50 PM
   No DVT.
 OR SENT - At [**2176-4-15**] 09:30 PM
   Pt transferred from [**Hospital Ward Name 77**] 4 and arrived on unit at 2045.  Anesthesia
   and neuro sug up to unit and escorted pt to OR at 2130.
 OR RECEIVED - At [**2176-4-15**] 11:45 PM
   No op note in OMR at time of re-admission to [**Hospital Unit Name 10**]; per brief chart
   note, operation involved:
   * removal of Omaya port (PATHOLOGY # [**-7/1942**])
   * craniotomy for exploration and evacuation of SDH
   Note reports no significant blood loss
   2 units RBC and 2 units FFP given
   Culture sent, NGTD; gram stain showed:
      GRAM STAIN (Final [**2176-4-16**]):
         2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
         2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                       IN PAIRS.
 ARTERIAL LINE - START [**2176-4-16**] 12:48 AM
   History obtained from Medical records
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Linezolid - [**2176-4-16**] 02:17 PM
   Meropenem - [**2176-4-16**] 03:54 PM
   Gentamicin - [**2176-4-16**] 10:05 PM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Metoprolol - [**2176-4-16**] 03:00 AM
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-17**] 12:44 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 99 (98 - 128) bpm
   BP: 117/81(95) {98/66(79) - 146/101(119)} mmHg
   RR: 26 (16 - 39) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  6,475 mL
                                                                     40 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                     40 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                      0 mL
   Urine:
                                                                  1,395 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                     40 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 131
   RSBI Deferred: No Spon Resp
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   Compliance: 34.6 cmH2O/mL
   SpO2: 99%
   ABG: 7.50/26/135/17/0  (TAKEN 10:50 am [**4-15**])
   Ve: 9.7 L/min
   PaO2 / FiO2: 270
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, No(t) Sclera edema, pupils from 3 mm to 1 mm
   in setting of sedation
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ),
   in limited anterior exam
   Abdominal: Bowel sounds present, Distended
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, Rash: some mild erythematous rash on upper chest, none
   seen on torso, no morbilliform rash
   Neurologic: Responds to: Noxious stimuli, Movement: Not assessed,
   Sedated
   Labs / Radiology
   116 K/uL
   9.9 g/dL
   109 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.1 mEq/L
   33 mg/dL
   112 mEq/L
   143 mEq/L
   27.2 %
   4.2 K/uL
        [image002.jpg]
                             [**2176-4-15**]  09:34 AM
                             [**2176-4-15**]  03:56 PM
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
   WBC
   3.5
   3.1
   4.2
   4.2
   Hct
   26.1
   19
   25.9
   30.0
   27.2
   Plt
   54
   128
   120
   116
   Cr
   0.9
   1.0
   1.0
   TCO2
   20
   21
   19
   20
   21
   Glucose
   82
   71
   84
   109
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:288/3.5, Amylase / Lipase:250/111, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.4 mmol/L, Albumin:2.0 g/dL, LDH:5880 IU/L, Ca++:8.0
   mg/dL, Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication: ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: VRE infection associated with Omaya port, s/p
   neurosurgical procedure to remove port
   24 Hour Events:
 TRANS ESOPHAGEAL ECHO - At [**2176-4-15**] 12:49 PM
   Read: ""The left atrium is normal in size. No atrial septal defect is
   seen by 2D or color Doppler. Left ventricular wall thicknesses and
   cavity size are normal. There is severe global left ventricular
   hypokinesis (LVEF = 20 %). No masses or thrombi are seen in the left
   ventricle. There is no ventricular septal defect. Right ventricular
   chamber size is normal. with mild global free wall hypokinesis. The
   aortic valve leaflets (3) are mildly thickened but aortic stenosis is
   not present. No masses or vegetations are seen on the aortic valve. No
   aortic regurgitation is seen. The mitral valve leaflets are mildly
   thickened. No mass or vegetation is seen on the mitral valve. Mild (1+)
   mitral regurgitation is seen. The pulmonary artery systolic pressure
   could not be determined. There is a small pericardial effusion. There
   are no echocardiographic signs of tamponade.  IMPRESSION:
   Cardiomyopathy. No valvular vegetations seen.""
 ULTRASOUND - At [**2176-4-15**] 01:50 PM
   No DVT.
 OR SENT - At [**2176-4-15**] 09:30 PM
   Pt transferred from [**Hospital Ward Name 77**] 4 and arrived on unit at 2045.  Anesthesia
   and neuro sug up to unit and escorted pt to OR at 2130.
 OR RECEIVED - At [**2176-4-15**] 11:45 PM
   No op note in OMR at time of re-admission to [**Hospital Unit Name 10**]; per brief chart
   note, operation involved:
   * removal of Omaya port (PATHOLOGY # [**-7/1942**])
   * craniotomy for exploration and evacuation of SDH
   Note reports no significant blood loss
   2 units RBC and 2 units FFP given
   Culture sent, NGTD; gram stain showed:
      GRAM STAIN (Final [**2176-4-16**]):
         2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
         2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                       IN PAIRS.
 ARTERIAL LINE - START [**2176-4-16**] 12:48 AM
   History obtained from Medical records
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Linezolid - [**2176-4-16**] 02:17 PM
   Meropenem - [**2176-4-16**] 03:54 PM
   Gentamicin - [**2176-4-16**] 10:05 PM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Metoprolol - [**2176-4-16**] 03:00 AM
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-17**] 12:44 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 99 (98 - 128) bpm
   BP: 117/81(95) {98/66(79) - 146/101(119)} mmHg
   RR: 26 (16 - 39) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  6,475 mL
                                                                     40 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                     40 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                      0 mL
   Urine:
                                                                  1,395 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                     40 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 131
   RSBI Deferred: No Spon Resp
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   Compliance: 34.6 cmH2O/mL
   SpO2: 99%
   ABG: 7.50/26/135/17/0  (TAKEN 10:50 am [**4-15**])
   Ve: 9.7 L/min
   PaO2 / FiO2: 270
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, No(t) Sclera edema, pupils from 3 mm to 1 mm
   in setting of sedation
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ),
   in limited anterior exam
   Abdominal: Bowel sounds present, Distended
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, Rash: some mild erythematous rash on upper chest, none
   seen on torso, no morbilliform rash
   Neurologic: Responds to: Noxious stimuli, Movement: Not assessed,
   Sedated
   Labs / Radiology
   116 K/uL
   9.9 g/dL
   109 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.1 mEq/L
   33 mg/dL
   112 mEq/L
   143 mEq/L
   27.2 %
   4.2 K/uL
        [image002.jpg]
                             [**2176-4-15**]  09:34 AM
                             [**2176-4-15**]  03:56 PM
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
   WBC
   3.5
   3.1
   4.2
   4.2
   Hct
   26.1
   19
   25.9
   30.0
   27.2
   Plt
   54
   128
   120
   116
   Cr
   0.9
   1.0
   1.0
   TCO2
   20
   21
   19
   20
   21
   Glucose
   82
   71
   84
   109
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:288/3.5, Amylase / Lipase:250/111, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.4 mmol/L, Albumin:2.0 g/dL, LDH:5880 IU/L, Ca++:8.0
   mg/dL, Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication: ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) and recurrent CNS involvement. She was admitted to the ICU with a VRE infection associated with an Omaya port, which was removed during a neurosurgical procedure. The patient has a cardiomyopathy with severe global left ventricular hypokinesis, mild mitral regurgitation, and a small pericardial effusion. She is receiving various medications, including antibiotics, and has undergone several procedures, including a craniotomy and evacuation of a subdural hematoma.

Potential Medical Complications:

1. Cardiac complications: The patient's cardiomyopathy and hypokinesis may lead to cardiac failure, arrhythmias, or cardiac arrest.
2. Infection: The patient has a VRE infection, which may spread to other parts of the body, such as the bloodstream or lungs.
3. Respiratory failure: The patient's cardiomyopathy and hypokinesis may lead to respiratory failure, particularly if there is a significant increase in fluid buildup in the lungs.
4. Neurological complications: The patient's history of CNS involvement and the recent craniotomy and evacuation of a subdural hematoma may lead to neurological complications, such as seizures, stroke, or brain edema.
5. Coagulopathy: The patient's history of leukemia and the use of anticoagulant medications may increase the risk of bleeding or coagulopathy.
6. Nutritional deficiencies: The patient's inability to eat and drink may lead to malnutrition and electrolyte imbalances.
7. Gastrointestinal complications: The patient's history of chemotherapy and the use of antacids may lead to gastrointestinal complications, such as nausea, vomiting, or diarrhea.
8. Thrombocytopenia: The patient's history of leukemia and the use of chemotherapy may lead to thrombocytopenia, which may increase the risk of bleeding.

It is essential to monitor the patient's condition closely and adjust her treatment plan accordingly to prevent or manage these potential complications."
112508.0,247400,2176-04-16 23:59:00,Physician ,Physician Resident Progress Note,"ACCEPT NOTE:
   Ms. [**Known lastname 5996**] was transferred back to the [**Hospital Unit Name 10**] from [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **]
   MICU/SICU after being transferred from the [**Hospital Unit Name 10**] to the [**Hospital Ward Name **] for
   neurosurgical intervention, detailed below. Metavision vitals reflect
   the 24 hour period of [**4-16**] essentially midnight-to-midnight. She was
   transferred to the [**Hospital Unit Name 10**] earlier in the evening, and remained stable
   during this time. This note is written reflecting my exam at that time
   and reflecting re-exam at 2330.
   Chief Complaint: VRE infection associated with Omaya port, s/p
   neurosurgical procedure to remove port
   24 Hour Events:
 TRANS ESOPHAGEAL ECHO - At [**2176-4-15**] 12:49 PM
   Read: ""The left atrium is normal in size. No atrial septal defect is
   seen by 2D or color Doppler. Left ventricular wall thicknesses and
   cavity size are normal. There is severe global left ventricular
   hypokinesis (LVEF = 20 %). No masses or thrombi are seen in the left
   ventricle. There is no ventricular septal defect. Right ventricular
   chamber size is normal. with mild global free wall hypokinesis. The
   aortic valve leaflets (3) are mildly thickened but aortic stenosis is
   not present. No masses or vegetations are seen on the aortic valve. No
   aortic regurgitation is seen. The mitral valve leaflets are mildly
   thickened. No mass or vegetation is seen on the mitral valve. Mild (1+)
   mitral regurgitation is seen. The pulmonary artery systolic pressure
   could not be determined. There is a small pericardial effusion. There
   are no echocardiographic signs of tamponade.  IMPRESSION:
   Cardiomyopathy. No valvular vegetations seen.""
 ULTRASOUND - At [**2176-4-15**] 01:50 PM
   No DVT.
 OR SENT - At [**2176-4-15**] 09:30 PM
   Pt transferred from [**Hospital Ward Name 77**] 4 and arrived on unit at 2045.  Anesthesia
   and neuro sug up to unit and escorted pt to OR at 2130.
 OR RECEIVED - At [**2176-4-15**] 11:45 PM
   No op note in OMR at time of re-admission to [**Hospital Unit Name 10**]; per brief chart
   note, operation involved:
   * removal of Omaya port (PATHOLOGY # [**-7/1942**])
   * craniotomy for exploration and evacuation of SDH
   Note reports no significant blood loss
   2 units RBC and 2 units FFP given
   CSF culture sent, NGTD; gram stain showed:
      GRAM STAIN (Final [**2176-4-16**]):
         2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
         2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                       IN PAIRS.
 ARTERIAL LINE - START [**2176-4-16**] 12:48 AM
   History obtained from Medical records
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Linezolid - [**2176-4-16**] 02:17 PM
   Meropenem - [**2176-4-16**] 03:54 PM
   Gentamicin - [**2176-4-16**] 10:05 PM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Metoprolol - [**2176-4-16**] 03:00 AM
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-17**] 00:44 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 99 (98 - 128) bpm
   BP: 117/81(95) {98/66(79) - 146/101(119)} mmHg
   RR: 26 (16 - 39) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  6,475 mL
                                                                     40 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                     40 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                      0 mL
   Urine:
                                                                  1,395 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                     40 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 131
   RSBI Deferred: No Spon Resp
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   Compliance: 34.6 cmH2O/mL
   SpO2: 99%
   ABG: 7.50/26/135/17/0  (TAKEN 10:50 am [**4-15**])
   Ve: 9.7 L/min
   PaO2 / FiO2: 270
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, No(t) Sclera edema, pupils from 3 mm to 1 mm
   in setting of sedation
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ),
   in limited anterior exam
   Abdominal: Bowel sounds present, Distended; Ostomy in place w
   protuberant ostomy, dark tea-colored fluid in bag. Femoral line in
   place as prior; no infectious signs at line site
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, Rash: some mild erythematous rash on upper chest, none
   seen on torso, no morbilliform rash
   Neurologic: Responds to: Noxious stimuli, Movement: Not assessed,
   Sedated
   Labs / Radiology
   116 K/uL
   9.9 g/dL
   109 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.1 mEq/L
   33 mg/dL
   112 mEq/L
   143 mEq/L
   27.2 %
   4.2 K/uL
        [image002.jpg]
                             [**2176-4-15**]  09:34 AM
                             [**2176-4-15**]  03:56 PM
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
   WBC
   3.5
   3.1
   4.2
   4.2
   Hct
   26.1
   19
   25.9
   30.0
   27.2
   Plt
   54
   128
   120
   116
   Cr
   0.9
   1.0
   1.0
   TCO2
   20
   21
   19
   20
   21
   Glucose
   82
   71
   84
   109
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:288/3.5, Amylase / Lipase:250/111, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.4 mmol/L, Albumin:2.0 g/dL, LDH:5880 IU/L, Ca++:8.0
   mg/dL, Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   ALTERED MENTAL STATUS
   CNS involvement by ALL as well as by enterococcus in association with
   the Omaya port, and SDH of chronic appearance seen on head CT s/p
   cardiac arrest, now s/p neurosurgical procedure as above. In
   retrospect, the subdural hematoma and gram-positive (likely
   enterococcal) infection may have been responsible for a considerable
   portion of what was described on her prior arrival to the [**Hospital Unit Name 10**] as
poor
   functional status
a vague worsening of cognition and function
   consistent with a diffuse cerebral process. Neurological exam currently
   showing promptly reactive pupils and some retreat of feet to noxious
   stimuli, but otherwise non-responsive in setting of sedation on vent.
   Assessment of neuro status confounded somewhat by her cardiac arrest,
   which may have created some anoxic brain injury.
   -          follow up neurosurgical recommendations
   -          continue to follow neurological exam
   -          titrate down sedation as tolerated, continue to evaluate
   mental status closely in this setting
   -          follow up CNS cultures, culture from Omaya device
   -          continue antibiotics as detailed below.
   -          Discuss w BMT service whether there are criteria that would
   allow return to treatment of CNS disease; may simply require ongoing
   assessment of relative risks and benefits in context
   [**Name (NI) 6041**] INFECTION, c/w VRE
   Per ID recommendations, linezolid superior to daptomycin for coverage
   of CNS infection. Has the unfortunate advantage of suppressing bone
   marrow in immune-compromised patient. Immediate treatment of infection
   is current priority. Should continue to weigh risks and benefits of
   anti-VRE abx choice.
   -          continue linezolid with gentamicin
   ALL
   Lengthy history with ALL, now recurring. S/p donor lymphocyte infusion.
   Giving G-CSF. Will need treatment for CNS disease at some point.
   -          follow up BMT recommendations
   -          has extensive medications for symptomatic treatment of
   mucositis and esophagitis; continue for now but continue to evaluate
   oral health, consider d/c
ing in setting of ventilation
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication: ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

ACCEPT NOTE:
   Ms. [**Known lastname 5996**] was transferred back to the [**Hospital Unit Name 10**] from [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **]
   MICU/SICU after being transferred from the [**Hospital Unit Name 10**] to the [**Hospital Ward Name **] for
   neurosurgical intervention, detailed below. Metavision vitals reflect
   the 24 hour period of [**4-16**] essentially midnight-to-midnight. She was
   transferred to the [**Hospital Unit Name 10**] earlier in the evening, and remained stable
   during this time. This note is written reflecting my exam at that time
   and reflecting re-exam at 2330.
   Chief Complaint: VRE infection associated with Omaya port, s/p
   neurosurgical procedure to remove port
   24 Hour Events:
 TRANS ESOPHAGEAL ECHO - At [**2176-4-15**] 12:49 PM
   Read: ""The left atrium is normal in size. No atrial septal defect is
   seen by 2D or color Doppler. Left ventricular wall thicknesses and
   cavity size are normal. There is severe global left ventricular
   hypokinesis (LVEF = 20 %). No masses or thrombi are seen in the left
   ventricle. There is no ventricular septal defect. Right ventricular
   chamber size is normal. with mild global free wall hypokinesis. The
   aortic valve leaflets (3) are mildly thickened but aortic stenosis is
   not present. No masses or vegetations are seen on the aortic valve. No
   aortic regurgitation is seen. The mitral valve leaflets are mildly
   thickened. No mass or vegetation is seen on the mitral valve. Mild (1+)
   mitral regurgitation is seen. The pulmonary artery systolic pressure
   could not be determined. There is a small pericardial effusion. There
   are no echocardiographic signs of tamponade.  IMPRESSION:
   Cardiomyopathy. No valvular vegetations seen.""
 ULTRASOUND - At [**2176-4-15**] 01:50 PM
   No DVT.
 OR SENT - At [**2176-4-15**] 09:30 PM
   Pt transferred from [**Hospital Ward Name 77**] 4 and arrived on unit at 2045.  Anesthesia
   and neuro sug up to unit and escorted pt to OR at 2130.
 OR RECEIVED - At [**2176-4-15**] 11:45 PM
   No op note in OMR at time of re-admission to [**Hospital Unit Name 10**]; per brief chart
   note, operation involved:
   * removal of Omaya port (PATHOLOGY # [**-7/1942**])
   * craniotomy for exploration and evacuation of SDH
   Note reports no significant blood loss
   2 units RBC and 2 units FFP given
   CSF culture sent, NGTD; gram stain showed:
      GRAM STAIN (Final [**2176-4-16**]):
         2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
         2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                       IN PAIRS.
 ARTERIAL LINE - START [**2176-4-16**] 12:48 AM
   History obtained from Medical records
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Linezolid - [**2176-4-16**] 02:17 PM
   Meropenem - [**2176-4-16**] 03:54 PM
   Gentamicin - [**2176-4-16**] 10:05 PM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Metoprolol - [**2176-4-16**] 03:00 AM
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-17**] 00:44 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 99 (98 - 128) bpm
   BP: 117/81(95) {98/66(79) - 146/101(119)} mmHg
   RR: 26 (16 - 39) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  6,475 mL
                                                                     40 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                     40 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                      0 mL
   Urine:
                                                                  1,395 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                     40 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 131
   RSBI Deferred: No Spon Resp
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   Compliance: 34.6 cmH2O/mL
   SpO2: 99%
   ABG: 7.50/26/135/17/0  (TAKEN 10:50 am [**4-15**])
   Ve: 9.7 L/min
   PaO2 / FiO2: 270
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, No(t) Sclera edema, pupils from 3 mm to 1 mm
   in setting of sedation
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ),
   in limited anterior exam
   Abdominal: Bowel sounds present, Distended; Ostomy in place w
   protuberant ostomy, dark tea-colored fluid in bag. Femoral line in
   place as prior; no infectious signs at line site
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, Rash: some mild erythematous rash on upper chest, none
   seen on torso, no morbilliform rash
   Neurologic: Responds to: Noxious stimuli, Movement: Not assessed,
   Sedated
   Labs / Radiology
   116 K/uL
   9.9 g/dL
   109 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.1 mEq/L
   33 mg/dL
   112 mEq/L
   143 mEq/L
   27.2 %
   4.2 K/uL
        [image002.jpg]
                             [**2176-4-15**]  09:34 AM
                             [**2176-4-15**]  03:56 PM
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
   WBC
   3.5
   3.1
   4.2
   4.2
   Hct
   26.1
   19
   25.9
   30.0
   27.2
   Plt
   54
   128
   120
   116
   Cr
   0.9
   1.0
   1.0
   TCO2
   20
   21
   19
   20
   21
   Glucose
   82
   71
   84
   109
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:288/3.5, Amylase / Lipase:250/111, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.4 mmol/L, Albumin:2.0 g/dL, LDH:5880 IU/L, Ca++:8.0
   mg/dL, Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   ALTERED MENTAL STATUS
   CNS involvement by ALL as well as by enterococcus in association with
   the Omaya port, and SDH of chronic appearance seen on head CT s/p
   cardiac arrest, now s/p neurosurgical procedure as above. In
   retrospect, the subdural hematoma and gram-positive (likely
   enterococcal) infection may have been responsible for a considerable
   portion of what was described on her prior arrival to the [**Hospital Unit Name 10**] as
poor
   functional status
a vague worsening of cognition and function
   consistent with a diffuse cerebral process. Neurological exam currently
   showing promptly reactive pupils and some retreat of feet to noxious
   stimuli, but otherwise non-responsive in setting of sedation on vent.
   Assessment of neuro status confounded somewhat by her cardiac arrest,
   which may have created some anoxic brain injury.
   -          follow up neurosurgical recommendations
   -          continue to follow neurological exam
   -          titrate down sedation as tolerated, continue to evaluate
   mental status closely in this setting
   -          follow up CNS cultures, culture from Omaya device
   -          continue antibiotics as detailed below.
   -          Discuss w BMT service whether there are criteria that would
   allow return to treatment of CNS disease; may simply require ongoing
   assessment of relative risks and benefits in context
   [**Name (NI) 6041**] INFECTION, c/w VRE
   Per ID recommendations, linezolid superior to daptomycin for coverage
   of CNS infection. Has the unfortunate advantage of suppressing bone
   marrow in immune-compromised patient. Immediate treatment of infection
   is current priority. Should continue to weigh risks and benefits of
   anti-VRE abx choice.
   -          continue linezolid with gentamicin
   ALL
   Lengthy history with ALL, now recurring. S/p donor lymphocyte infusion.
   Giving G-CSF. Will need treatment for CNS disease at some point.
   -          follow up BMT recommendations
   -          has extensive medications for symptomatic treatment of
   mucositis and esophagitis; continue for now but continue to evaluate
   oral health, consider d/c
ing in setting of ventilation
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication: ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) and past successful treatment of this, now with recurrence including central nervous system (CNS) involvement. She was admitted to the intensive care unit (ICU) with a chief complaint of VRE infection associated with an Omaya port, which was removed during a neurosurgical procedure.

The patient's 24-hour events include a transesophageal echo, which showed severe global left ventricular hypokinesis with an ejection fraction of 20%. An ultrasound revealed no deep vein thrombosis (DVT). She was transferred to the ICU for further care and continued follow-up by both the ICU team and the bone marrow transplant (BMT) team.

The patient's current vital signs are:

* Temperature: 37.4°C (99.4°F)
* Heart rate: 99 beats per minute (98-128)
* Blood pressure: 117/81 mmHg (95-146/101)
* Respiratory rate: 26 breaths per minute (16-39)
* Oxygen saturation: 99%
* Heart rhythm: Sinus rhythm

The patient is receiving various medications, including antibiotics for the VRE infection, and has undergone several procedures, including the removal of the Omaya port and evacuation of a subdural hematoma.

The patient's laboratory results show:

* White blood cell count: 3.5 x 10^9/L
* Hemoglobin: 9.9 g/dL
* Platelet count: 54 x 10^9/L
* Creatinine: 0.9 mg/dL
* Glucose: 82 mg/dL
* Albumin: 2.0 g/dL
* Lactic acid: 2.4 mmol/L
* Calcium: 8.0 mg/dL
* Magnesium: 1.8 mg/dL
* Phosphorus: 2.9 mg/dL

The patient's assessment and plan include:

* Altered mental status
* Fever, unknown origin
* CNS involvement by ALL and enterococcus
* Subdural hematoma and gram-positive (likely enterococcal) infection
* Neurological exam showing promptly reactive pupils and some retreat of feet to noxious stimuli, but otherwise non-responsive in setting of sedation on vent.

The plan is to:

* Follow up neurosurgical recommendations
* Continue to follow neurological exam
* Titrate down sedation as tolerated, continue to evaluate mental status closely in this setting
* Follow up CNS cultures, culture from Omaya device
* Continue antibiotics as detailed below
* Discuss with BMT service whether there are criteria that would allow return to treatment of CNS disease; may simply require ongoing assessment of relative risks and benefits in context.

The patient is at risk for several potential medical complications, including:

* Ventilator-associated pneumonia (VAP)
* Deep vein thrombosis (DVT)
* Stress ulcer
* Septic shock
* Cardiac arrest
* Neurological deterioration

The patient's current ICU care includes:

* Nutrition: IV fluids and total parenteral nutrition (TPN)
* Glycemic control: Insulin therapy
* Lines: Arterial line, central venous catheter, and peripheral IV lines
* Prophylaxis: DVT prophylaxis with boots, stress ulcer prophylaxis with histamine-2 (H2) blockers, and VAP prophylaxis with head-of-bed elevation and oral care."
112508.0,247400,2176-04-16 23:59:00,Physician ,Physician Resident Progress Note,"Chief Complaint: VRE infection associated with Omaya port, s/p
   neurosurgical procedure to remove port
   24 Hour Events:
 TRANS ESOPHAGEAL ECHO - At [**2176-4-15**] 12:49 PM
   Read: ""The left atrium is normal in size. No atrial septal defect is
   seen by 2D or color Doppler. Left ventricular wall thicknesses and
   cavity size are normal. There is severe global left ventricular
   hypokinesis (LVEF = 20 %). No masses or thrombi are seen in the left
   ventricle. There is no ventricular septal defect. Right ventricular
   chamber size is normal. with mild global free wall hypokinesis. The
   aortic valve leaflets (3) are mildly thickened but aortic stenosis is
   not present. No masses or vegetations are seen on the aortic valve. No
   aortic regurgitation is seen. The mitral valve leaflets are mildly
   thickened. No mass or vegetation is seen on the mitral valve. Mild (1+)
   mitral regurgitation is seen. The pulmonary artery systolic pressure
   could not be determined. There is a small pericardial effusion. There
   are no echocardiographic signs of tamponade.  IMPRESSION:
   Cardiomyopathy. No valvular vegetations seen.""
 ULTRASOUND - At [**2176-4-15**] 01:50 PM
   No DVT.
 OR SENT - At [**2176-4-15**] 09:30 PM
   Pt transferred from [**Hospital Ward Name 77**] 4 and arrived on unit at 2045.  Anesthesia
   and neuro sug up to unit and escorted pt to OR at 2130.
 OR RECEIVED - At [**2176-4-15**] 11:45 PM
   No op note in OMR at time of re-admission to [**Hospital Unit Name 10**]; per brief chart
   note, operation involved:
   * removal of Omaya port (PATHOLOGY # [**-7/1942**])
   * craniotomy for exploration and evacuation of SDH
   Note reports no significant blood loss
   2 units RBC and 2 units FFP given
   Culture sent, NGTD; gram stain showed:
      GRAM STAIN (Final [**2176-4-16**]):
         2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
         2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                       IN PAIRS.
 ARTERIAL LINE - START [**2176-4-16**] 12:48 AM
   History obtained from Medical records
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Linezolid - [**2176-4-16**] 02:17 PM
   Meropenem - [**2176-4-16**] 03:54 PM
   Gentamicin - [**2176-4-16**] 10:05 PM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Metoprolol - [**2176-4-16**] 03:00 AM
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-17**] 12:44 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 99 (98 - 128) bpm
   BP: 117/81(95) {98/66(79) - 146/101(119)} mmHg
   RR: 26 (16 - 39) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  6,475 mL
                                                                     40 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                     40 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                      0 mL
   Urine:
                                                                  1,395 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                     40 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 131
   RSBI Deferred: No Spon Resp
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   Compliance: 34.6 cmH2O/mL
   SpO2: 99%
   ABG: 7.50/26/135/17/0  (TAKEN 10:50 am [**4-15**])
   Ve: 9.7 L/min
   PaO2 / FiO2: 270
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, No(t) Sclera edema, pupils from 3 mm to 1 mm
   in setting of sedation
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ),
   in limited anterior exam
   Abdominal: Bowel sounds present, Distended
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, Rash: some mild erythematous rash on upper chest, none
   seen on torso, no morbilliform rash
   Neurologic: Responds to: Noxious stimuli, Movement: Not assessed,
   Sedated
   Labs / Radiology
   116 K/uL
   9.9 g/dL
   109 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.1 mEq/L
   33 mg/dL
   112 mEq/L
   143 mEq/L
   27.2 %
   4.2 K/uL
        [image002.jpg]
                             [**2176-4-15**]  09:34 AM
                             [**2176-4-15**]  03:56 PM
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
   WBC
   3.5
   3.1
   4.2
   4.2
   Hct
   26.1
   19
   25.9
   30.0
   27.2
   Plt
   54
   128
   120
   116
   Cr
   0.9
   1.0
   1.0
   TCO2
   20
   21
   19
   20
   21
   Glucose
   82
   71
   84
   109
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:288/3.5, Amylase / Lipase:250/111, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.4 mmol/L, Albumin:2.0 g/dL, LDH:5880 IU/L, Ca++:8.0
   mg/dL, Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication: ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: VRE infection associated with Omaya port, s/p
   neurosurgical procedure to remove port
   24 Hour Events:
 TRANS ESOPHAGEAL ECHO - At [**2176-4-15**] 12:49 PM
   Read: ""The left atrium is normal in size. No atrial septal defect is
   seen by 2D or color Doppler. Left ventricular wall thicknesses and
   cavity size are normal. There is severe global left ventricular
   hypokinesis (LVEF = 20 %). No masses or thrombi are seen in the left
   ventricle. There is no ventricular septal defect. Right ventricular
   chamber size is normal. with mild global free wall hypokinesis. The
   aortic valve leaflets (3) are mildly thickened but aortic stenosis is
   not present. No masses or vegetations are seen on the aortic valve. No
   aortic regurgitation is seen. The mitral valve leaflets are mildly
   thickened. No mass or vegetation is seen on the mitral valve. Mild (1+)
   mitral regurgitation is seen. The pulmonary artery systolic pressure
   could not be determined. There is a small pericardial effusion. There
   are no echocardiographic signs of tamponade.  IMPRESSION:
   Cardiomyopathy. No valvular vegetations seen.""
 ULTRASOUND - At [**2176-4-15**] 01:50 PM
   No DVT.
 OR SENT - At [**2176-4-15**] 09:30 PM
   Pt transferred from [**Hospital Ward Name 77**] 4 and arrived on unit at 2045.  Anesthesia
   and neuro sug up to unit and escorted pt to OR at 2130.
 OR RECEIVED - At [**2176-4-15**] 11:45 PM
   No op note in OMR at time of re-admission to [**Hospital Unit Name 10**]; per brief chart
   note, operation involved:
   * removal of Omaya port (PATHOLOGY # [**-7/1942**])
   * craniotomy for exploration and evacuation of SDH
   Note reports no significant blood loss
   2 units RBC and 2 units FFP given
   Culture sent, NGTD; gram stain showed:
      GRAM STAIN (Final [**2176-4-16**]):
         2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
         2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                       IN PAIRS.
 ARTERIAL LINE - START [**2176-4-16**] 12:48 AM
   History obtained from Medical records
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Linezolid - [**2176-4-16**] 02:17 PM
   Meropenem - [**2176-4-16**] 03:54 PM
   Gentamicin - [**2176-4-16**] 10:05 PM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Metoprolol - [**2176-4-16**] 03:00 AM
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-17**] 12:44 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 99 (98 - 128) bpm
   BP: 117/81(95) {98/66(79) - 146/101(119)} mmHg
   RR: 26 (16 - 39) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  6,475 mL
                                                                     40 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                     40 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                      0 mL
   Urine:
                                                                  1,395 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                     40 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 131
   RSBI Deferred: No Spon Resp
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   Compliance: 34.6 cmH2O/mL
   SpO2: 99%
   ABG: 7.50/26/135/17/0  (TAKEN 10:50 am [**4-15**])
   Ve: 9.7 L/min
   PaO2 / FiO2: 270
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, No(t) Sclera edema, pupils from 3 mm to 1 mm
   in setting of sedation
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ),
   in limited anterior exam
   Abdominal: Bowel sounds present, Distended
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, Rash: some mild erythematous rash on upper chest, none
   seen on torso, no morbilliform rash
   Neurologic: Responds to: Noxious stimuli, Movement: Not assessed,
   Sedated
   Labs / Radiology
   116 K/uL
   9.9 g/dL
   109 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.1 mEq/L
   33 mg/dL
   112 mEq/L
   143 mEq/L
   27.2 %
   4.2 K/uL
        [image002.jpg]
                             [**2176-4-15**]  09:34 AM
                             [**2176-4-15**]  03:56 PM
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
   WBC
   3.5
   3.1
   4.2
   4.2
   Hct
   26.1
   19
   25.9
   30.0
   27.2
   Plt
   54
   128
   120
   116
   Cr
   0.9
   1.0
   1.0
   TCO2
   20
   21
   19
   20
   21
   Glucose
   82
   71
   84
   109
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:288/3.5, Amylase / Lipase:250/111, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.4 mmol/L, Albumin:2.0 g/dL, LDH:5880 IU/L, Ca++:8.0
   mg/dL, Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication: ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) and past successful treatment of this, now with recurrence including CNS involvement. She was admitted to the ICU with a VRE infection associated with an Omaya port, which was removed and an SDH evacuated. The patient underwent a neurosurgical procedure to remove the port and evacuate the SDH. She was sedated and unable to provide a history.

The patient's current condition is as follows:

* Cardiomyopathy with severe global left ventricular hypokinesis (LVEF = 20%)
* Mild mitral regurgitation
* Small pericardial effusion
* No valvular vegetations seen
* No signs of tamponade
* Fever, unknown origin
* Altered mental status (not delirium)
* Leukopenia (WBC = 3.5 K/uL)
* Anemia (Hct = 26.1%)
* Thrombocytopenia (Plt = 54)
* Elevated liver enzymes (ALT = 1757, AST = 3393)
* Elevated lactate levels (2.4 mmol/L)

Potential Medical Complications:

* Cardiac complications:
	+ Cardiac arrest
	+ Congestive heart failure
	+ Arrhythmias
* Respiratory complications:
	+ Respiratory failure
	+ Pneumonia
	+ Respiratory distress syndrome
* Infectious complications:
	+ Sepsis
	+ Bacteremia
	+ Meningitis
* Hematological complications:
	+ Leukopenia
	+ Anemia
	+ Thrombocytopenia
* Neurological complications:
	+ Seizures
	+ Stroke
	+ Encephalopathy
* Gastrointestinal complications:
	+ Gastrointestinal bleeding
	+ Gastrointestinal perforation
	+ Pancreatitis

Assessment and Plan:

The patient requires close monitoring and management of her cardiomyopathy, fever, and altered mental status. She also requires ongoing treatment for her VRE infection and potential complications. The patient's code status is full code, and she is currently receiving ICU care with prophylaxis for DVT, stress ulcer, and VAP."
112508.0,247400,2176-04-17 05:52:00,Physician ,Physician Resident Progress Note,"Chief Complaint: ALL; altered mental status
   24 Hour Events:
   - Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
   - sedation weaned because she was intermittently hypotensive,  but
   patient not any more responsive
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.  Currently off all sedation, with reactive pupils but not
   following commands.  CSF drawn off of Omaya with gram positive cocci,
   likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now likely VRE in
   CSF.  Omaya port, the likely source, has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, suspicion is high for endocarditis.
   - continue linezolid and gentamicin
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   .
   # ALL:  s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - continue filgastrim
   - follow ANC
   .
   # RESPIRATORY FAILURE:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.
   - no change in ventilator management right now given other acute issues
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:
   Thought to be immediately associated with increase in calcium channel
   blocker dose; this was in response to tachyarrythmia in setting of
   infection. Recent echo shows ongoing cardiac compromise, worsened EF
   compared to earlier in this admission. Difficult to tell at this point
   whether this is a feature of the acute setting of infection and s/p
   arrest, vs an earlier decline that predisposed her to arrest.
   -          follow up echo in [**3-4**] weeks
   -          avoid nodal agents
   -          replete lytes closely
   -          no longer requiring pressors
   ICU Care
   Nutrition:
   Comments: npo for now; put in for tube feeding recs
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: ALL; altered mental status
   24 Hour Events:
   - Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
   - sedation weaned because she was intermittently hypotensive,  but
   patient not any more responsive
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.  Currently off all sedation, with reactive pupils but not
   following commands.  CSF drawn off of Omaya with gram positive cocci,
   likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now likely VRE in
   CSF.  Omaya port, the likely source, has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, suspicion is high for endocarditis.
   - continue linezolid and gentamicin
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   .
   # ALL:  s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - continue filgastrim
   - follow ANC
   .
   # RESPIRATORY FAILURE:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.
   - no change in ventilator management right now given other acute issues
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:
   Thought to be immediately associated with increase in calcium channel
   blocker dose; this was in response to tachyarrythmia in setting of
   infection. Recent echo shows ongoing cardiac compromise, worsened EF
   compared to earlier in this admission. Difficult to tell at this point
   whether this is a feature of the acute setting of infection and s/p
   arrest, vs an earlier decline that predisposed her to arrest.
   -          follow up echo in [**3-4**] weeks
   -          avoid nodal agents
   -          replete lytes closely
   -          no longer requiring pressors
   ICU Care
   Nutrition:
   Comments: npo for now; put in for tube feeding recs
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) and past successful treatment, now with recurrence including central nervous system (CNS) involvement. She has been admitted to the ICU with altered mental status, fever, and respiratory failure.

Potential medical complications that can arise from the patient's conditions include:

1. Central nervous system (CNS) infection: The patient has a likely enterococcal infection of the Omaya port, which was used for intrathecal chemotherapy, and has CSF cultures showing gram-positive cocci. This may lead to further CNS complications such as meningitis or abscesses.
2. Endocarditis: The patient has a high suspicion for endocarditis due to the finding of likely VRE in her CSF, and the Omaya port, which was removed, was likely the source. This may lead to cardiac complications such as septic emboli or valve damage.
3. Respiratory failure: The patient is intubated and has primary metabolic alkalosis and over-breathing the ventilator. The cause is likely an intracranial process, such as ongoing infection or recent surgery. This may lead to further respiratory complications such as ventilator-associated pneumonia or respiratory failure.
4. Sepsis: The patient has a high fever, and her WBC count is improving, although many immature/atypical forms. This may lead to further sepsis-related complications such as organ dysfunction or death.
5. Cardiac compromise: The patient had an asystolic arrest, and recent echo shows ongoing cardiac compromise, worsened EF compared to earlier in this admission. This may lead to further cardiac complications such as heart failure or arrhythmias.
6. Liver dysfunction: The patient has elevated liver enzymes, consistent with shock liver. This may lead to further liver-related complications such as coagulopathy or encephalopathy.
7. Neurological complications: The patient has altered mental status, which may be due to the CNS infection, recent SDH, or recurrent CNS lymphoma. This may lead to further neurological complications such as seizures or brain edema.

In conclusion, the patient is at risk for a variety of medical complications, and close monitoring and management are necessary to prevent or treat these complications."
112508.0,247400,2176-04-17 05:52:00,Physician ,Physician Resident Progress Note,"Chief Complaint: ALL; altered mental status
   24 Hour Events:
   Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: (S1: Normal), (S2: Normal), Rub
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm
   Neurologic: No(t) Attentive, No(t) Follows simple commands, Responds
   to: Noxious stimuli, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   ICU Care
   Nutrition:
   Comments: npo for now; put in for tube feeding recs
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: ALL; altered mental status
   24 Hour Events:
   Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: (S1: Normal), (S2: Normal), Rub
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm
   Neurologic: No(t) Attentive, No(t) Follows simple commands, Responds
   to: Noxious stimuli, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   ICU Care
   Nutrition:
   Comments: npo for now; put in for tube feeding recs
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a critically ill individual with altered mental status, transferred to the ICU from a neurosurgical ward. The patient has a complex medical history, including leukemia, and is receiving multiple medications and infusions.

The patient's vital signs are stable, with a temperature of 36.7°C, heart rate of 102 bpm, and blood pressure of 114/80 mmHg. The patient is receiving mechanical ventilation, with a FiO2 of 50% and a PEEP of 5 cmH2O.

The patient's laboratory results show elevated white blood cell count, platelet count, and lactate dehydrogenase (LDH) levels, indicating a possible sepsis or infection. The patient's electrolyte levels are within normal limits, except for a slightly elevated potassium level.

The patient's physical examination reveals a patent endotracheal tube, a dressing in place, and a Foley catheter. The patient's neurologic examination is abnormal, with no attentiveness, no following of simple commands, and a response to noxious stimuli only.

Potential medical complications that can arise from this patient's condition include:

1. Sepsis: The patient's elevated white blood cell count and LDH levels suggest a possible sepsis or infection, which can lead to organ dysfunction and failure.
2. Respiratory failure: The patient's mechanical ventilation and elevated respiratory rate suggest a possible respiratory failure, which can lead to hypoxemia and hypercapnia.
3. Neurologic deterioration: The patient's altered mental status and lack of responsiveness to commands suggest a possible neurologic deterioration, which can lead to brain death or permanent brain damage.
4. Infection: The patient's indwelling catheters and invasive lines increase the risk of infection, which can lead to sepsis and organ failure.
5. Bleeding: The patient's elevated platelet count and possible coagulopathy increase the risk of bleeding, which can lead to hemorrhagic complications.

Based on this information, the patient requires close monitoring and management to prevent and treat potential complications."
112508.0,247400,2176-04-17 05:52:00,Physician ,Physician Resident Progress Note,"Chief Complaint: ALL; altered mental status
   24 Hour Events:
   - Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
   - sedation weaned because she was intermittently hypotensive,  but
   patient not any more responsive
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.  Currently off all sedation, with reactive pupils but not
   following commands.  CSF drawn off of Omaya with gram positive cocci,
   likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now likely VRE in
   CSF.  Omaya port, the likely source, has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, suspicion is high for endocarditis.
   - continue linezolid and gentamicin
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   .
   # ALL:  s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - continue filgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: npo for now, will place NGT and put in for tube feeding recs,
   plan to restart bowel regimen when feeding tube in place
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: ALL; altered mental status
   24 Hour Events:
   - Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
   - sedation weaned because she was intermittently hypotensive,  but
   patient not any more responsive
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.  Currently off all sedation, with reactive pupils but not
   following commands.  CSF drawn off of Omaya with gram positive cocci,
   likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now likely VRE in
   CSF.  Omaya port, the likely source, has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, suspicion is high for endocarditis.
   - continue linezolid and gentamicin
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   .
   # ALL:  s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - continue filgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: npo for now, will place NGT and put in for tube feeding recs,
   plan to restart bowel regimen when feeding tube in place
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) who has experienced a recurrence with CNS involvement. She has undergone neurosurgical intervention, removal of an Omaya port, and evacuation of a subdural hematoma (SDH). The patient is currently in the ICU with altered mental status, likely due to a combination of factors including recent SDH, prolonged asystolic arrest, CNS infection, and possible recurrent CNS lymphoma.

The patient's laboratory results indicate a possible enterococcal infection, with gram-positive cocci present in the CSF. The Omaya port, which was used for intrathecal chemotherapy, is likely the source of the infection. The patient is currently receiving treatment with linezolid and gentamicin, which will require careful monitoring of culture data and sensitivities.

The patient's respiratory status is concerning, with respiratory alkalosis and over-breathing the ventilator. The cause of this is likely an intracranial process, such as ongoing infection or recent surgery. The patient's blood pressure is not tolerating increased sedation, and small boluses of sedation are being used to attempt to control hyperventilation.

The patient's liver enzymes are elevated, consistent with shock liver, and are being closely monitored. Her white blood cell count is improving, although many immature/atypical forms are present.

The patient's cardiac status is also concerning, with a significant decline in left ventricular ejection fraction (EF) over the past two weeks. She has had a recent episode of asystolic arrest, which was likely secondary to calcium channel blocker (CCB) use in the setting of a heart compromised by prior cardiotoxic chemotherapy.

Based on the patient's complex medical condition, the following potential medical complications may arise:

1. Sepsis: The patient's enterococcal infection and underlying immunosuppression make her at high risk for developing sepsis.
2. Respiratory failure: The patient's respiratory alkalosis and over-breathing the ventilator may lead to respiratory failure if not addressed.
3. Cardiac complications: The patient's declining EF and recent episode of asystolic arrest make her at risk for cardiac complications, such as arrhythmias or cardiac arrest.
4. Neurological deterioration: The patient's altered mental status and possible recurrent CNS lymphoma make her at risk for neurological deterioration.
5. Gastrointestinal complications: The patient's NPO status and recent evacuation procedure make her at risk for gastrointestinal complications, such as bowel obstruction or perforation.

To address these potential complications, the patient will require close monitoring and management by the ICU team, as well as collaboration with the BMT team to develop a plan for further treatment of her CNS lymphoma."
112508.0,247400,2176-04-17 05:52:00,Physician ,Physician Resident Progress Note,"Chief Complaint: ALL; altered mental status
   24 Hour Events:
   - Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
   - sedation weaned because she was intermittently hypotensive,  but
   patient not any more responsive
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.  Currently off all sedation, with reactive pupils but not
   following commands.  CSF drawn off of Omaya with gram positive cocci,
   likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now likely VRE in
   CSF.  Omaya port, the likely source, has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, suspicion is high for endocarditis.
   - continue linezolid and gentamicin
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   .
   # ALL:  s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - continue filgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: npo for now, will place NGT and put in for tube feeding recs,
   plan to restart bowel regimen when feeding tube in place
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: ALL; altered mental status
   24 Hour Events:
   - Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
   - sedation weaned because she was intermittently hypotensive,  but
   patient not any more responsive
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.  Currently off all sedation, with reactive pupils but not
   following commands.  CSF drawn off of Omaya with gram positive cocci,
   likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now likely VRE in
   CSF.  Omaya port, the likely source, has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, suspicion is high for endocarditis.
   - continue linezolid and gentamicin
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   .
   # ALL:  s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - continue filgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: npo for now, will place NGT and put in for tube feeding recs,
   plan to restart bowel regimen when feeding tube in place
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's daily progress note, the following potential medical complications can arise:

1. Infection: The patient has a history of enterococcal infection, and the Omaya port has been removed. There is a high suspicion of VRE (Vancomycin-resistant Enterococcus) in the CSF. The patient is receiving antibiotics, including linezolid and gentamicin, but there is a risk of endocarditis and further complications.
2. Neurological complications: The patient has altered mental status, likely due to a combination of factors, including recent SDH (subdural hematoma), prolonged asystolic arrest, CNS infection, and possible recurrent CNS lymphoma. There is a risk of seizure with alkalemia, and the patient's BP is not tolerating increased sedation.
3. Respiratory alkalosis: The patient is intubated and has primary metabolic alkalosis and over-breathing the ventilator. The cause is likely an intracranial process, and there is concern for the risk of seizure with alkalemia.
4. Cardiac complications: The patient had a cardiac arrest, likely secondary to CCB (calcium channel blocker) in the setting of a heart compromised by prior cardiotoxic chemotherapy. The patient's EF (ejection fraction) has decreased significantly, and there is a risk of further cardiac complications.
5. Gastrointestinal complications: The patient is NPO (nothing by mouth) and has a risk of gastrointestinal bleeding, particularly with the use of anticoagulant medications.
6. Hematological complications: The patient has a history of leukemia and is receiving chemotherapy. There is a risk of bone marrow suppression, particularly with the use of linezolid.
7. Infections: The patient has a history of infections, including VRE, and there is a risk of further infections, particularly with the use of antibiotics.
8. Liver complications: The patient has elevated liver enzymes, consistent with shock liver, and there is a risk of further liver damage.

In terms of the patient's laboratory results, the following abnormalities are noted:

* Elevated liver enzymes (ALT, AST, Alk Phos, T Bili)
* Elevated white blood cell count with many immature/atypical forms
* Elevated lactate levels
* Elevated LDH (lactate dehydrogenase) levels
* Elevated CRP (C-reactive protein) levels
* Elevated ESR (erythrocyte sedimentation rate) levels
* Abnormal CSF results (2+ polymorphonuclear leukocytes, 2+ gram-positive cocci)

Overall, the patient is at risk for a range of medical complications, and close monitoring and management are necessary to prevent and treat these complications."
112508.0,247400,2176-04-17 05:52:00,Physician ,Physician Resident Progress Note,"Chief Complaint: ALL; altered mental status
   24 Hour Events:
   Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: (S1: Normal), (S2: Normal), Rub
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm
   Neurologic: No(t) Attentive, No(t) Follows simple commands, Responds
   to: Noxious stimuli, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS
   CNS involvement by ALL as well as by enterococcus in association with
   the Omaya port, and SDH of chronic appearance seen on head CT s/p
   cardiac arrest, now s/p neurosurgical procedure as above. In
   retrospect, the subdural hematoma and gram-positive (likely
   enterococcal) infection may have been responsible for a considerable
   portion of what was described on her prior arrival to the [**Hospital Unit Name 10**] as
poor
   functional status
a vague worsening of cognition and function
   consistent with a diffuse cerebral process. Neurological exam currently
   showing promptly reactive pupils and some retreat of feet to noxious
   stimuli, but otherwise non-responsive in setting of sedation on vent.
   Assessment of neuro status confounded somewhat by her cardiac arrest,
   which may have created some anoxic brain injury.
   -          follow up neurosurgical recommendations
   -          continue to follow neurological exam
   -          titrate down sedation as tolerated, continue to evaluate
   mental status closely in this setting
   -          follow up CNS cultures, culture from Omaya device
   -          continue antibiotics as detailed below; current increase in
   neutrophils may allow sooner d/c of these
   -          Discuss w BMT service whether there are criteria that would
   allow return to treatment of CNS disease; may simply require ongoing
   assessment of relative risks and benefits in context
   # GRAM-POSITIVE INFECTION, c/w VRE
   Per ID recommendations, linezolid superior to daptomycin for coverage
   of CNS infection. Has the unfortunate advantage of suppressing bone
   marrow in immune-compromised patient. Immediate treatment of infection
   is current priority. Should continue to weigh risks and benefits of
   anti-VRE abx choice.
   -          continue linezolid with gentamicin
   # ALL
   Lengthy history with ALL, now recurring. S/p donor lymphocyte infusion.
   Giving G-CSF. Will need treatment for CNS disease at some point.
   -          follow up BMT recommendations
   -          has extensive medications for symptomatic treatment of
   mucositis and esophagitis; continue for now but continue to evaluate
   oral health, consider d/c
ing in setting of ventilation
   -          continue filgrastim
   -          follow ANC, appears to be normalizing by CBC/diff
   # S/P ASYSTOLIC ARREST
   Thought to be immediately associated with increase in calcium channel
   blocker dose; this was in response to tachyarrythmia in setting of
   infection. Recent echo shows ongoing cardiac compromise, worsened EF
   compared to earlier in this admission. Difficult to tell at this point
   whether this is a feature of the acute setting of infection and s/p
   arrest, vs an earlier decline that predisposed her to arrest.
   -          follow up echo in [**3-4**] weeks
   -          avoid nodal agents
   -          replete lytes closely
   -          no longer requiring pressors
   RESPIRATORY FAILURE
   Originally intubated in setting of cardiac arrest; kept on vent since
   then. ABGs have suggested metabolic alkalosis. LENIs negative for DVT;
   PE-CT unable to perform because of reported CT contrast allergy.
   Currently on AC settings. Getting ABG to evaluate current status.
   - wean FiO2 and PEEP as tolerated
   .
   FEVERS
   Afebrile post-op. On vanc, linezolid, meropenem, gentamicin,
   micafungin, and acyclovir. This should ensure the death of most of the
   microbial universe. As above, changed to linezolid to cover CNS VRE.
   Following up cultures, etc.
   -          heartening to see increase in WBC, neuts, bands.
   -          Continue filgrastim
   -          Continue abx as above
   ELEVATED LIVER ENZYMES
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   In summary, this is a 60 year old woman with ALL and a difficult
   hospital course s/p DLI, with apparently resolving neutropenia but now
   s/p craniotomy, cardiac arrest, respiratory failure, and shock liver.
   Currently stable on the vent; hope for improvement with improvement in
   WBC, antibiotics, removal of CNS source of infection. Following cardiac
   and liver function to evaluate for recovery s/p arrest.
   ICU Care
   Nutrition:
   Comments: npo for now; put in for tube feeding recs
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: ALL; altered mental status
   24 Hour Events:
   Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: (S1: Normal), (S2: Normal), Rub
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm
   Neurologic: No(t) Attentive, No(t) Follows simple commands, Responds
   to: Noxious stimuli, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS
   CNS involvement by ALL as well as by enterococcus in association with
   the Omaya port, and SDH of chronic appearance seen on head CT s/p
   cardiac arrest, now s/p neurosurgical procedure as above. In
   retrospect, the subdural hematoma and gram-positive (likely
   enterococcal) infection may have been responsible for a considerable
   portion of what was described on her prior arrival to the [**Hospital Unit Name 10**] as
poor
   functional status
a vague worsening of cognition and function
   consistent with a diffuse cerebral process. Neurological exam currently
   showing promptly reactive pupils and some retreat of feet to noxious
   stimuli, but otherwise non-responsive in setting of sedation on vent.
   Assessment of neuro status confounded somewhat by her cardiac arrest,
   which may have created some anoxic brain injury.
   -          follow up neurosurgical recommendations
   -          continue to follow neurological exam
   -          titrate down sedation as tolerated, continue to evaluate
   mental status closely in this setting
   -          follow up CNS cultures, culture from Omaya device
   -          continue antibiotics as detailed below; current increase in
   neutrophils may allow sooner d/c of these
   -          Discuss w BMT service whether there are criteria that would
   allow return to treatment of CNS disease; may simply require ongoing
   assessment of relative risks and benefits in context
   # GRAM-POSITIVE INFECTION, c/w VRE
   Per ID recommendations, linezolid superior to daptomycin for coverage
   of CNS infection. Has the unfortunate advantage of suppressing bone
   marrow in immune-compromised patient. Immediate treatment of infection
   is current priority. Should continue to weigh risks and benefits of
   anti-VRE abx choice.
   -          continue linezolid with gentamicin
   # ALL
   Lengthy history with ALL, now recurring. S/p donor lymphocyte infusion.
   Giving G-CSF. Will need treatment for CNS disease at some point.
   -          follow up BMT recommendations
   -          has extensive medications for symptomatic treatment of
   mucositis and esophagitis; continue for now but continue to evaluate
   oral health, consider d/c
ing in setting of ventilation
   -          continue filgrastim
   -          follow ANC, appears to be normalizing by CBC/diff
   # S/P ASYSTOLIC ARREST
   Thought to be immediately associated with increase in calcium channel
   blocker dose; this was in response to tachyarrythmia in setting of
   infection. Recent echo shows ongoing cardiac compromise, worsened EF
   compared to earlier in this admission. Difficult to tell at this point
   whether this is a feature of the acute setting of infection and s/p
   arrest, vs an earlier decline that predisposed her to arrest.
   -          follow up echo in [**3-4**] weeks
   -          avoid nodal agents
   -          replete lytes closely
   -          no longer requiring pressors
   RESPIRATORY FAILURE
   Originally intubated in setting of cardiac arrest; kept on vent since
   then. ABGs have suggested metabolic alkalosis. LENIs negative for DVT;
   PE-CT unable to perform because of reported CT contrast allergy.
   Currently on AC settings. Getting ABG to evaluate current status.
   - wean FiO2 and PEEP as tolerated
   .
   FEVERS
   Afebrile post-op. On vanc, linezolid, meropenem, gentamicin,
   micafungin, and acyclovir. This should ensure the death of most of the
   microbial universe. As above, changed to linezolid to cover CNS VRE.
   Following up cultures, etc.
   -          heartening to see increase in WBC, neuts, bands.
   -          Continue filgrastim
   -          Continue abx as above
   ELEVATED LIVER ENZYMES
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   In summary, this is a 60 year old woman with ALL and a difficult
   hospital course s/p DLI, with apparently resolving neutropenia but now
   s/p craniotomy, cardiac arrest, respiratory failure, and shock liver.
   Currently stable on the vent; hope for improvement with improvement in
   WBC, antibiotics, removal of CNS source of infection. Following cardiac
   and liver function to evaluate for recovery s/p arrest.
   ICU Care
   Nutrition:
   Comments: npo for now; put in for tube feeding recs
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) who has undergone a neurosurgical procedure for a subdural hematoma and likely enterococcal infection of an Omaya port used for intrathecal chemotherapy. She has been intubated and is currently on mechanical ventilation due to respiratory failure. She has also had a cardiac arrest, which may have caused anoxic brain injury. Her mental status is altered, and she is not responsive to noxious stimuli. She has a prolonged QT interval, and her liver enzymes are elevated, consistent with shock liver.

Potential Medical Complications:

1. Continued respiratory failure: The patient's respiratory status is unstable, and she may require continued mechanical ventilation.
2. Cardiac compromise: The patient's cardiac function is compromised, and she may require further evaluation and treatment.
3. Infection: The patient has a likely enterococcal infection, and she may be at risk for further infections, particularly in the setting of immunosuppression.
4. Neurological deterioration: The patient's altered mental status and lack of responsiveness to noxious stimuli may indicate ongoing neurological deterioration.
5. Liver dysfunction: The patient's elevated liver enzymes may indicate ongoing liver dysfunction, which could have serious consequences.
6. Coagulopathy: The patient's prolonged QT interval and elevated liver enzymes may indicate a coagulopathy, which could increase her risk of bleeding.
7. Sepsis: The patient's fever and elevated white blood cell count may indicate sepsis, which could lead to multi-organ failure.
8. Vascular complications: The patient's cardiac arrest and compromised cardiac function may increase her risk of vascular complications, such as pulmonary embolism or stroke.

Plan:

1. Continue mechanical ventilation and respiratory support as needed.
2. Monitor the patient's cardiac function and consider further evaluation and treatment as necessary.
3. Continue antibiotics and antifungal therapy to treat the likely enterococcal infection.
4. Monitor the patient's neurological status and consider further evaluation and treatment as necessary.
5. Continue to monitor the patient's liver function and consider further evaluation and treatment as necessary.
6. Consider further evaluation and treatment of the patient's coagulopathy.
7. Monitor the patient's white blood cell count and consider further evaluation and treatment as necessary.
8. Consider further evaluation and treatment of the patient's sepsis.
9. Consider further evaluation and treatment of the patient's vascular complications."
112508.0,247400,2176-04-18 06:47:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2176-4-18**] 01:36 AM
   - Neurosurgery recs Q4H neuro recs, avoid subQ heparin until [**4-18**],
   staples out in 2 weeks
   - ID recs decrease gentamicin from Q8H to Q12H, check peak/trough after
   4th dose
   - VRE in CSF
   - code status clarified with BMT and HCP:   full code
   - discussed current status with family including son/HCP
   - stopped Neupogen as counts are recovering
   - OGT placed, TF started
   - off sedation all day but not waking up (switched from fent/midaz
   drips to boluses)
   - NPO for ?TEE in AM, consented by TEE fellow
   - overnight BP trending down into the 80s, lactate rising
giving NS
   bolus in the morning
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Vancomycin - [**2176-4-16**] 12:00 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Micafungin - [**2176-4-17**] 07:53 PM
   Acyclovir - [**2176-4-17**] 09:31 PM
   Meropenem - [**2176-4-18**] 12:24 AM
   Linezolid - [**2176-4-18**] 02:13 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-18**] 06:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.7
   Tcurrent: 36.6
C (97.9
   HR: 96 (91 - 116) bpm
   BP: 86/60(70) {86/60(70) - 120/83(97)} mmHg
   RR: 21 (20 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  2,764 mL
                                                                  1,425 mL
   PO:
             TF:
                                                                     58 mL
   IVF:
                                                                  2,706 mL
                                                                  1,425 mL
   Blood products:
   Total out:
                                                                  1,418 mL
                                                                    563 mL
   Urine:
                                                                  1,368 mL
                                                                    388 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,346 mL
                                                                    862 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 346 (346 - 346) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 65
   PIP: 17 cmH2O
   Plateau: 15 cmH2O
   Compliance: 45 cmH2O/mL
   SpO2: 95%
   ABG: 7.49/25/104/17/-1
   Ve: 10.2 L/min
   PaO2 / FiO2: 260
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   97 K/uL
   11.3 g/dL
   102 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.7 mEq/L
   34 mg/dL
   114 mEq/L
   145 mEq/L
   33.0 %
   27.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
   WBC
   4.2
   7.9
   27.3
   Hct
   27.2
   29.1
   33.0
   Plt
   116
   97
   Cr
   1.1
   1.0
   TCO2
   21
   19
   20
   21
   20
   20
   20
   Glucose
   162
   102
   Other labs: PT / PTT / INR:16.2/38.8/1.4, ALT / AST:1205/385, Alk Phos
   / T Bili:355/2.5, Amylase / Lipase:76/50, Differential-Neuts:71.0 %,
   Band:1.0 %, Lymph:3.0 %, Mono:3.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:3.3 mmol/L, Albumin:2.3 g/dL, LDH:1843 IU/L, Ca++:7.8
   mg/dL, Mg++:2.0 mg/dL, PO4:2.2 mg/dL
   Blood cultures:  NGTD since [**4-11**] VRE
   CSF [**4-16**]:  enterococcus
   CXR [**4-17**]:
   Nasogastric tube ends in the mid stomach, ET tube in standard
   placement.
   Opacification at the lung bases is probably a combination of
   atelectasis and
   small bilateral pleural effusion. Pulmonary edema has cleared from the
   upper
   lungs. Heart size normal although the configuration suggests left
   atrial
   enlargement. ET tube in standard placement. No pneumothorax.
   Assessment and Plan
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Improved today in that Likely multifactorial
   including recent SDH, prolonged asystolic arrest, CNS infection,
   possible recurrent CNS lymphoma.  Currently off all sedation, with
   reactive pupils but not following commands.  CSF drawn off of Omaya
   with gram positive cocci, likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port, the likely source, has
   now been removed.    Daptomycin was switched to linezolid for better
   CSF penetration, although linezolid will cause BM suppression.
   Gentamicin for synergy.  TTE was negative for vegetation [**4-15**], but
   given new finding of likely VRE in CSF, suspicion is high for
   endocarditis.
   - continue linezolid and gentamicin
   - gentamicin dose changed per BMT recs:  will check level after 3^rd
   dose
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   - may d/c meropenem now that low suspicion for any GNR process
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   She is s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off ilgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: NPO for TEE today, restart TF after
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2176-4-18**] 01:36 AM
   - Neurosurgery recs Q4H neuro recs, avoid subQ heparin until [**4-18**],
   staples out in 2 weeks
   - ID recs decrease gentamicin from Q8H to Q12H, check peak/trough after
   4th dose
   - VRE in CSF
   - code status clarified with BMT and HCP:   full code
   - discussed current status with family including son/HCP
   - stopped Neupogen as counts are recovering
   - OGT placed, TF started
   - off sedation all day but not waking up (switched from fent/midaz
   drips to boluses)
   - NPO for ?TEE in AM, consented by TEE fellow
   - overnight BP trending down into the 80s, lactate rising
giving NS
   bolus in the morning
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Vancomycin - [**2176-4-16**] 12:00 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Micafungin - [**2176-4-17**] 07:53 PM
   Acyclovir - [**2176-4-17**] 09:31 PM
   Meropenem - [**2176-4-18**] 12:24 AM
   Linezolid - [**2176-4-18**] 02:13 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-18**] 06:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.7
   Tcurrent: 36.6
C (97.9
   HR: 96 (91 - 116) bpm
   BP: 86/60(70) {86/60(70) - 120/83(97)} mmHg
   RR: 21 (20 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  2,764 mL
                                                                  1,425 mL
   PO:
             TF:
                                                                     58 mL
   IVF:
                                                                  2,706 mL
                                                                  1,425 mL
   Blood products:
   Total out:
                                                                  1,418 mL
                                                                    563 mL
   Urine:
                                                                  1,368 mL
                                                                    388 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,346 mL
                                                                    862 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 346 (346 - 346) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 65
   PIP: 17 cmH2O
   Plateau: 15 cmH2O
   Compliance: 45 cmH2O/mL
   SpO2: 95%
   ABG: 7.49/25/104/17/-1
   Ve: 10.2 L/min
   PaO2 / FiO2: 260
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   97 K/uL
   11.3 g/dL
   102 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.7 mEq/L
   34 mg/dL
   114 mEq/L
   145 mEq/L
   33.0 %
   27.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
   WBC
   4.2
   7.9
   27.3
   Hct
   27.2
   29.1
   33.0
   Plt
   116
   97
   Cr
   1.1
   1.0
   TCO2
   21
   19
   20
   21
   20
   20
   20
   Glucose
   162
   102
   Other labs: PT / PTT / INR:16.2/38.8/1.4, ALT / AST:1205/385, Alk Phos
   / T Bili:355/2.5, Amylase / Lipase:76/50, Differential-Neuts:71.0 %,
   Band:1.0 %, Lymph:3.0 %, Mono:3.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:3.3 mmol/L, Albumin:2.3 g/dL, LDH:1843 IU/L, Ca++:7.8
   mg/dL, Mg++:2.0 mg/dL, PO4:2.2 mg/dL
   Blood cultures:  NGTD since [**4-11**] VRE
   CSF [**4-16**]:  enterococcus
   CXR [**4-17**]:
   Nasogastric tube ends in the mid stomach, ET tube in standard
   placement.
   Opacification at the lung bases is probably a combination of
   atelectasis and
   small bilateral pleural effusion. Pulmonary edema has cleared from the
   upper
   lungs. Heart size normal although the configuration suggests left
   atrial
   enlargement. ET tube in standard placement. No pneumothorax.
   Assessment and Plan
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Improved today in that Likely multifactorial
   including recent SDH, prolonged asystolic arrest, CNS infection,
   possible recurrent CNS lymphoma.  Currently off all sedation, with
   reactive pupils but not following commands.  CSF drawn off of Omaya
   with gram positive cocci, likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port, the likely source, has
   now been removed.    Daptomycin was switched to linezolid for better
   CSF penetration, although linezolid will cause BM suppression.
   Gentamicin for synergy.  TTE was negative for vegetation [**4-15**], but
   given new finding of likely VRE in CSF, suspicion is high for
   endocarditis.
   - continue linezolid and gentamicin
   - gentamicin dose changed per BMT recs:  will check level after 3^rd
   dose
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   - may d/c meropenem now that low suspicion for any GNR process
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   She is s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off ilgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: NPO for TEE today, restart TF after
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's condition as follows:

The patient is a 60-year-old woman with a lengthy history of acute lymphoblastic leukemia (ALL) and past successful treatment. She has recently relapsed, including CNS involvement, and likely enterococcal infection of an Omaya port used for intrathecal chemotherapy. She has undergone cardiac arrest, removal of the Omaya port, and evacuation of a subdural hematoma (SDH). She is currently in the ICU for further care and treatment.

The patient's current condition is characterized by:

1. Altered mental status: She is off all sedation, with reactive pupils but not following commands. Her CSF culture shows gram-positive cocci, likely VRE, which seeded from her blood.
2. VRE: She has previously had VRE in her blood, and now has enterococcus in her CSF, presumably from the same bacteria. The Omaya port has been removed, and she is receiving linezolid and gentamicin for treatment.
3. ALL: Her WBC count is improving, likely due to recovery of her bone marrow. She has received intrathecal methotrexate and DLI this admission and will need further treatment for CNS lymphoma in the future.
4. Respiratory alkalosis: She is intubated with primary metabolic alkalosis and over-breathing the ventilator, likely due to an intracranial process. Her BP is not tolerating increased sedation.
5. Fever: She has been afebrile since her evacuation procedure and is receiving antibiotics for suspected infections.
6. Elevated liver enzymes: Her liver enzymes are elevated, consistent with shock liver, and are downtrending.
7. S/P asystolic arrest: She had a cardiac arrest likely secondary to CCB in the setting of a heart compromised by prior cardiotoxic chemotherapy. Her EF has worsened significantly over the past two weeks.

Potential medical complications that may arise include:

1. Seizure risk: With her alkalosis, there is a concern for the risk of seizure.
2. Endocarditis: Given the finding of likely VRE in her CSF, there is a high suspicion for endocarditis, which needs to be monitored and treated.
3. CNS lymphoma progression: The patient's ALL has recurred, and she will need further treatment for CNS lymphoma in the future.
4. Respiratory failure: Her respiratory alkalosis may lead to respiratory failure if not managed properly.
5. Sepsis: With her elevated WBC count and suspected infections, there is a risk of sepsis.
6. Liver dysfunction: Her elevated liver enzymes may indicate liver dysfunction, which needs to be monitored and treated.
7. Cardiac complications: Her cardiac arrest and worsening EF may lead to further cardiac complications, such as arrhythmias or heart failure."
112508.0,247400,2176-04-18 06:47:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2176-4-18**] 01:36 AM
   - Neurosurgery recs Q4H neuro recs, avoid subQ heparin until [**4-18**],
   staples out in 2 weeks
   - ID recs decrease gentamicin from Q8H to Q12H, check peak/trough after
   4th dose
   - VRE in CSF
   - code status clarified with BMT and HCP:   full code
   - discussed current status with family including son/HCP
   - stopped Neupogen as counts are recovering
   - OGT placed, TF started
   - off sedation all day but not waking up (switched from fent/midaz
   drips to boluses)
   - NPO for ?TEE in AM, consented by TEE fellow
   - SBT tomorrow
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Vancomycin - [**2176-4-16**] 12:00 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Micafungin - [**2176-4-17**] 07:53 PM
   Acyclovir - [**2176-4-17**] 09:31 PM
   Meropenem - [**2176-4-18**] 12:24 AM
   Linezolid - [**2176-4-18**] 02:13 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-18**] 06:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.7
   Tcurrent: 36.6
C (97.9
   HR: 96 (91 - 116) bpm
   BP: 86/60(70) {86/60(70) - 120/83(97)} mmHg
   RR: 21 (20 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  2,764 mL
                                                                  1,425 mL
   PO:
             TF:
                                                                     58 mL
   IVF:
                                                                  2,706 mL
                                                                  1,425 mL
   Blood products:
   Total out:
                                                                  1,418 mL
                                                                    563 mL
   Urine:
                                                                  1,368 mL
                                                                    388 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,346 mL
                                                                    862 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 346 (346 - 346) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 65
   PIP: 17 cmH2O
   Plateau: 15 cmH2O
   Compliance: 45 cmH2O/mL
   SpO2: 95%
   ABG: 7.49/25/104/17/-1
   Ve: 10.2 L/min
   PaO2 / FiO2: 260
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   97 K/uL
   11.3 g/dL
   102 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.7 mEq/L
   34 mg/dL
   114 mEq/L
   145 mEq/L
   33.0 %
   27.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
   WBC
   4.2
   7.9
   27.3
   Hct
   27.2
   29.1
   33.0
   Plt
   116
   97
   Cr
   1.1
   1.0
   TCO2
   21
   19
   20
   21
   20
   20
   20
   Glucose
   162
   102
   Other labs: PT / PTT / INR:16.2/38.8/1.4, ALT / AST:1205/385, Alk Phos
   / T Bili:355/2.5, Amylase / Lipase:76/50, Differential-Neuts:71.0 %,
   Band:1.0 %, Lymph:3.0 %, Mono:3.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:3.3 mmol/L, Albumin:2.3 g/dL, LDH:1843 IU/L, Ca++:7.8
   mg/dL, Mg++:2.0 mg/dL, PO4:2.2 mg/dL
   Blood cultures:  NGTD since [**4-11**] VRE
   CSF [**4-16**]:  enterococcus
   CXR [**4-17**]:
   Nasogastric tube ends in the mid stomach, ET tube in standard
   placement.
   Opacification at the lung bases is probably a combination of
   atelectasis and
   small bilateral pleural effusion. Pulmonary edema has cleared from the
   upper
   lungs. Heart size normal although the configuration suggests left
   atrial
   enlargement. ET tube in standard placement. No pneumothorax.
   Assessment and Plan
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Improved today in that Likely multifactorial
   including recent SDH, prolonged asystolic arrest, CNS infection,
   possible recurrent CNS lymphoma.  Currently off all sedation, with
   reactive pupils but not following commands.  CSF drawn off of Omaya
   with gram positive cocci, likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port, the likely source, has
   now been removed.    Daptomycin was switched to linezolid for better
   CSF penetration, although linezolid will cause BM suppression.
   Gentamicin for synergy.  TTE was negative for vegetation [**4-15**], but
   given new finding of likely VRE in CSF, suspicion is high for
   endocarditis.
   - continue linezolid and gentamicin
   - gentamicin dose changed per BMT recs:  will check level after 3^rd
   dose
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   - may d/c meropenem now that low suspicion for any GNR process
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   She is s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off ilgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: NPO for TEE today, restart TF after
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2176-4-18**] 01:36 AM
   - Neurosurgery recs Q4H neuro recs, avoid subQ heparin until [**4-18**],
   staples out in 2 weeks
   - ID recs decrease gentamicin from Q8H to Q12H, check peak/trough after
   4th dose
   - VRE in CSF
   - code status clarified with BMT and HCP:   full code
   - discussed current status with family including son/HCP
   - stopped Neupogen as counts are recovering
   - OGT placed, TF started
   - off sedation all day but not waking up (switched from fent/midaz
   drips to boluses)
   - NPO for ?TEE in AM, consented by TEE fellow
   - SBT tomorrow
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Vancomycin - [**2176-4-16**] 12:00 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Micafungin - [**2176-4-17**] 07:53 PM
   Acyclovir - [**2176-4-17**] 09:31 PM
   Meropenem - [**2176-4-18**] 12:24 AM
   Linezolid - [**2176-4-18**] 02:13 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-18**] 06:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.7
   Tcurrent: 36.6
C (97.9
   HR: 96 (91 - 116) bpm
   BP: 86/60(70) {86/60(70) - 120/83(97)} mmHg
   RR: 21 (20 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  2,764 mL
                                                                  1,425 mL
   PO:
             TF:
                                                                     58 mL
   IVF:
                                                                  2,706 mL
                                                                  1,425 mL
   Blood products:
   Total out:
                                                                  1,418 mL
                                                                    563 mL
   Urine:
                                                                  1,368 mL
                                                                    388 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,346 mL
                                                                    862 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 346 (346 - 346) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 65
   PIP: 17 cmH2O
   Plateau: 15 cmH2O
   Compliance: 45 cmH2O/mL
   SpO2: 95%
   ABG: 7.49/25/104/17/-1
   Ve: 10.2 L/min
   PaO2 / FiO2: 260
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   97 K/uL
   11.3 g/dL
   102 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.7 mEq/L
   34 mg/dL
   114 mEq/L
   145 mEq/L
   33.0 %
   27.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
   WBC
   4.2
   7.9
   27.3
   Hct
   27.2
   29.1
   33.0
   Plt
   116
   97
   Cr
   1.1
   1.0
   TCO2
   21
   19
   20
   21
   20
   20
   20
   Glucose
   162
   102
   Other labs: PT / PTT / INR:16.2/38.8/1.4, ALT / AST:1205/385, Alk Phos
   / T Bili:355/2.5, Amylase / Lipase:76/50, Differential-Neuts:71.0 %,
   Band:1.0 %, Lymph:3.0 %, Mono:3.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:3.3 mmol/L, Albumin:2.3 g/dL, LDH:1843 IU/L, Ca++:7.8
   mg/dL, Mg++:2.0 mg/dL, PO4:2.2 mg/dL
   Blood cultures:  NGTD since [**4-11**] VRE
   CSF [**4-16**]:  enterococcus
   CXR [**4-17**]:
   Nasogastric tube ends in the mid stomach, ET tube in standard
   placement.
   Opacification at the lung bases is probably a combination of
   atelectasis and
   small bilateral pleural effusion. Pulmonary edema has cleared from the
   upper
   lungs. Heart size normal although the configuration suggests left
   atrial
   enlargement. ET tube in standard placement. No pneumothorax.
   Assessment and Plan
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Improved today in that Likely multifactorial
   including recent SDH, prolonged asystolic arrest, CNS infection,
   possible recurrent CNS lymphoma.  Currently off all sedation, with
   reactive pupils but not following commands.  CSF drawn off of Omaya
   with gram positive cocci, likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port, the likely source, has
   now been removed.    Daptomycin was switched to linezolid for better
   CSF penetration, although linezolid will cause BM suppression.
   Gentamicin for synergy.  TTE was negative for vegetation [**4-15**], but
   given new finding of likely VRE in CSF, suspicion is high for
   endocarditis.
   - continue linezolid and gentamicin
   - gentamicin dose changed per BMT recs:  will check level after 3^rd
   dose
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   - may d/c meropenem now that low suspicion for any GNR process
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   She is s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off ilgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: NPO for TEE today, restart TF after
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) and recurrent CNS involvement. She has undergone multiple treatments, including intrathecal chemotherapy and stem cell transplantation. She was admitted to the ICU after cardiac arrest and evacuation of a subdural hematoma (SDH). She has been diagnosed with VRE (vancomycin-resistant Enterococcus) in her cerebrospinal fluid (CSF) and enterococcus in her blood. She has also been diagnosed with acute respiratory alkalosis due to over-breathing the ventilator.

Potential Medical Complications:

1. Seizure risk due to alkalemia: The patient's blood pH is elevated, which may increase the risk of seizure activity.
2. Endocarditis: The presence of VRE in the CSF and the patient's history of cardiac arrest increase the suspicion of endocarditis.
3. Recurrent CNS lymphoma: The patient's history of ALL and recurrent CNS involvement suggests that she may be at risk for recurrent CNS lymphoma.
4. Liver dysfunction: The patient's elevated liver enzymes may indicate liver dysfunction, which could be related to shock liver or other underlying conditions.
5. Respiratory failure: The patient's respiratory alkalosis and requirement for mechanical ventilation increase the risk of respiratory failure.
6. Infection: The patient's diagnosis of VRE and enterococcus in her blood and CSF increases the risk of infection.
7. Neurological deterioration: The patient's altered mental status and lack of response to commands suggest the possibility of neurological deterioration.
8. Hemodynamic instability: The patient's history of cardiac arrest and requirement for pressors suggests that she may be at risk for hemodynamic instability.
9. Gastrointestinal complications: The patient's NPO status and requirement for enteral nutrition may increase the risk of gastrointestinal complications.
10. Thrombotic complications: The patient's history of cardiac arrest and requirement for anticoagulation therapy increase the risk of thrombotic complications.

Recommendations:

1. Monitor the patient's seizure risk and consider prophylactic anticonvulsant therapy.
2. Continue linezolid and gentamicin therapy for the treatment of VRE and enterococcus.
3. Repeat imaging studies to monitor for any changes in the patient's CNS condition.
4. Consider further treatment for recurrent CNS lymphoma, as recommended by the BMT team.
5. Monitor the patient's liver enzymes and consider further evaluation if they continue to elevate.
6. Continue respiratory support and monitor for signs of respiratory failure.
7. Monitor the patient's neurological status and consider further evaluation if there is any deterioration.
8. Monitor the patient's hemodynamic status and consider further evaluation if there is any instability.
9. Consider enteral nutrition and monitor for signs of gastrointestinal complications.
10. Monitor the patient's anticoagulation therapy and consider further evaluation if there are any signs of thrombotic complications."
112508.0,247400,2176-04-18 06:47:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2176-4-18**] 01:36 AM
   - Neurosurgery recs Q4H neuro recs, avoid subQ heparin until [**4-18**],
   staples out in 2 weeks
   - ID recs decrease gentamicin from Q8H to Q12H, check peak/trough after
   4th dose
   - VRE in CSF
   - code status clarified with BMT and HCP:   full code
   - discussed current status with family including son/HCP
   - stopped Neupogen as counts are recovering
   - OGT placed, TF started
   - off sedation all day but not waking up (switched from fent/midaz
   drips to boluses)
   - NPO for ?TEE in AM, consented by TEE fellow
   - overnight BP trending down into the 80s, lactate rising
giving NS
   bolus in the morning
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Vancomycin - [**2176-4-16**] 12:00 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Micafungin - [**2176-4-17**] 07:53 PM
   Acyclovir - [**2176-4-17**] 09:31 PM
   Meropenem - [**2176-4-18**] 12:24 AM
   Linezolid - [**2176-4-18**] 02:13 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-18**] 06:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.7
   Tcurrent: 36.6
C (97.9
   HR: 96 (91 - 116) bpm
   BP: 86/60(70) {86/60(70) - 120/83(97)} mmHg
   RR: 21 (20 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  2,764 mL
                                                                  1,425 mL
   PO:
             TF:
                                                                     58 mL
   IVF:
                                                                  2,706 mL
                                                                  1,425 mL
   Blood products:
   Total out:
                                                                  1,418 mL
                                                                    563 mL
   Urine:
                                                                  1,368 mL
                                                                    388 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,346 mL
                                                                    862 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 346 (346 - 346) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 65
   PIP: 17 cmH2O
   Plateau: 15 cmH2O
   Compliance: 45 cmH2O/mL
   SpO2: 95%
   ABG: 7.49/25/104/17/-1
   Ve: 10.2 L/min
   PaO2 / FiO2: 260
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   97 K/uL
   11.3 g/dL
   102 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.7 mEq/L
   34 mg/dL
   114 mEq/L
   145 mEq/L
   33.0 %
   27.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
   WBC
   4.2
   7.9
   27.3
   Hct
   27.2
   29.1
   33.0
   Plt
   116
   97
   Cr
   1.1
   1.0
   TCO2
   21
   19
   20
   21
   20
   20
   20
   Glucose
   162
   102
   Other labs: PT / PTT / INR:16.2/38.8/1.4, ALT / AST:1205/385, Alk Phos
   / T Bili:355/2.5, Amylase / Lipase:76/50, Differential-Neuts:71.0 %,
   Band:1.0 %, Lymph:3.0 %, Mono:3.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:3.3 mmol/L, Albumin:2.3 g/dL, LDH:1843 IU/L, Ca++:7.8
   mg/dL, Mg++:2.0 mg/dL, PO4:2.2 mg/dL
   Blood cultures:  NGTD since [**4-11**] VRE
   CSF [**4-16**]:  enterococcus
   CXR [**4-17**]:
   Nasogastric tube ends in the mid stomach, ET tube in standard
   placement.
   Opacification at the lung bases is probably a combination of
   atelectasis and
   small bilateral pleural effusion. Pulmonary edema has cleared from the
   upper
   lungs. Heart size normal although the configuration suggests left
   atrial
   enlargement. ET tube in standard placement. No pneumothorax.
   Assessment and Plan
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port which was seeded has now
   been removed.    Daptomycin was switched to linezolid for better CSF
   penetration, although linezolid will cause BM suppression.  Gentamicin
   for synergy.  TTE was negative for vegetation [**4-15**], but given new
   finding of likely VRE in CSF, suspicion is high for endocarditis.
   Would need 8 weeks of abx if vegetation present vs 4 week if only CNS
   infection s/p source removal.
   - continue linezolid and gentamicin
   - after discussion with ID and high trough, gentamicin dose decreased:
   will check level after 4th dose tomorrow PM
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - d/c meropenem now that low suspicion for any GNR process
   # HYPOTENSION:  New this morning, SBP 80s, did not respond to 750 cc
   bolus so far.  Lactate also elevated, likely secondary to poor
   perfusion.  Differential includes sepsis, and her new leukocytosis
   would go along with this (although she is  not neutropenic, on very
   broad abx coverage, and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, adrenal insufficiency, CNS etiology, PE (but
   not hypoxic nor impressively more tachycardic).  Limbs are warm, neck
   veins difficult to assess, and there is some question about the
   accuracy of art line BP [**Location (un) 103**].  Regarding management, would prefer to
   give a pressor with inotropic activity such as levophed if needed.
   - check BP in all 4 limbs
   - assess neck veins
   - trend lactate
   - [**Last Name (un) **] stim
   - Infectious work-up:  repeat blood and urine cx, sputum cx, stool for
   c diff, monitor line for signs of infection
   - IVNS x 500 cc bolus now
   - consider Levophed if persistently hypotensive despite fluid boluses
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  However, off sedation she is not alert or following
   commands.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal MTX and
   DLI this admission.  Per BMT, will need further treatment for CNS
   lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   - discuss whether the fungal and viral coverage is still needed with
   BMT and ID
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest,
   with ongoing primary metabolic alkalosis.  Cause is most likely
   intracranial process (ongoing infection, recent surgery).  PE was on
   the differential but LENIs negative; unable to do CTA [**1-1**] contrast
   allergy.  There is some concern for the risk of seizure with alkalemia,
   but we are not able to give opiates to depress her respiratory drive
   because of hypotension.  Regarding her ventilated status, her
   neurologic exam is currently not such that she could protect her airway
   if extubated
   -continue mechanical ventilation at current settings for now
   - consider SBT if mental status improves.
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms), however very sharp bump today is also
   concerning for an infectious etiology.   She has been afebrile since
   her evacuation procedure and is on very broad coverage as above.  Will
   work-up for infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - stop meropenem, no longer  indicated anyway as above
   - follow clinically
   - would discuss if alternative antibiotic regimen could be constructed
   if rash persists/worsens and linezolid is possibly implicated
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.  INR climbing, which may be secondary to synthetic
   dysfunction after hepatic injury.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated and climbing.  Concern for DIC in this
   woman with cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:
   Comments: NPO for TEE today, restart TF after
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2176-4-18**] 01:36 AM
   - Neurosurgery recs Q4H neuro recs, avoid subQ heparin until [**4-18**],
   staples out in 2 weeks
   - ID recs decrease gentamicin from Q8H to Q12H, check peak/trough after
   4th dose
   - VRE in CSF
   - code status clarified with BMT and HCP:   full code
   - discussed current status with family including son/HCP
   - stopped Neupogen as counts are recovering
   - OGT placed, TF started
   - off sedation all day but not waking up (switched from fent/midaz
   drips to boluses)
   - NPO for ?TEE in AM, consented by TEE fellow
   - overnight BP trending down into the 80s, lactate rising
giving NS
   bolus in the morning
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Vancomycin - [**2176-4-16**] 12:00 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Micafungin - [**2176-4-17**] 07:53 PM
   Acyclovir - [**2176-4-17**] 09:31 PM
   Meropenem - [**2176-4-18**] 12:24 AM
   Linezolid - [**2176-4-18**] 02:13 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-18**] 06:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.7
   Tcurrent: 36.6
C (97.9
   HR: 96 (91 - 116) bpm
   BP: 86/60(70) {86/60(70) - 120/83(97)} mmHg
   RR: 21 (20 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  2,764 mL
                                                                  1,425 mL
   PO:
             TF:
                                                                     58 mL
   IVF:
                                                                  2,706 mL
                                                                  1,425 mL
   Blood products:
   Total out:
                                                                  1,418 mL
                                                                    563 mL
   Urine:
                                                                  1,368 mL
                                                                    388 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,346 mL
                                                                    862 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 346 (346 - 346) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 65
   PIP: 17 cmH2O
   Plateau: 15 cmH2O
   Compliance: 45 cmH2O/mL
   SpO2: 95%
   ABG: 7.49/25/104/17/-1
   Ve: 10.2 L/min
   PaO2 / FiO2: 260
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   97 K/uL
   11.3 g/dL
   102 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.7 mEq/L
   34 mg/dL
   114 mEq/L
   145 mEq/L
   33.0 %
   27.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
   WBC
   4.2
   7.9
   27.3
   Hct
   27.2
   29.1
   33.0
   Plt
   116
   97
   Cr
   1.1
   1.0
   TCO2
   21
   19
   20
   21
   20
   20
   20
   Glucose
   162
   102
   Other labs: PT / PTT / INR:16.2/38.8/1.4, ALT / AST:1205/385, Alk Phos
   / T Bili:355/2.5, Amylase / Lipase:76/50, Differential-Neuts:71.0 %,
   Band:1.0 %, Lymph:3.0 %, Mono:3.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:3.3 mmol/L, Albumin:2.3 g/dL, LDH:1843 IU/L, Ca++:7.8
   mg/dL, Mg++:2.0 mg/dL, PO4:2.2 mg/dL
   Blood cultures:  NGTD since [**4-11**] VRE
   CSF [**4-16**]:  enterococcus
   CXR [**4-17**]:
   Nasogastric tube ends in the mid stomach, ET tube in standard
   placement.
   Opacification at the lung bases is probably a combination of
   atelectasis and
   small bilateral pleural effusion. Pulmonary edema has cleared from the
   upper
   lungs. Heart size normal although the configuration suggests left
   atrial
   enlargement. ET tube in standard placement. No pneumothorax.
   Assessment and Plan
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port which was seeded has now
   been removed.    Daptomycin was switched to linezolid for better CSF
   penetration, although linezolid will cause BM suppression.  Gentamicin
   for synergy.  TTE was negative for vegetation [**4-15**], but given new
   finding of likely VRE in CSF, suspicion is high for endocarditis.
   Would need 8 weeks of abx if vegetation present vs 4 week if only CNS
   infection s/p source removal.
   - continue linezolid and gentamicin
   - after discussion with ID and high trough, gentamicin dose decreased:
   will check level after 4th dose tomorrow PM
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - d/c meropenem now that low suspicion for any GNR process
   # HYPOTENSION:  New this morning, SBP 80s, did not respond to 750 cc
   bolus so far.  Lactate also elevated, likely secondary to poor
   perfusion.  Differential includes sepsis, and her new leukocytosis
   would go along with this (although she is  not neutropenic, on very
   broad abx coverage, and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, adrenal insufficiency, CNS etiology, PE (but
   not hypoxic nor impressively more tachycardic).  Limbs are warm, neck
   veins difficult to assess, and there is some question about the
   accuracy of art line BP [**Location (un) 103**].  Regarding management, would prefer to
   give a pressor with inotropic activity such as levophed if needed.
   - check BP in all 4 limbs
   - assess neck veins
   - trend lactate
   - [**Last Name (un) **] stim
   - Infectious work-up:  repeat blood and urine cx, sputum cx, stool for
   c diff, monitor line for signs of infection
   - IVNS x 500 cc bolus now
   - consider Levophed if persistently hypotensive despite fluid boluses
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  However, off sedation she is not alert or following
   commands.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal MTX and
   DLI this admission.  Per BMT, will need further treatment for CNS
   lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   - discuss whether the fungal and viral coverage is still needed with
   BMT and ID
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest,
   with ongoing primary metabolic alkalosis.  Cause is most likely
   intracranial process (ongoing infection, recent surgery).  PE was on
   the differential but LENIs negative; unable to do CTA [**1-1**] contrast
   allergy.  There is some concern for the risk of seizure with alkalemia,
   but we are not able to give opiates to depress her respiratory drive
   because of hypotension.  Regarding her ventilated status, her
   neurologic exam is currently not such that she could protect her airway
   if extubated
   -continue mechanical ventilation at current settings for now
   - consider SBT if mental status improves.
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms), however very sharp bump today is also
   concerning for an infectious etiology.   She has been afebrile since
   her evacuation procedure and is on very broad coverage as above.  Will
   work-up for infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - stop meropenem, no longer  indicated anyway as above
   - follow clinically
   - would discuss if alternative antibiotic regimen could be constructed
   if rash persists/worsens and linezolid is possibly implicated
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.  INR climbing, which may be secondary to synthetic
   dysfunction after hepatic injury.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated and climbing.  Concern for DIC in this
   woman with cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:
   Comments: NPO for TEE today, restart TF after
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) who has undergone several treatments, including cardiac arrest, removal of an Omaya port, and evacuation of a subdural hematoma (SDH). She is currently admitted to the ICU for further care and treatment.

The patient's current condition is as follows:

* Respiratory status: intubated due to respiratory failure, with a primary metabolic alkalosis and ongoing intracranial process (infection or recent surgery) as the likely cause.
* Cardiovascular status: hypotensive with a systolic blood pressure in the 80s, lactate rising, and a concern for sepsis, cardiogenic shock, volume depletion, adrenal insufficiency, CNS etiology, or pulmonary embolism (PE).
* Neurological status: altered mental status with a Glasgow Coma Scale (GCS) of 3, likely due to recent SDH, prolonged asystolic arrest, CNS infection, and possible recurrent CNS lymphoma.
* Hematological status: leukocytosis with a white blood cell count (WBC) of 27.3 K/uL, likely secondary to recovery of bone marrow function after chemotherapy.
* Infection status: VRE in the cerebrospinal fluid (CSF), enterococcus in the CSF, and a concern for endocarditis.
* Medications: linezolid, gentamicin, acyclovir, micafungin, and other antibiotics.
* Laboratory results: elevated liver enzymes, INR, and lactate.

Potential medical complications that can arise from the patient's current condition include:

1. Sepsis: given the patient's hypotension, lactate rising, and concern for sepsis, it is possible that the patient may develop sepsis, which can lead to organ dysfunction and failure.
2. Endocarditis: given the patient's VRE in the CSF and enterococcus in the CSF, it is possible that the patient may develop endocarditis, which can lead to cardiac complications and death.
3. Respiratory failure: given the patient's intubation and ongoing primary metabolic alkalosis, it is possible that the patient may develop respiratory failure, which can lead to hypoxia and death.
4. Neurological deterioration: given the patient's altered mental status and concern for recurrent CNS lymphoma, it is possible that the patient may develop neurological deterioration, which can lead to brain herniation and death.
5. Coagulopathy: given the patient's INR and concern for disseminated intravascular coagulation (DIC), it is possible that the patient may develop coagulopathy, which can lead to bleeding and death.
6. Cardiac complications: given the patient's recent cardiac arrest and concern for cardiogenic shock, it is possible that the patient may develop cardiac complications, such as arrhythmias, heart failure, or cardiac arrest.

To prevent or manage these potential complications, the patient should be closely monitored and receive aggressive treatment, including:

1. Antibiotics: the patient should receive broad-spectrum antibiotics to cover potential infections, including VRE and enterococcus.
2. Cardiovascular support: the patient should receive cardiovascular support, including pressors and inotropes, to maintain blood pressure and cardiac output.
3. Respiratory support: the patient should receive respiratory support, including mechanical ventilation, to maintain oxygenation and ventilation.
4. Neurological support: the patient should receive neurological support, including sedation and analgesia, to manage her altered mental status and pain.
5. Coagulation support: the patient should receive coagulation support, including fresh frozen plasma and platelets, to manage her coagulopathy.
6. Cardiac support: the patient should receive cardiac support, including anti-arrhythmic medications and cardiac monitoring, to manage her cardiac complications."
112508.0,247400,2176-04-19 07:39:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 BLOOD CULTURED - At [**2176-4-18**] 11:26 AM
 SPUTUM CULTURE - At [**2176-4-18**] 11:26 AM
 URINE CULTURE - At [**2176-4-18**] 11:26 AM
 BLOOD CULTURED - At [**2176-4-18**] 12:52 PM
   [**4-18**]
   - Hypotension during the afternoon requiring norepinephrine, on/off
   overnight for borderline BP
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Micafungin - [**2176-4-18**] 07:35 PM
   Gentamicin - [**2176-4-18**] 08:59 PM
   Linezolid - [**2176-4-19**] 01:49 AM
   Acyclovir - [**2176-4-19**] 06:18 AM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-18**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-19**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98.1
   HR: 89 (80 - 110) bpm
   BP: 116/73(89) {73/47(58) - 136/86(104)} mmHg
   RR: 24 (14 - 27) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  5,499 mL
                                                                  1,535 mL
   PO:
             TF:
                                                                    217 mL
                                                                    253 mL
   IVF:
                                                                  5,283 mL
                                                                  1,202 mL
   Blood products:
   Total out:
                                                                  1,358 mL
                                                                    288 mL
   Urine:
                                                                  1,163 mL
                                                                    288 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,141 mL
                                                                  1,247 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 450 (450 - 450) mL
   PS : 5 cmH2O
   RR (Set): 12
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 63
   PIP: 18 cmH2O
   Plateau: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/24/134/15/-4
   Ve: 11 L/min
   PaO2 / FiO2: 335
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   90 K/uL
   12.3 g/dL
   157 mg/dL
   0.9 mg/dL
   15 mEq/L
   3.9 mEq/L
   33 mg/dL
   113 mEq/L
   140 mEq/L
   36.0 %
   30.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
                             [**2176-4-18**]  02:42 PM
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
   WBC
   4.2
   7.9
   20.7
   30.3
   Hct
   27.2
   29.1
   33.0
   36.0
   Plt
   116
   97
   91
   90
   Cr
   1.1
   1.0
   0.9
   0.9
   TCO2
   20
   20
   20
   18
   17
   Glucose
   162
   102
   117
   157
   Other labs: PT / PTT / INR:15.0/34.3/1.3, ALT / AST:464/117, Alk Phos /
   T Bili:460/1.7, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:3.2 mmol/L, Albumin:2.1 g/dL, LDH:1213 IU/L, Ca++:7.6
   mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   Imaging: CXR [**4-18**]: ET tube projects 2 cm above the carina. Interval
   improvement in
   pulmonary edema. Cardiac size is top normal. Bibasilar atelectases
   greater
   on the left side are unchanged. There is increase in left perihilar
   opacity
   to suggest atelectasis.
   CXR:
   Microbiology: bxc [**Date range (1) 6111**] ngtd
   ucx ngtd
   cryptococcus negative
   VRE (also amp R, linezolid S) in CSF [**4-15**]
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-19**] 06:27 AM 40 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 BLOOD CULTURED - At [**2176-4-18**] 11:26 AM
 SPUTUM CULTURE - At [**2176-4-18**] 11:26 AM
 URINE CULTURE - At [**2176-4-18**] 11:26 AM
 BLOOD CULTURED - At [**2176-4-18**] 12:52 PM
   [**4-18**]
   - Hypotension during the afternoon requiring norepinephrine, on/off
   overnight for borderline BP
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Micafungin - [**2176-4-18**] 07:35 PM
   Gentamicin - [**2176-4-18**] 08:59 PM
   Linezolid - [**2176-4-19**] 01:49 AM
   Acyclovir - [**2176-4-19**] 06:18 AM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-18**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-19**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98.1
   HR: 89 (80 - 110) bpm
   BP: 116/73(89) {73/47(58) - 136/86(104)} mmHg
   RR: 24 (14 - 27) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  5,499 mL
                                                                  1,535 mL
   PO:
             TF:
                                                                    217 mL
                                                                    253 mL
   IVF:
                                                                  5,283 mL
                                                                  1,202 mL
   Blood products:
   Total out:
                                                                  1,358 mL
                                                                    288 mL
   Urine:
                                                                  1,163 mL
                                                                    288 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,141 mL
                                                                  1,247 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 450 (450 - 450) mL
   PS : 5 cmH2O
   RR (Set): 12
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 63
   PIP: 18 cmH2O
   Plateau: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/24/134/15/-4
   Ve: 11 L/min
   PaO2 / FiO2: 335
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   90 K/uL
   12.3 g/dL
   157 mg/dL
   0.9 mg/dL
   15 mEq/L
   3.9 mEq/L
   33 mg/dL
   113 mEq/L
   140 mEq/L
   36.0 %
   30.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
                             [**2176-4-18**]  02:42 PM
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
   WBC
   4.2
   7.9
   20.7
   30.3
   Hct
   27.2
   29.1
   33.0
   36.0
   Plt
   116
   97
   91
   90
   Cr
   1.1
   1.0
   0.9
   0.9
   TCO2
   20
   20
   20
   18
   17
   Glucose
   162
   102
   117
   157
   Other labs: PT / PTT / INR:15.0/34.3/1.3, ALT / AST:464/117, Alk Phos /
   T Bili:460/1.7, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:3.2 mmol/L, Albumin:2.1 g/dL, LDH:1213 IU/L, Ca++:7.6
   mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   Imaging: CXR [**4-18**]: ET tube projects 2 cm above the carina. Interval
   improvement in
   pulmonary edema. Cardiac size is top normal. Bibasilar atelectases
   greater
   on the left side are unchanged. There is increase in left perihilar
   opacity
   to suggest atelectasis.
   CXR:
   Microbiology: bxc [**Date range (1) 6111**] ngtd
   ucx ngtd
   cryptococcus negative
   VRE (also amp R, linezolid S) in CSF [**4-15**]
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-19**] 06:27 AM 40 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 24-hour-old ICU patient with a diagnosis of sepsis without organ dysfunction. The patient has a history of acute leukemia and has undergone multiple antibiotic treatments, including Meropenem, Micafungin, Gentamicin, Linezolid, and Acyclovir.

The patient's vital signs are stable, with a temperature of 36.9°C (98.5°F), heart rate of 89 beats per minute, blood pressure of 116/73 mmHg, respiratory rate of 24 breaths per minute, and oxygen saturation of 97%. The patient is receiving mechanical ventilation with a tidal volume of 450 mL, positive end-expiratory pressure of 5 cmH2O, and fraction of inspired oxygen of 40%.

The patient's laboratory results show elevated white blood cell count, lactate level, and liver enzymes. The patient's cardiac enzymes, including troponin and creatine kinase, are within normal limits. The patient's electrolyte levels, including potassium, sodium, and chloride, are within normal limits.

The patient's imaging studies, including chest X-ray, show improvement in pulmonary edema and atelectasis. The patient's microbiology results show the presence of VRE (vancomycin-resistant Enterococcus) in the cerebrospinal fluid.

The patient's assessment and plan include sepsis without organ dysfunction, impaired skin integrity, altered mental status, and fever of unknown origin. The patient's ICU care plan includes nutrition, glycemic control, and prophylaxis for DVT, stress ulcer, and VAP.

Potential medical complications that may arise include:

1. Sepsis progression: The patient's sepsis may progress to septic shock, which can lead to multiple organ dysfunction and death.
2. Ventilator-associated pneumonia (VAP): The patient's prolonged use of mechanical ventilation increases the risk of developing VAP, which can lead to respiratory failure and death.
3. Catheter-related bloodstream infections: The patient's multiple central lines and arterial lines increase the risk of developing catheter-related bloodstream infections, which can lead to sepsis and death.
4. Deep vein thrombosis (DVT): The patient's prolonged immobility increases the risk of developing DVT, which can lead to pulmonary embolism and death.
5. Stress ulcer: The patient's critical illness increases the risk of developing stress ulcer, which can lead to gastrointestinal bleeding and death.
6. Renal failure: The patient's sepsis and critical illness increase the risk of developing acute kidney injury, which can lead to chronic kidney disease and death.
7. Cardiac complications: The patient's sepsis and critical illness increase the risk of developing cardiac complications, including arrhythmias and cardiogenic shock.

In summary, the patient is a 24-hour-old ICU patient with a diagnosis of sepsis without organ dysfunction. The patient's vital signs are stable, and the patient is receiving mechanical ventilation and multiple antibiotic treatments. The patient's laboratory results show elevated white blood cell count, lactate level, and liver enzymes. The patient's imaging studies show improvement in pulmonary edema and atelectasis. The patient's assessment and plan include sepsis without organ dysfunction, impaired skin integrity, altered mental status, and fever of unknown origin. The patient's ICU care plan includes nutrition, glycemic control, and prophylaxis for DVT, stress ulcer, and VAP."
112508.0,247400,2176-04-19 07:39:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 BLOOD CULTURED - At [**2176-4-18**] 11:26 AM
 SPUTUM CULTURE - At [**2176-4-18**] 11:26 AM
 URINE CULTURE - At [**2176-4-18**] 11:26 AM
 BLOOD CULTURED - At [**2176-4-18**] 12:52 PM
   [**4-18**]
   - Hypotension during the afternoon requiring norepinephrine, on/off
   overnight for borderline BP, discontinued at 8:30am
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Micafungin - [**2176-4-18**] 07:35 PM
   Gentamicin - [**2176-4-18**] 08:59 PM
   Linezolid - [**2176-4-19**] 01:49 AM
   Acyclovir - [**2176-4-19**] 06:18 AM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-18**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-19**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98.1
   HR: 89 (80 - 110) bpm
   BP: 116/73(89) {73/47(58) - 136/86(104)} mmHg
   RR: 24 (14 - 27) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  5,499 mL
                                                                  1,535 mL
   PO:
             TF:
                                                                    217 mL
                                                                    253 mL
   IVF:
                                                                  5,283 mL
                                                                  1,202 mL
   Blood products:
   Total out:
                                                                  1,358 mL
                                                                    288 mL
   Urine:
                                                                  1,163 mL
                                                                    288 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,141 mL
                                                                  1,247 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 450 (450 - 450) mL
   PS : 5 cmH2O
   RR (Set): 12
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 63
   PIP: 18 cmH2O
   Plateau: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/24/134/15/-4
   Ve: 11 L/min
   PaO2 / FiO2: 335
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   90 K/uL
   12.3 g/dL
   157 mg/dL
   0.9 mg/dL
   15 mEq/L
   3.9 mEq/L
   33 mg/dL
   113 mEq/L
   140 mEq/L
   36.0 %
   30.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
                             [**2176-4-18**]  02:42 PM
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
   WBC
   4.2
   7.9
   20.7
   30.3
   Hct
   27.2
   29.1
   33.0
   36.0
   Plt
   116
   97
   91
   90
   Cr
   1.1
   1.0
   0.9
   0.9
   TCO2
   20
   20
   20
   18
   17
   Glucose
   162
   102
   117
   157
   Other labs: PT / PTT / INR:15.0/34.3/1.3, ALT / AST:464/117, Alk Phos /
   T Bili:460/1.7, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:3.2 mmol/L, Albumin:2.1 g/dL, LDH:1213 IU/L, Ca++:7.6
   mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   Imaging: CXR [**4-18**]: ET tube projects 2 cm above the carina. Interval
   improvement in
   pulmonary edema. Cardiac size is top normal. Bibasilar atelectases
   greater
   on the left side are unchanged. There is increase in left perihilar
   opacity
   to suggest atelectasis.
   CXR:
   Microbiology: bxc [**Date range (1) 6111**] ngtd
   ucx ngtd
   cryptococcus negative
   VRE (also amp R, linezolid S) in CSF [**4-15**]
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now with VRE (amp R,
   linezolid S)  in CSF, presumably the same bacteria which was in the
   blood previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - d/w micro re: additional sensitivities: tigacycline?
   # HYPOTENSION:  New on [**4-18**],  did not respond to bolus and required
   levophed until this morning.  Lactate also elevated, likely secondary
   to poor perfusion.  Differential includes sepsis, and her new
   leukocytosis would go along with this (although ID feels that this is
   more likely [**1-1**] G-CSF and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, CNS etiology. Adreanl insufficeincy r/o by
   [**Last Name (un) **] stim. Limbs are warm, neck veins difficult to assess, and there is
   some question about the accuracy of art line BP [**Location (un) 103**].
   - monitor BP of pressors, low threshold to resume levophed to maintain
   MAP > 65
   - trend lactate
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest.
   Cause is most likely intracranial process (ongoing infection, recent
   surgery).  PE was on the differential but LENIs negative; unable to do
   CTA [**1-1**] contrast allergy.  There is some concern for the risk of
   seizure with alkalemia, but we are not able to give opiates to depress
   her respiratory drive because of hypotension.  Previously mental status
   has been major boundary to extubation, but improvement today permits
   SBT
   - SBT with possible extubation
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms) and GCSF, however very CONTINUED bump today
   to 30 is also concerning.   She has been afebrile since her evacuation
   procedure and is on very broad coverage as above.  Will work-up for
   infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Some concern for DIC in this woman with
   cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-19**] 06:27 AM 40 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: icu
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 BLOOD CULTURED - At [**2176-4-18**] 11:26 AM
 SPUTUM CULTURE - At [**2176-4-18**] 11:26 AM
 URINE CULTURE - At [**2176-4-18**] 11:26 AM
 BLOOD CULTURED - At [**2176-4-18**] 12:52 PM
   [**4-18**]
   - Hypotension during the afternoon requiring norepinephrine, on/off
   overnight for borderline BP, discontinued at 8:30am
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Micafungin - [**2176-4-18**] 07:35 PM
   Gentamicin - [**2176-4-18**] 08:59 PM
   Linezolid - [**2176-4-19**] 01:49 AM
   Acyclovir - [**2176-4-19**] 06:18 AM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-18**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-19**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98.1
   HR: 89 (80 - 110) bpm
   BP: 116/73(89) {73/47(58) - 136/86(104)} mmHg
   RR: 24 (14 - 27) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  5,499 mL
                                                                  1,535 mL
   PO:
             TF:
                                                                    217 mL
                                                                    253 mL
   IVF:
                                                                  5,283 mL
                                                                  1,202 mL
   Blood products:
   Total out:
                                                                  1,358 mL
                                                                    288 mL
   Urine:
                                                                  1,163 mL
                                                                    288 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,141 mL
                                                                  1,247 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 450 (450 - 450) mL
   PS : 5 cmH2O
   RR (Set): 12
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 63
   PIP: 18 cmH2O
   Plateau: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/24/134/15/-4
   Ve: 11 L/min
   PaO2 / FiO2: 335
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   90 K/uL
   12.3 g/dL
   157 mg/dL
   0.9 mg/dL
   15 mEq/L
   3.9 mEq/L
   33 mg/dL
   113 mEq/L
   140 mEq/L
   36.0 %
   30.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
                             [**2176-4-18**]  02:42 PM
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
   WBC
   4.2
   7.9
   20.7
   30.3
   Hct
   27.2
   29.1
   33.0
   36.0
   Plt
   116
   97
   91
   90
   Cr
   1.1
   1.0
   0.9
   0.9
   TCO2
   20
   20
   20
   18
   17
   Glucose
   162
   102
   117
   157
   Other labs: PT / PTT / INR:15.0/34.3/1.3, ALT / AST:464/117, Alk Phos /
   T Bili:460/1.7, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:3.2 mmol/L, Albumin:2.1 g/dL, LDH:1213 IU/L, Ca++:7.6
   mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   Imaging: CXR [**4-18**]: ET tube projects 2 cm above the carina. Interval
   improvement in
   pulmonary edema. Cardiac size is top normal. Bibasilar atelectases
   greater
   on the left side are unchanged. There is increase in left perihilar
   opacity
   to suggest atelectasis.
   CXR:
   Microbiology: bxc [**Date range (1) 6111**] ngtd
   ucx ngtd
   cryptococcus negative
   VRE (also amp R, linezolid S) in CSF [**4-15**]
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now with VRE (amp R,
   linezolid S)  in CSF, presumably the same bacteria which was in the
   blood previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - d/w micro re: additional sensitivities: tigacycline?
   # HYPOTENSION:  New on [**4-18**],  did not respond to bolus and required
   levophed until this morning.  Lactate also elevated, likely secondary
   to poor perfusion.  Differential includes sepsis, and her new
   leukocytosis would go along with this (although ID feels that this is
   more likely [**1-1**] G-CSF and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, CNS etiology. Adreanl insufficeincy r/o by
   [**Last Name (un) **] stim. Limbs are warm, neck veins difficult to assess, and there is
   some question about the accuracy of art line BP [**Location (un) 103**].
   - monitor BP of pressors, low threshold to resume levophed to maintain
   MAP > 65
   - trend lactate
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest.
   Cause is most likely intracranial process (ongoing infection, recent
   surgery).  PE was on the differential but LENIs negative; unable to do
   CTA [**1-1**] contrast allergy.  There is some concern for the risk of
   seizure with alkalemia, but we are not able to give opiates to depress
   her respiratory drive because of hypotension.  Previously mental status
   has been major boundary to extubation, but improvement today permits
   SBT
   - SBT with possible extubation
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms) and GCSF, however very CONTINUED bump today
   to 30 is also concerning.   She has been afebrile since her evacuation
   procedure and is on very broad coverage as above.  Will work-up for
   infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Some concern for DIC in this woman with
   cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-19**] 06:27 AM 40 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: icu<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) who has recently experienced a recurrence, including central nervous system (CNS) involvement. She was intubated after a cardiac arrest and has been receiving mechanical ventilation. She has been diagnosed with sepsis without organ dysfunction, and her blood cultures have grown VRE (vancomycin-resistant Enterococcus) in the CSF. She has also developed hypotension, leukocytosis, and a rash, which is concerning for a drug allergy.

The patient's current medications include linezolid, gentamicin, and micafungin, which were started to treat her CNS infection and sepsis. She is also receiving nutrition through a nasogastric tube and has a central line for medication administration.

Potential medical complications:

1. Sepsis: The patient's sepsis may worsen, leading to organ dysfunction and potentially life-threatening complications.
2. Hypotension: The patient's hypotension may persist or worsen, leading to organ hypoperfusion and potentially life-threatening complications.
3. Leukocytosis: The patient's leukocytosis may be a sign of an underlying infection, which could worsen her sepsis and other complications.
4. Rash: The patient's rash may be a sign of a drug allergy, which could worsen her condition and lead to other complications.
5. Coagulopathy: The patient's coagulopathy may worsen, leading to bleeding complications.
6. Cardiac dysfunction: The patient's cardiac dysfunction may worsen, leading to cardiogenic shock and potentially life-threatening complications.
7. Respiratory failure: The patient's respiratory failure may worsen, leading to respiratory arrest and potentially life-threatening complications.

Recommendations:

1. Continue to monitor the patient's vital signs and laboratory results closely to detect any changes in her condition.
2. Adjust the patient's medications as needed to optimize her treatment and minimize side effects.
3. Consider adding additional antibiotics to the patient's regimen to cover for potential infections.
4. Monitor the patient's coagulation profile closely to detect any changes in her coagulopathy.
5. Consider consulting with a cardiologist to evaluate the patient's cardiac function and develop a plan to manage her cardiac dysfunction.
6. Continue to provide mechanical ventilation as needed to support the patient's respiratory function.
7. Monitor the patient's mental status closely to detect any changes in her level of consciousness."
112508.0,247400,2176-04-19 07:39:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 BLOOD CULTURED - At [**2176-4-18**] 11:26 AM
 SPUTUM CULTURE - At [**2176-4-18**] 11:26 AM
 URINE CULTURE - At [**2176-4-18**] 11:26 AM
 BLOOD CULTURED - At [**2176-4-18**] 12:52 PM
   [**4-18**]
   - Hypotension during the afternoon requiring norepinephrine, on/off
   overnight for borderline BP
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Micafungin - [**2176-4-18**] 07:35 PM
   Gentamicin - [**2176-4-18**] 08:59 PM
   Linezolid - [**2176-4-19**] 01:49 AM
   Acyclovir - [**2176-4-19**] 06:18 AM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-18**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-19**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98.1
   HR: 89 (80 - 110) bpm
   BP: 116/73(89) {73/47(58) - 136/86(104)} mmHg
   RR: 24 (14 - 27) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  5,499 mL
                                                                  1,535 mL
   PO:
             TF:
                                                                    217 mL
                                                                    253 mL
   IVF:
                                                                  5,283 mL
                                                                  1,202 mL
   Blood products:
   Total out:
                                                                  1,358 mL
                                                                    288 mL
   Urine:
                                                                  1,163 mL
                                                                    288 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,141 mL
                                                                  1,247 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 450 (450 - 450) mL
   PS : 5 cmH2O
   RR (Set): 12
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 63
   PIP: 18 cmH2O
   Plateau: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/24/134/15/-4
   Ve: 11 L/min
   PaO2 / FiO2: 335
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   90 K/uL
   12.3 g/dL
   157 mg/dL
   0.9 mg/dL
   15 mEq/L
   3.9 mEq/L
   33 mg/dL
   113 mEq/L
   140 mEq/L
   36.0 %
   30.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
                             [**2176-4-18**]  02:42 PM
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
   WBC
   4.2
   7.9
   20.7
   30.3
   Hct
   27.2
   29.1
   33.0
   36.0
   Plt
   116
   97
   91
   90
   Cr
   1.1
   1.0
   0.9
   0.9
   TCO2
   20
   20
   20
   18
   17
   Glucose
   162
   102
   117
   157
   Other labs: PT / PTT / INR:15.0/34.3/1.3, ALT / AST:464/117, Alk Phos /
   T Bili:460/1.7, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:3.2 mmol/L, Albumin:2.1 g/dL, LDH:1213 IU/L, Ca++:7.6
   mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   Imaging: CXR [**4-18**]: ET tube projects 2 cm above the carina. Interval
   improvement in
   pulmonary edema. Cardiac size is top normal. Bibasilar atelectases
   greater
   on the left side are unchanged. There is increase in left perihilar
   opacity
   to suggest atelectasis.
   CXR:
   Microbiology: bxc [**Date range (1) 6111**] ngtd
   ucx ngtd
   cryptococcus negative
   VRE (also amp R, linezolid S) in CSF [**4-15**]
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port which was seeded has now
   been removed.    Daptomycin was switched to linezolid for better CSF
   penetration, although linezolid will cause BM suppression.  Gentamicin
   for synergy.  TTE was negative for vegetation [**4-15**], but given new
   finding of likely VRE in CSF, suspicion is high for endocarditis.
   Would need 8 weeks of abx if vegetation present vs 4 week if only CNS
   infection s/p source removal.
   - continue linezolid and gentamicin
   - after discussion with ID and high trough, gentamicin dose decreased:
   will check level after 4th dose tomorrow PM
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - d/c meropenem now that low suspicion for any GNR process
   # HYPOTENSION:  New this morning, SBP 80s, did not respond to 750 cc
   bolus so far.  Lactate also elevated, likely secondary to poor
   perfusion.  Differential includes sepsis, and her new leukocytosis
   would go along with this (although she is  not neutropenic, on very
   broad abx coverage, and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, adrenal insufficiency, CNS etiology, PE (but
   not hypoxic nor impressively more tachycardic).  Limbs are warm, neck
   veins difficult to assess, and there is some question about the
   accuracy of art line BP [**Location (un) 103**].  Regarding management, would prefer to
   give a pressor with inotropic activity such as levophed if needed.
   - check BP in all 4 limbs
   - assess neck veins
   - trend lactate
   - [**Last Name (un) **] stim
   - Infectious work-up:  repeat blood and urine cx, sputum cx, stool for
   c diff, monitor line for signs of infection
   - IVNS x 500 cc bolus now
   - consider Levophed if persistently hypotensive despite fluid boluses
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  However, off sedation she is not alert or following
   commands.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal MTX and
   DLI this admission.  Per BMT, will need further treatment for CNS
   lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   - discuss whether the fungal and viral coverage is still needed with
   BMT and ID
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest,
   with ongoing primary metabolic alkalosis.  Cause is most likely
   intracranial process (ongoing infection, recent surgery).  PE was on
   the differential but LENIs negative; unable to do CTA [**1-1**] contrast
   allergy.  There is some concern for the risk of seizure with alkalemia,
   but we are not able to give opiates to depress her respiratory drive
   because of hypotension.  Regarding her ventilated status, her
   neurologic exam is currently not such that she could protect her airway
   if extubated
   -continue mechanical ventilation at current settings for now
   - consider SBT if mental status improves.
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms), however very sharp bump today is also
   concerning for an infectious etiology.   She has been afebrile since
   her evacuation procedure and is on very broad coverage as above.  Will
   work-up for infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - stop meropenem, no longer  indicated anyway as above
   - follow clinically
   - would discuss if alternative antibiotic regimen could be constructed
   if rash persists/worsens and linezolid is possibly implicated
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.  INR climbing, which may be secondary to synthetic
   dysfunction after hepatic injury.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated and climbing.  Concern for DIC in this
   woman with cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-19**] 06:27 AM 40 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 BLOOD CULTURED - At [**2176-4-18**] 11:26 AM
 SPUTUM CULTURE - At [**2176-4-18**] 11:26 AM
 URINE CULTURE - At [**2176-4-18**] 11:26 AM
 BLOOD CULTURED - At [**2176-4-18**] 12:52 PM
   [**4-18**]
   - Hypotension during the afternoon requiring norepinephrine, on/off
   overnight for borderline BP
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Micafungin - [**2176-4-18**] 07:35 PM
   Gentamicin - [**2176-4-18**] 08:59 PM
   Linezolid - [**2176-4-19**] 01:49 AM
   Acyclovir - [**2176-4-19**] 06:18 AM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-18**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-19**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98.1
   HR: 89 (80 - 110) bpm
   BP: 116/73(89) {73/47(58) - 136/86(104)} mmHg
   RR: 24 (14 - 27) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  5,499 mL
                                                                  1,535 mL
   PO:
             TF:
                                                                    217 mL
                                                                    253 mL
   IVF:
                                                                  5,283 mL
                                                                  1,202 mL
   Blood products:
   Total out:
                                                                  1,358 mL
                                                                    288 mL
   Urine:
                                                                  1,163 mL
                                                                    288 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,141 mL
                                                                  1,247 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 450 (450 - 450) mL
   PS : 5 cmH2O
   RR (Set): 12
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 63
   PIP: 18 cmH2O
   Plateau: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/24/134/15/-4
   Ve: 11 L/min
   PaO2 / FiO2: 335
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   90 K/uL
   12.3 g/dL
   157 mg/dL
   0.9 mg/dL
   15 mEq/L
   3.9 mEq/L
   33 mg/dL
   113 mEq/L
   140 mEq/L
   36.0 %
   30.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
                             [**2176-4-18**]  02:42 PM
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
   WBC
   4.2
   7.9
   20.7
   30.3
   Hct
   27.2
   29.1
   33.0
   36.0
   Plt
   116
   97
   91
   90
   Cr
   1.1
   1.0
   0.9
   0.9
   TCO2
   20
   20
   20
   18
   17
   Glucose
   162
   102
   117
   157
   Other labs: PT / PTT / INR:15.0/34.3/1.3, ALT / AST:464/117, Alk Phos /
   T Bili:460/1.7, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:3.2 mmol/L, Albumin:2.1 g/dL, LDH:1213 IU/L, Ca++:7.6
   mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   Imaging: CXR [**4-18**]: ET tube projects 2 cm above the carina. Interval
   improvement in
   pulmonary edema. Cardiac size is top normal. Bibasilar atelectases
   greater
   on the left side are unchanged. There is increase in left perihilar
   opacity
   to suggest atelectasis.
   CXR:
   Microbiology: bxc [**Date range (1) 6111**] ngtd
   ucx ngtd
   cryptococcus negative
   VRE (also amp R, linezolid S) in CSF [**4-15**]
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port which was seeded has now
   been removed.    Daptomycin was switched to linezolid for better CSF
   penetration, although linezolid will cause BM suppression.  Gentamicin
   for synergy.  TTE was negative for vegetation [**4-15**], but given new
   finding of likely VRE in CSF, suspicion is high for endocarditis.
   Would need 8 weeks of abx if vegetation present vs 4 week if only CNS
   infection s/p source removal.
   - continue linezolid and gentamicin
   - after discussion with ID and high trough, gentamicin dose decreased:
   will check level after 4th dose tomorrow PM
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - d/c meropenem now that low suspicion for any GNR process
   # HYPOTENSION:  New this morning, SBP 80s, did not respond to 750 cc
   bolus so far.  Lactate also elevated, likely secondary to poor
   perfusion.  Differential includes sepsis, and her new leukocytosis
   would go along with this (although she is  not neutropenic, on very
   broad abx coverage, and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, adrenal insufficiency, CNS etiology, PE (but
   not hypoxic nor impressively more tachycardic).  Limbs are warm, neck
   veins difficult to assess, and there is some question about the
   accuracy of art line BP [**Location (un) 103**].  Regarding management, would prefer to
   give a pressor with inotropic activity such as levophed if needed.
   - check BP in all 4 limbs
   - assess neck veins
   - trend lactate
   - [**Last Name (un) **] stim
   - Infectious work-up:  repeat blood and urine cx, sputum cx, stool for
   c diff, monitor line for signs of infection
   - IVNS x 500 cc bolus now
   - consider Levophed if persistently hypotensive despite fluid boluses
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  However, off sedation she is not alert or following
   commands.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal MTX and
   DLI this admission.  Per BMT, will need further treatment for CNS
   lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   - discuss whether the fungal and viral coverage is still needed with
   BMT and ID
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest,
   with ongoing primary metabolic alkalosis.  Cause is most likely
   intracranial process (ongoing infection, recent surgery).  PE was on
   the differential but LENIs negative; unable to do CTA [**1-1**] contrast
   allergy.  There is some concern for the risk of seizure with alkalemia,
   but we are not able to give opiates to depress her respiratory drive
   because of hypotension.  Regarding her ventilated status, her
   neurologic exam is currently not such that she could protect her airway
   if extubated
   -continue mechanical ventilation at current settings for now
   - consider SBT if mental status improves.
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms), however very sharp bump today is also
   concerning for an infectious etiology.   She has been afebrile since
   her evacuation procedure and is on very broad coverage as above.  Will
   work-up for infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - stop meropenem, no longer  indicated anyway as above
   - follow clinically
   - would discuss if alternative antibiotic regimen could be constructed
   if rash persists/worsens and linezolid is possibly implicated
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.  INR climbing, which may be secondary to synthetic
   dysfunction after hepatic injury.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated and climbing.  Concern for DIC in this
   woman with cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-19**] 06:27 AM 40 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) and recurrent CNS involvement. She was admitted to the ICU after a cardiac arrest and evacuation of a subdural hematoma. She has been diagnosed with sepsis without organ dysfunction, airway compromise, impaired skin integrity, and altered mental status. She is currently intubated and receiving mechanical ventilation. Her laboratory results show leukocytosis, elevated liver enzymes, and coagulopathy.

Potential Medical Complications:

1. Sepsis: The patient's sepsis is likely caused by an enterococcal infection in her central nervous system (CNS) and may lead to further organ dysfunction if not adequately treated.
2. Endocarditis: The patient's VRE-positive CSF and cardiac arrest history make endocarditis a possibility, which would require prolonged antibiotic treatment.
3. Respiratory Failure: The patient's respiratory failure is likely caused by her intracranial process and may worsen if not managed properly.
4. Neurologic Complications: The patient's altered mental status and risk of seizure may worsen if not managed properly.
5. Coagulopathy: The patient's coagulopathy may lead to bleeding complications if not managed properly.
6. Liver Dysfunction: The patient's elevated liver enzymes may indicate liver dysfunction, which may worsen if not managed properly.
7. Cardiovascular Complications: The patient's cardiac arrest history and ongoing cardiac dysfunction may lead to further cardiovascular complications if not managed properly.

Recommendations:

1. Continue broad-spectrum antibiotics to treat sepsis and potential endocarditis.
2. Monitor the patient's respiratory status closely and consider weaning from mechanical ventilation if her mental status improves.
3. Manage the patient's coagulopathy with serial laboratory monitoring and consider platelet transfusions if necessary.
4. Monitor the patient's liver enzymes and consider liver function tests if necessary.
5. Monitor the patient's cardiovascular status closely and consider echocardiograms to assess cardiac function.
6. Consider further treatment for CNS lymphoma, as recommended by the BMT team.
7. Monitor the patient's skin integrity and consider wound care if necessary.
8. Consider stress ulcer prophylaxis and DVT prophylaxis as recommended by the ICU team."
112508.0,247400,2176-04-20 06:56:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2176-4-19**] 03:01 PM
   - Extubated, with improved mental status over the course of the day and
   able to respond verbally and follow comands by evening
   - No TEE done
   - CVL femoral ok to stay unless spikes again
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-19**] 09:57 AM
   Micafungin - [**2176-4-19**] 07:58 PM
   Linezolid - [**2176-4-20**] 02:33 AM
   Acyclovir - [**2176-4-20**] 06:00 AM
   Infusions:
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-19**] 06:25 PM
   Heparin Sodium (Prophylaxis) - [**2176-4-19**] 11:11 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-20**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.4
C (95.8
   HR: 88 (83 - 107) bpm
   BP: 119/76(93) {88/60(72) - 132/87(105)} mmHg
   RR: 18 (15 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  3,364 mL
                                                                    568 mL
   PO:
             TF:
                                                                    542 mL
   IVF:
                                                                  2,743 mL
                                                                    568 mL
   Blood products:
   Total out:
                                                                  2,958 mL
                                                                    975 mL
   Urine:
                                                                  2,808 mL
                                                                    975 mL
   NG:
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                    406 mL
                                                                   -408 mL
   Respiratory support
   O2 Delivery Device: Face tent
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 330 (330 - 451) mL
   PS : 0 cmH2O
   RR (Spontaneous): 22
   PEEP: 0 cmH2O
   FiO2: 40%
   SpO2: 100%
   ABG: 7.48/28/124/19/0
   Ve: 9.8 L/min
   PaO2 / FiO2: 310
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   75 K/uL
   11.2 g/dL
   117 mg/dL
   0.9 mg/dL
   19 mEq/L
   3.7 mEq/L
   31 mg/dL
   111 mEq/L
   140 mEq/L
   31.3 %
   27.0 K/uL
        [image002.jpg]
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
   WBC
   30.3
   27.0
   Hct
   36.0
   29.9
   29.8
   31.3
   Plt
   90
   75
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   117
   157
   157
   137
   117
   Other labs: PT / PTT / INR:15.0/33.9/1.3, ALT / AST:262/68, Alk Phos /
   T Bili:447/1.3, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:863 IU/L, Ca++:7.8 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Since yesterday, ETT tip is now in expected position. Nasogastric tube
   ends
   below the diaphragm with its tip not imaged on this study. Pulmonary
   edema
   improved. Small left pleural effusion is unchanged. Severe left basal
   atelectasis is unchanged. Milder atelectasis at the right base is also
   stable. Heart size and hilar contours are normal.
   [**4-16**] CSF:   VRE (tigecycline sensitivities pending)
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now with VRE (amp R,
   linezolid S)  in CSF, presumably the same bacteria which was in the
   blood previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - d/w micro re: additional sensitivities: tigacycline?
   # HYPOTENSION:  New on [**4-18**],  did not respond to bolus and required
   levophed until this morning.  Lactate also elevated, likely secondary
   to poor perfusion.  Differential includes sepsis, and her new
   leukocytosis would go along with this (although ID feels that this is
   more likely [**1-1**] G-CSF and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, CNS etiology. Adreanl insufficeincy r/o by
   [**Last Name (un) **] stim. Limbs are warm, neck veins difficult to assess, and there is
   some question about the accuracy of art line BP [**Location (un) 103**].
   - monitor BP of pressors, low threshold to resume levophed to maintain
   MAP > 65
   - trend lactate
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest.
   Cause is most likely intracranial process (ongoing infection, recent
   surgery).  PE was on the differential but LENIs negative; unable to do
   CTA [**1-1**] contrast allergy.  There is some concern for the risk of
   seizure with alkalemia, but we are not able to give opiates to depress
   her respiratory drive because of hypotension.  Previously mental status
   has been major boundary to extubation, but improvement today permits
   SBT
   - SBT with possible extubation
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms) and GCSF, however very CONTINUED bump today
   to 30 is also concerning.   She has been afebrile since her evacuation
   procedure and is on very broad coverage as above.  Will work-up for
   infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Some concern for DIC in this woman with
   cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:  tube feeds
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2176-4-19**] 03:01 PM
   - Extubated, with improved mental status over the course of the day and
   able to respond verbally and follow comands by evening
   - No TEE done
   - CVL femoral ok to stay unless spikes again
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-19**] 09:57 AM
   Micafungin - [**2176-4-19**] 07:58 PM
   Linezolid - [**2176-4-20**] 02:33 AM
   Acyclovir - [**2176-4-20**] 06:00 AM
   Infusions:
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-19**] 06:25 PM
   Heparin Sodium (Prophylaxis) - [**2176-4-19**] 11:11 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-20**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.4
C (95.8
   HR: 88 (83 - 107) bpm
   BP: 119/76(93) {88/60(72) - 132/87(105)} mmHg
   RR: 18 (15 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  3,364 mL
                                                                    568 mL
   PO:
             TF:
                                                                    542 mL
   IVF:
                                                                  2,743 mL
                                                                    568 mL
   Blood products:
   Total out:
                                                                  2,958 mL
                                                                    975 mL
   Urine:
                                                                  2,808 mL
                                                                    975 mL
   NG:
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                    406 mL
                                                                   -408 mL
   Respiratory support
   O2 Delivery Device: Face tent
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 330 (330 - 451) mL
   PS : 0 cmH2O
   RR (Spontaneous): 22
   PEEP: 0 cmH2O
   FiO2: 40%
   SpO2: 100%
   ABG: 7.48/28/124/19/0
   Ve: 9.8 L/min
   PaO2 / FiO2: 310
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   75 K/uL
   11.2 g/dL
   117 mg/dL
   0.9 mg/dL
   19 mEq/L
   3.7 mEq/L
   31 mg/dL
   111 mEq/L
   140 mEq/L
   31.3 %
   27.0 K/uL
        [image002.jpg]
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
   WBC
   30.3
   27.0
   Hct
   36.0
   29.9
   29.8
   31.3
   Plt
   90
   75
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   117
   157
   157
   137
   117
   Other labs: PT / PTT / INR:15.0/33.9/1.3, ALT / AST:262/68, Alk Phos /
   T Bili:447/1.3, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:863 IU/L, Ca++:7.8 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Since yesterday, ETT tip is now in expected position. Nasogastric tube
   ends
   below the diaphragm with its tip not imaged on this study. Pulmonary
   edema
   improved. Small left pleural effusion is unchanged. Severe left basal
   atelectasis is unchanged. Milder atelectasis at the right base is also
   stable. Heart size and hilar contours are normal.
   [**4-16**] CSF:   VRE (tigecycline sensitivities pending)
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now with VRE (amp R,
   linezolid S)  in CSF, presumably the same bacteria which was in the
   blood previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - d/w micro re: additional sensitivities: tigacycline?
   # HYPOTENSION:  New on [**4-18**],  did not respond to bolus and required
   levophed until this morning.  Lactate also elevated, likely secondary
   to poor perfusion.  Differential includes sepsis, and her new
   leukocytosis would go along with this (although ID feels that this is
   more likely [**1-1**] G-CSF and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, CNS etiology. Adreanl insufficeincy r/o by
   [**Last Name (un) **] stim. Limbs are warm, neck veins difficult to assess, and there is
   some question about the accuracy of art line BP [**Location (un) 103**].
   - monitor BP of pressors, low threshold to resume levophed to maintain
   MAP > 65
   - trend lactate
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest.
   Cause is most likely intracranial process (ongoing infection, recent
   surgery).  PE was on the differential but LENIs negative; unable to do
   CTA [**1-1**] contrast allergy.  There is some concern for the risk of
   seizure with alkalemia, but we are not able to give opiates to depress
   her respiratory drive because of hypotension.  Previously mental status
   has been major boundary to extubation, but improvement today permits
   SBT
   - SBT with possible extubation
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms) and GCSF, however very CONTINUED bump today
   to 30 is also concerning.   She has been afebrile since her evacuation
   procedure and is on very broad coverage as above.  Will work-up for
   infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Some concern for DIC in this woman with
   cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:  tube feeds
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) who has relapsed and developed central nervous system (CNS) involvement. She has undergone multiple treatments, including chemotherapy and intrathecal chemotherapy, and has been intubated since a cardiac arrest. The patient has been diagnosed with sepsis without organ dysfunction, VRE in the CNS, and possible recurrent CNS lymphoma.

The patient's current condition is as follows:

* Respiratory: intubated, with improved mental status and able to respond verbally and follow commands
* Cardiovascular: hypotensive, with a MAP of 65, and elevated lactate levels
* Neurological: altered mental status, with improved withdrawal to stimulation
* Hematological: leukocytosis, with a WBC count of 30.3
* Liver enzymes: elevated, but downtrending
* Coagulopathy: INR slightly elevated, with bleeding from lines

Potential medical complications:

1. Sepsis: the patient's sepsis has not yet resolved, and she remains at risk for further complications, including organ dysfunction and death.
2. VRE infection: the patient has VRE in her CNS, which may not be fully treated with current antibiotics, and may require longer-term treatment.
3. Recurrent CNS lymphoma: the patient's recurrent CNS lymphoma may require further treatment, including chemotherapy and radiation therapy.
4. Coagulopathy: the patient's INR is slightly elevated, and she is bleeding from lines, which may increase her risk of bleeding complications.
5. Cardiac dysfunction: the patient's cardiac function has worsened since her cardiac arrest, and she may require further treatment to improve her cardiac function.
6. Respiratory failure: the patient remains intubated, and her respiratory function may not be fully recovered, which may increase her risk of respiratory failure.
7. Gastrointestinal bleeding: the patient's elevated liver enzymes and coagulopathy may increase her risk of gastrointestinal bleeding.
8. Infection: the patient's immunocompromised state and ongoing infection may increase her risk of developing further infections.

Assessment and plan:

The patient's sepsis, VRE infection, and coagulopathy require ongoing treatment and monitoring. The patient's altered mental status and respiratory failure require continued respiratory support and monitoring. The patient's cardiac dysfunction and recurrent CNS lymphoma require further evaluation and treatment. The patient's gastrointestinal bleeding and infection risk require ongoing monitoring and prophylaxis."
112508.0,247400,2176-04-20 06:56:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2176-4-19**] 03:01 PM
   - Extubated, with improved mental status over the course of the day and
   able to respond verbally and follow comands by evening
   - No TEE done
   - CVL femoral ok to stay unless spikes again
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-19**] 09:57 AM
   Micafungin - [**2176-4-19**] 07:58 PM
   Linezolid - [**2176-4-20**] 02:33 AM
   Acyclovir - [**2176-4-20**] 06:00 AM
   Infusions:
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-19**] 06:25 PM
   Heparin Sodium (Prophylaxis) - [**2176-4-19**] 11:11 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-20**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.4
C (95.8
   HR: 88 (83 - 107) bpm
   BP: 119/76(93) {88/60(72) - 132/87(105)} mmHg
   RR: 18 (15 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  3,364 mL
                                                                    568 mL
   PO:
             TF:
                                                                    542 mL
   IVF:
                                                                  2,743 mL
                                                                    568 mL
   Blood products:
   Total out:
                                                                  2,958 mL
                                                                    975 mL
   Urine:
                                                                  2,808 mL
                                                                    975 mL
   NG:
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                    406 mL
                                                                   -408 mL
   Respiratory support
   O2 Delivery Device: Face tent
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 330 (330 - 451) mL
   PS : 0 cmH2O
   RR (Spontaneous): 22
   PEEP: 0 cmH2O
   FiO2: 40%
   SpO2: 100%
   ABG: 7.48/28/124/19/0
   Ve: 9.8 L/min
   PaO2 / FiO2: 310
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   75 K/uL
   11.2 g/dL
   117 mg/dL
   0.9 mg/dL
   19 mEq/L
   3.7 mEq/L
   31 mg/dL
   111 mEq/L
   140 mEq/L
   31.3 %
   27.0 K/uL
        [image002.jpg]
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
   WBC
   30.3
   27.0
   Hct
   36.0
   29.9
   29.8
   31.3
   Plt
   90
   75
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   117
   157
   157
   137
   117
   Other labs: PT / PTT / INR:15.0/33.9/1.3, ALT / AST:262/68, Alk Phos /
   T Bili:447/1.3, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:863 IU/L, Ca++:7.8 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Since yesterday, ETT tip is now in expected position. Nasogastric tube
   ends
   below the diaphragm with its tip not imaged on this study. Pulmonary
   edema
   improved. Small left pleural effusion is unchanged. Severe left basal
   atelectasis is unchanged. Milder atelectasis at the right base is also
   stable. Heart size and hilar contours are normal.
   [**4-16**] CSF:   VRE (tigecycline sensitivities pending)
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now with VRE (amp R,
   linezolid S)  in CSF, presumably the same bacteria which was in the
   blood previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - f/u tigacycline sensitivities as this may be a better choice in the
   long-run
   .
   # LEUKOCYTOSIS:   Most likely secondary to GCSF.  No blasts or
   singificant lymphs to suggest recurrence of ALL.  There is also some
   suspicion for infection given recent hypotensive episode.  However, she
   has been afebrile since the procedure.  She is now off pressors and
   hemodynamically stable, and she has been afebrile since her evacuation
   procedure and is on very broad coverage as above.   C diff negative x
   2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   .
   # HYPOTENSION:  Required levophed [**2089-4-17**].  Now  off pressors and
   hemodynamically stable.  Lactate now trending down.  Adrenal
   insufficiency ruled out by [**Last Name (un) **] stim.  Low suspicion for sepsis
   currently and all cx negative.  d
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest.
   Cause is most likely intracranial process (ongoing infection, recent
   surgery).  PE was on the differential but LENIs negative; unable to do
   CTA [**1-1**] contrast allergy.  There is some concern for the risk of
   seizure with alkalemia, but we are not able to give opiates to depress
   her respiratory drive because of hypotension.  Previously mental status
   has been major boundary to extubation, but improvement today permits
   SBT
   - SBT with possible extubation
   .
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Some concern for DIC in this woman with
   cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:  tube feeds
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2176-4-19**] 03:01 PM
   - Extubated, with improved mental status over the course of the day and
   able to respond verbally and follow comands by evening
   - No TEE done
   - CVL femoral ok to stay unless spikes again
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-19**] 09:57 AM
   Micafungin - [**2176-4-19**] 07:58 PM
   Linezolid - [**2176-4-20**] 02:33 AM
   Acyclovir - [**2176-4-20**] 06:00 AM
   Infusions:
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-19**] 06:25 PM
   Heparin Sodium (Prophylaxis) - [**2176-4-19**] 11:11 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-20**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.4
C (95.8
   HR: 88 (83 - 107) bpm
   BP: 119/76(93) {88/60(72) - 132/87(105)} mmHg
   RR: 18 (15 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  3,364 mL
                                                                    568 mL
   PO:
             TF:
                                                                    542 mL
   IVF:
                                                                  2,743 mL
                                                                    568 mL
   Blood products:
   Total out:
                                                                  2,958 mL
                                                                    975 mL
   Urine:
                                                                  2,808 mL
                                                                    975 mL
   NG:
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                    406 mL
                                                                   -408 mL
   Respiratory support
   O2 Delivery Device: Face tent
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 330 (330 - 451) mL
   PS : 0 cmH2O
   RR (Spontaneous): 22
   PEEP: 0 cmH2O
   FiO2: 40%
   SpO2: 100%
   ABG: 7.48/28/124/19/0
   Ve: 9.8 L/min
   PaO2 / FiO2: 310
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   75 K/uL
   11.2 g/dL
   117 mg/dL
   0.9 mg/dL
   19 mEq/L
   3.7 mEq/L
   31 mg/dL
   111 mEq/L
   140 mEq/L
   31.3 %
   27.0 K/uL
        [image002.jpg]
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
   WBC
   30.3
   27.0
   Hct
   36.0
   29.9
   29.8
   31.3
   Plt
   90
   75
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   117
   157
   157
   137
   117
   Other labs: PT / PTT / INR:15.0/33.9/1.3, ALT / AST:262/68, Alk Phos /
   T Bili:447/1.3, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:863 IU/L, Ca++:7.8 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Since yesterday, ETT tip is now in expected position. Nasogastric tube
   ends
   below the diaphragm with its tip not imaged on this study. Pulmonary
   edema
   improved. Small left pleural effusion is unchanged. Severe left basal
   atelectasis is unchanged. Milder atelectasis at the right base is also
   stable. Heart size and hilar contours are normal.
   [**4-16**] CSF:   VRE (tigecycline sensitivities pending)
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now with VRE (amp R,
   linezolid S)  in CSF, presumably the same bacteria which was in the
   blood previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - f/u tigacycline sensitivities as this may be a better choice in the
   long-run
   .
   # LEUKOCYTOSIS:   Most likely secondary to GCSF.  No blasts or
   singificant lymphs to suggest recurrence of ALL.  There is also some
   suspicion for infection given recent hypotensive episode.  However, she
   has been afebrile since the procedure.  She is now off pressors and
   hemodynamically stable, and she has been afebrile since her evacuation
   procedure and is on very broad coverage as above.   C diff negative x
   2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   .
   # HYPOTENSION:  Required levophed [**2089-4-17**].  Now  off pressors and
   hemodynamically stable.  Lactate now trending down.  Adrenal
   insufficiency ruled out by [**Last Name (un) **] stim.  Low suspicion for sepsis
   currently and all cx negative.  d
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest.
   Cause is most likely intracranial process (ongoing infection, recent
   surgery).  PE was on the differential but LENIs negative; unable to do
   CTA [**1-1**] contrast allergy.  There is some concern for the risk of
   seizure with alkalemia, but we are not able to give opiates to depress
   her respiratory drive because of hypotension.  Previously mental status
   has been major boundary to extubation, but improvement today permits
   SBT
   - SBT with possible extubation
   .
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Some concern for DIC in this woman with
   cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:  tube feeds
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 60-year-old woman with a lengthy history of acute lymphoblastic leukemia (ALL), who has undergone treatment, including intrathecal chemotherapy, and has developed a recurrence of ALL with CNS involvement. She has been intubated since cardiac arrest and has been treated with various antibiotics and antifungals.

The patient's current condition is as follows:

* She is extubated and able to respond verbally and follow commands.
* Her mental status has improved, but she still has altered mental status.
* She has a diffuse maculopapular erythematous rash on her back, which is concerning for a drug allergy.
* Her liver enzymes are elevated, consistent with shock liver.
* She has a low suspicion for sepsis and is on broad-spectrum antimicrobial coverage.
* She has a low suspicion for DVT and is on prophylaxis.

Potential medical complications that may arise include:

* Sepsis: The patient has a low suspicion for sepsis, but she is still at risk due to her underlying condition and the presence of a central line.
* Drug allergy: The patient's rash may be a sign of a drug allergy, and she should be monitored closely for any further reactions.
* Liver dysfunction: The patient's elevated liver enzymes may indicate liver dysfunction, and she should be monitored for any further changes.
* Coagulopathy: The patient has a slightly elevated INR and is bleeding from her lines, which may indicate coagulopathy.
* DIC: The patient's cancer and ongoing infection may increase her risk of developing disseminated intravascular coagulation (DIC).
* Respiratory failure: The patient's underlying condition and her recent cardiac arrest may increase her risk of respiratory failure.
* Cardiovascular instability: The patient's recent cardiac arrest and her underlying condition may increase her risk of cardiovascular instability.

The patient's treatment plan includes:

* Continue linezolid and gentamicin for CNS infection.
* Monitor the patient's rash and adjust her antibiotic regimen as needed.
* Monitor the patient's liver enzymes and adjust her treatment plan as needed.
* Monitor the patient's coagulopathy and adjust her treatment plan as needed.
* Continue to monitor the patient's respiratory status and adjust her treatment plan as needed.
* Consider further treatment for CNS lymphoma in the future.

The patient's code status is full code, and her disposition is ICU care."
112508.0,247400,2176-04-20 06:56:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2176-4-19**] 03:01 PM
   - Extubated, with improved mental status over the course of the day and
   able to respond verbally and follow comands by evening
   - No TEE done, will need to be done eventually but not emergent
   - CVL femoral ok to stay unless spikes again
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-19**] 09:57 AM
   Micafungin - [**2176-4-19**] 07:58 PM
   Linezolid - [**2176-4-20**] 02:33 AM
   Acyclovir - [**2176-4-20**] 06:00 AM
   Infusions:
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-19**] 06:25 PM
   Heparin Sodium (Prophylaxis) - [**2176-4-19**] 11:11 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-20**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.4
C (95.8
   HR: 88 (83 - 107) bpm
   BP: 119/76(93) {88/60(72) - 132/87(105)} mmHg
   RR: 18 (15 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  3,364 mL
                                                                    568 mL
   PO:
             TF:
                                                                    542 mL
   IVF:
                                                                  2,743 mL
                                                                    568 mL
   Blood products:
   Total out:
                                                                  2,958 mL
                                                                    975 mL
   Urine:
                                                                  2,808 mL
                                                                    975 mL
   NG:
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                    406 mL
                                                                   -408 mL
   Respiratory support
   O2 Delivery Device: Face tent
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 330 (330 - 451) mL
   PS : 0 cmH2O
   RR (Spontaneous): 22
   PEEP: 0 cmH2O
   FiO2: 40%
   SpO2: 100%
   ABG: 7.48/28/124/19/0
   Ve: 9.8 L/min
   PaO2 / FiO2: 310
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive, alert, appropriate,
   following commans
   Head, Ears, Nose, Throat:  face tent, breathing comfortably
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back,
   appears less erythematous than yesterday
   Neurologic: following commands and answering appropriately, can name
   [**1-2**] children
   Labs / Radiology
   75 K/uL
   11.2 g/dL
   117 mg/dL
   0.9 mg/dL
   19 mEq/L
   3.7 mEq/L
   31 mg/dL
   111 mEq/L
   140 mEq/L
   31.3 %
   27.0 K/uL
        [image002.jpg]
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
   WBC
   30.3
   27.0
   Hct
   36.0
   29.9
   29.8
   31.3
   Plt
   90
   75
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   117
   157
   157
   137
   117
   Other labs: PT / PTT / INR:15.0/33.9/1.3, ALT / AST:262/68, Alk Phos /
   T Bili:447/1.3, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:863 IU/L, Ca++:7.8 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Since yesterday, ETT tip is now in expected position. Nasogastric tube
   ends
   below the diaphragm with its tip not imaged on this study. Pulmonary
   edema
   improved. Small left pleural effusion is unchanged. Severe left basal
   atelectasis is unchanged. Milder atelectasis at the right base is also
   stable. Heart size and hilar contours are normal.
   [**4-16**] CSF:   VRE (tigecycline sensitivities pending)
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but VRE (amp R, linezolid
   S)  in CSF, presumably the same bacteria which was in the blood
   previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE next weak for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - f/u tigacycline sensitivities as this may be a better choice in the
   long-run
   - consider d/c gentamicin
   .
   # LEUKOCYTOSIS:   Most likely secondary to GCSF.  No blasts or
   singificant lymphs to suggest recurrence of ALL.  There is also some
   suspicion for infection given recent hypotensive episode.  However, she
   has been afebrile since the procedure.  She is now off pressors and
   hemodynamically stable, and she has been afebrile since her evacuation
   procedure and is on very broad coverage as above.   C diff negative x
   2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   .
   # HYPOTENSION:  Required levophed [**2089-4-17**].  Now  off pressors and
   hemodynamically stable.  Lactate now trending down.  Adrenal
   insufficiency ruled out by [**Last Name (un) **] stim.  Low suspicion for sepsis
   currently, afebrile and all cx negative.
   # ALTERED MENTAL STATUS:  Improved today, conversant.  This is likely
   multifactorial including recent SDH, prolonged asystolic arrest, CNS
   infection, possible recurrent CNS lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   - discuss with BMT stopping the acyclovir given that all viral cx
   negative
   .
   # RESPIRATORY FAILURE:  Now extubated, oxygenating well on face tent
   and with improvement in respiratory alkalosis.
   Likely has some volume overload as seen on cxr but making good urine.
   - allow auto-diuresis, aim for net even to negative.
   .
   # RASH:  Appears improved today.  Concerning for a drug allergy.
   Meropenem was a possible culprit, now off for 3 days.  After discussion
   with ID, meropenem is a likely culprit.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending except alk phos which remains elevated.  Tbili normal.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Low suspicion for DIC currently.
   .
   # ACCESS:  has clots in her upper extremity veins, access has been
   difficult.  Currently has femoral line.
   - discuss with IR changing line over a wire
   ICU Care
   Nutrition:  tube feeds
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2176-4-19**] 03:01 PM
   - Extubated, with improved mental status over the course of the day and
   able to respond verbally and follow comands by evening
   - No TEE done, will need to be done eventually but not emergent
   - CVL femoral ok to stay unless spikes again
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-19**] 09:57 AM
   Micafungin - [**2176-4-19**] 07:58 PM
   Linezolid - [**2176-4-20**] 02:33 AM
   Acyclovir - [**2176-4-20**] 06:00 AM
   Infusions:
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-19**] 06:25 PM
   Heparin Sodium (Prophylaxis) - [**2176-4-19**] 11:11 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-20**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.4
C (95.8
   HR: 88 (83 - 107) bpm
   BP: 119/76(93) {88/60(72) - 132/87(105)} mmHg
   RR: 18 (15 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  3,364 mL
                                                                    568 mL
   PO:
             TF:
                                                                    542 mL
   IVF:
                                                                  2,743 mL
                                                                    568 mL
   Blood products:
   Total out:
                                                                  2,958 mL
                                                                    975 mL
   Urine:
                                                                  2,808 mL
                                                                    975 mL
   NG:
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                    406 mL
                                                                   -408 mL
   Respiratory support
   O2 Delivery Device: Face tent
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 330 (330 - 451) mL
   PS : 0 cmH2O
   RR (Spontaneous): 22
   PEEP: 0 cmH2O
   FiO2: 40%
   SpO2: 100%
   ABG: 7.48/28/124/19/0
   Ve: 9.8 L/min
   PaO2 / FiO2: 310
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive, alert, appropriate,
   following commans
   Head, Ears, Nose, Throat:  face tent, breathing comfortably
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back,
   appears less erythematous than yesterday
   Neurologic: following commands and answering appropriately, can name
   [**1-2**] children
   Labs / Radiology
   75 K/uL
   11.2 g/dL
   117 mg/dL
   0.9 mg/dL
   19 mEq/L
   3.7 mEq/L
   31 mg/dL
   111 mEq/L
   140 mEq/L
   31.3 %
   27.0 K/uL
        [image002.jpg]
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
   WBC
   30.3
   27.0
   Hct
   36.0
   29.9
   29.8
   31.3
   Plt
   90
   75
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   117
   157
   157
   137
   117
   Other labs: PT / PTT / INR:15.0/33.9/1.3, ALT / AST:262/68, Alk Phos /
   T Bili:447/1.3, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:863 IU/L, Ca++:7.8 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Since yesterday, ETT tip is now in expected position. Nasogastric tube
   ends
   below the diaphragm with its tip not imaged on this study. Pulmonary
   edema
   improved. Small left pleural effusion is unchanged. Severe left basal
   atelectasis is unchanged. Milder atelectasis at the right base is also
   stable. Heart size and hilar contours are normal.
   [**4-16**] CSF:   VRE (tigecycline sensitivities pending)
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but VRE (amp R, linezolid
   S)  in CSF, presumably the same bacteria which was in the blood
   previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE next weak for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - f/u tigacycline sensitivities as this may be a better choice in the
   long-run
   - consider d/c gentamicin
   .
   # LEUKOCYTOSIS:   Most likely secondary to GCSF.  No blasts or
   singificant lymphs to suggest recurrence of ALL.  There is also some
   suspicion for infection given recent hypotensive episode.  However, she
   has been afebrile since the procedure.  She is now off pressors and
   hemodynamically stable, and she has been afebrile since her evacuation
   procedure and is on very broad coverage as above.   C diff negative x
   2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   .
   # HYPOTENSION:  Required levophed [**2089-4-17**].  Now  off pressors and
   hemodynamically stable.  Lactate now trending down.  Adrenal
   insufficiency ruled out by [**Last Name (un) **] stim.  Low suspicion for sepsis
   currently, afebrile and all cx negative.
   # ALTERED MENTAL STATUS:  Improved today, conversant.  This is likely
   multifactorial including recent SDH, prolonged asystolic arrest, CNS
   infection, possible recurrent CNS lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   - discuss with BMT stopping the acyclovir given that all viral cx
   negative
   .
   # RESPIRATORY FAILURE:  Now extubated, oxygenating well on face tent
   and with improvement in respiratory alkalosis.
   Likely has some volume overload as seen on cxr but making good urine.
   - allow auto-diuresis, aim for net even to negative.
   .
   # RASH:  Appears improved today.  Concerning for a drug allergy.
   Meropenem was a possible culprit, now off for 3 days.  After discussion
   with ID, meropenem is a likely culprit.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending except alk phos which remains elevated.  Tbili normal.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Low suspicion for DIC currently.
   .
   # ACCESS:  has clots in her upper extremity veins, access has been
   difficult.  Currently has femoral line.
   - discuss with IR changing line over a wire
   ICU Care
   Nutrition:  tube feeds
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 60-year-old woman with a lengthy history of acute lymphoblastic leukemia (ALL) and past successful treatment, now with recurrence including CNS involvement. She has undergone cardiac arrest and intubation, and removal of the Omaya port and evacuation of subdural hematoma (SDH).

The patient has been diagnosed with sepsis without organ dysfunction, airway compromise, impaired skin integrity, altered mental status, and fever of unknown origin. She has also been diagnosed with leukocytosis, hypotension, and altered mental status.

The patient has been receiving various medications, including linezolid, gentamicin, and micafungin, for her infections. She has also been receiving tube feeds and has been monitored for glycemic control.

The patient's physical examination reveals a diffuse maculopapular erythematous rash on her back, which appears to be improving. She has also been experiencing respiratory failure, which has been treated with extubation and oxygen therapy.

The patient's laboratory results show elevated liver enzymes, which are consistent with shock liver. Her coagulation profile shows an elevated INR, which is being monitored. She has also been experiencing bleeding from her lines, which is being treated with platelet transfusions.

The patient's neurologic status has improved, and she is now able to follow commands and answer questions appropriately. Her mental status has also improved, and she is no longer experiencing confusion or disorientation.

The patient's medical history includes a history of cardiac arrest, which has resulted in significant damage to her heart. She has also undergone chemotherapy for her leukemia, which has caused damage to her heart and lungs.

The patient's current condition is stable, and she is being monitored closely for any changes in her status. She is at risk for developing further complications, including respiratory failure, sepsis, and cardiac arrest.

Potential medical complications that can arise include:

1. Respiratory failure: The patient's respiratory failure can worsen, leading to further decline in her oxygenation and ventilation.
2. Sepsis: The patient's sepsis can progress to septic shock, leading to further organ dysfunction and potential mortality.
3. Cardiac arrest: The patient's cardiac arrest can recur, leading to further damage to her heart and potential mortality.
4. Leukemia recurrence: The patient's leukemia can recur, leading to further treatment and potential complications.
5. Infection: The patient can develop further infections, including pneumonia, urinary tract infections, and bloodstream infections.
6. Bleeding: The patient can experience further bleeding, including bleeding from her lines and gastrointestinal bleeding.
7. Liver dysfunction: The patient's liver dysfunction can worsen, leading to further elevation of her liver enzymes and potential liver failure.
8. Kidney dysfunction: The patient's kidney dysfunction can worsen, leading to further decline in her kidney function and potential kidney failure.

Overall, the patient's condition is complex and requires close monitoring and management to prevent further complications."
112508.0,247400,2176-04-21 07:17:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   NGT placed/TF started
   Femoral line changed over wire by IR
   c diff x 2 negative, 3rd pending
   d/c'ed gentamicin per ID
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-20**] 07:35 PM
   Linezolid - [**2176-4-21**] 02:30 AM
   Acyclovir - [**2176-4-21**] 06:22 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-20**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-20**] 01:16 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-21**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 98 (82 - 105) bpm
   BP: 128/83(101) {95/60(74) - 128/83(101)} mmHg
   RR: 18 (15 - 28) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  1,500 mL
                                                                    532 mL
   PO:
             TF:
             86 mL
   IVF:
                                                                  1,500 mL
                                                                    447 mL
   Blood products:
   Total out:
                                                                  2,044 mL
                                                                    335 mL
   Urine:
                                                                  2,044 mL
                                                                    335 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -544 mL
                                                                    197 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///18/
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive, alert, appropriate,
   following commands
   Head, Ears, Nose, Throat:  PERRL
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back,
   appears less erythematous than yesterday
   Neurologic: following commands and answering appropriately but slowly
   Labs / Radiology
   73 K/uL
   11.0 g/dL
   111 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.6 mEq/L
   28 mg/dL
   109 mEq/L
   137 mEq/L
   32.2 %
   23.7 K/uL
        [image002.jpg]  Ca++:7.6 mg/dL, Mg++:1.6 mg/dL, PO4:3.2 mg/dL
   Differential-Neuts:87.0 %, Band:5.0 %, Lymph:3.0 %, Mono:1.0 %, Eos:0.0
   %,
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
   WBC
   30.3
   27.0
   32.1
   23.7
   Hct
   36.0
   29.9
   29.8
   31.3
   32.2
   Plt
   90
   75
   73
   73
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   157
   157
   137
   117
   111
   ALT: 161 AP: 455 Tbili: 1.1
   AST: 52 LDH: 721
   PT: 15.2  PTT: 34.3  INR: 1.3
   Fibrinogen: 484
   Imaging: None
   Microbiology: [**4-21**]: Cath tip culture P
   [**Date range (1) 6157**] BCx pending
   Assessment and Plan
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  She is now doing
   well and awake s/p extubation, afebrile and her WBC count is trending
   downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   despite risk of CNS penetration. No TEE performed.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks) gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia, c. diff, ALL.
   Diff not consistent with return of ALL. C diff negative x 2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.
   -Trend LFTs and INR
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 20 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition: floor transfer
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   NGT placed/TF started
   Femoral line changed over wire by IR
   c diff x 2 negative, 3rd pending
   d/c'ed gentamicin per ID
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-20**] 07:35 PM
   Linezolid - [**2176-4-21**] 02:30 AM
   Acyclovir - [**2176-4-21**] 06:22 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-20**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-20**] 01:16 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-21**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 98 (82 - 105) bpm
   BP: 128/83(101) {95/60(74) - 128/83(101)} mmHg
   RR: 18 (15 - 28) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  1,500 mL
                                                                    532 mL
   PO:
             TF:
             86 mL
   IVF:
                                                                  1,500 mL
                                                                    447 mL
   Blood products:
   Total out:
                                                                  2,044 mL
                                                                    335 mL
   Urine:
                                                                  2,044 mL
                                                                    335 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -544 mL
                                                                    197 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///18/
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive, alert, appropriate,
   following commands
   Head, Ears, Nose, Throat:  PERRL
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back,
   appears less erythematous than yesterday
   Neurologic: following commands and answering appropriately but slowly
   Labs / Radiology
   73 K/uL
   11.0 g/dL
   111 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.6 mEq/L
   28 mg/dL
   109 mEq/L
   137 mEq/L
   32.2 %
   23.7 K/uL
        [image002.jpg]  Ca++:7.6 mg/dL, Mg++:1.6 mg/dL, PO4:3.2 mg/dL
   Differential-Neuts:87.0 %, Band:5.0 %, Lymph:3.0 %, Mono:1.0 %, Eos:0.0
   %,
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
   WBC
   30.3
   27.0
   32.1
   23.7
   Hct
   36.0
   29.9
   29.8
   31.3
   32.2
   Plt
   90
   75
   73
   73
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   157
   157
   137
   117
   111
   ALT: 161 AP: 455 Tbili: 1.1
   AST: 52 LDH: 721
   PT: 15.2  PTT: 34.3  INR: 1.3
   Fibrinogen: 484
   Imaging: None
   Microbiology: [**4-21**]: Cath tip culture P
   [**Date range (1) 6157**] BCx pending
   Assessment and Plan
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  She is now doing
   well and awake s/p extubation, afebrile and her WBC count is trending
   downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   despite risk of CNS penetration. No TEE performed.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks) gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia, c. diff, ALL.
   Diff not consistent with return of ALL. C diff negative x 2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.
   -Trend LFTs and INR
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 20 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition: floor transfer<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with recurrent acute lymphoblastic leukemia (ALL) and central nervous system (CNS) involvement, who underwent Omaya removal due to vancomycin-resistant Enterococcus (VRE) contamination and subdural hematoma evacuation. She is currently awake and afebrile, with a trending downward white blood cell count. The patient is receiving various medications, including linezolid, micafungin, and acyclovir, and has a history of gentamicin and meropenem use.

The patient's vital signs are stable, with a temperature of 36°C, heart rate of 98 bpm, and blood pressure of 128/83 mmHg. Her respiratory status is stable, with an oxygen saturation of 95% and no respiratory support. Her neurologic status is also stable, with a Glasgow Coma Scale (GCS) of 15 and no signs of increased intracranial pressure.

The patient's laboratory results show a white blood cell count of 30.3, with a differential count of 87.0% neutrophils, 5.0% bands, 3.0% lymphocytes, 1.0% monocytes, and 0.0% eosinophils. Her liver enzymes are elevated, with an aspartate aminotransferase (AST) level of 52 and an alanine aminotransferase (ALT) level of 161. Her blood urea nitrogen (BUN) and creatinine levels are within normal limits.

Potential medical complications:

1. Infection: The patient's history of CNS involvement and VRE contamination increases her risk of developing infections, including bacteremia and meningitis.
2. Liver dysfunction: The patient's elevated liver enzymes may indicate liver dysfunction, which could worsen if not addressed.
3. Leukocytosis: The patient's white blood cell count is elevated, which may indicate a return of her ALL or another underlying condition.
4. Thrombocytopenia: The patient's platelet count is low, which may increase her risk of bleeding.
5. Fluid imbalance: The patient's fluid balance is slightly negative, which may indicate dehydration or fluid overload.
6. Electrolyte imbalance: The patient's electrolyte levels, including calcium, magnesium, and phosphate, are within normal limits, but may require monitoring to prevent electrolyte imbalances.
7. Medication toxicity: The patient is receiving multiple medications, including linezolid, micafungin, and acyclovir, which may have toxic effects if not monitored closely.

Recommendations:

1. Continue to monitor the patient's vital signs, laboratory results, and medication levels to detect any potential complications early.
2. Adjust the patient's medications as needed to prevent toxicity and optimize treatment.
3. Monitor the patient's fluid and electrolyte balance to prevent dehydration or fluid overload.
4. Consider performing a lumbar puncture to rule out meningitis or other central nervous system infections.
5. Continue to follow the patient's liver enzymes and adjust treatment as needed to prevent liver dysfunction.
6. Monitor the patient's platelet count and adjust treatment as needed to prevent bleeding.
7. Consider performing a bone marrow biopsy to assess the patient's bone marrow function and detect any potential relapse of her ALL."
112508.0,247400,2176-04-21 07:17:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   NGT placed/TF started
   Femoral line changed over wire by IR
   c diff x 2 negative, 3rd pending
   d/c'ed gentamicin per ID
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-20**] 07:35 PM
   Linezolid - [**2176-4-21**] 02:30 AM
   Acyclovir - [**2176-4-21**] 06:22 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-20**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-20**] 01:16 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-21**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 98 (82 - 105) bpm
   BP: 128/83(101) {95/60(74) - 128/83(101)} mmHg
   RR: 18 (15 - 28) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  1,500 mL
                                                                    532 mL
   PO:
             TF:
             86 mL
   IVF:
                                                                  1,500 mL
                                                                    447 mL
   Blood products:
   Total out:
                                                                  2,044 mL
                                                                    335 mL
   Urine:
                                                                  2,044 mL
                                                                    335 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -544 mL
                                                                    197 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///18/
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive, alert, appropriate,
   following commans
   Head, Ears, Nose, Throat:  face tent, breathing comfortably
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back,
   appears less erythematous than yesterday
   Neurologic: following commands and answering appropriately, can name
   [**1-2**] children
   Labs / Radiology
   73 K/uL
   11.0 g/dL
   111 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.6 mEq/L
   28 mg/dL
   109 mEq/L
   137 mEq/L
   32.2 %
   23.7 K/uL
        [image002.jpg]  Ca++:7.6 mg/dL, Mg++:1.6 mg/dL, PO4:3.2 mg/dL
   Differential-Neuts:87.0 %, Band:5.0 %, Lymph:3.0 %, Mono:1.0 %, Eos:0.0
   %,
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
   WBC
   30.3
   27.0
   32.1
   23.7
   Hct
   36.0
   29.9
   29.8
   31.3
   32.2
   Plt
   90
   75
   73
   73
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   157
   157
   137
   117
   111
   ALT: 161 AP: 455 Tbili: 1.1
   AST: 52 LDH: 721
   PT: 15.2  PTT: 34.3  INR: 1.3
   Fibrinogen: 484
   Imaging: None
   Microbiology: [**4-21**]: Cath tip culture P
   [**Date range (1) 6157**] BCx pending
   Assessment and Plan
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  She is now doing
   well and awake s/p extubation, afebrile and her WBC count is trending
   downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   despite risk of CNS penetration. No TEE performed.  Will need 4-8 weeks
   of Linezolid.
   - continue linezolid (D1=[**4-16**]), gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - ?TEE next week for r/o vegetation to determine lenghth of TX
   - f/u tigacycline sensitivities as this may be a better choice in the
   long-run
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia, c. diff, ALL.
   Diff not consistent with return of ALL. C diff negative x 2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid
   # RESPIRATORY FAILURE:  Now extubated, oxygenating well on face tent
   and with improvement in respiratory alkalosis.
   Likely has some volume overload as seen on cxr but making good urine.
   - allow auto-diuresis, aim for net even to negative.
   # DRUH RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.
   -Trend LFTs and INR
   # S/P ASYSTOLIC ARREST:  temporally related to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 20 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU/Potential floor transfer
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   NGT placed/TF started
   Femoral line changed over wire by IR
   c diff x 2 negative, 3rd pending
   d/c'ed gentamicin per ID
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-20**] 07:35 PM
   Linezolid - [**2176-4-21**] 02:30 AM
   Acyclovir - [**2176-4-21**] 06:22 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-20**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-20**] 01:16 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-21**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 98 (82 - 105) bpm
   BP: 128/83(101) {95/60(74) - 128/83(101)} mmHg
   RR: 18 (15 - 28) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  1,500 mL
                                                                    532 mL
   PO:
             TF:
             86 mL
   IVF:
                                                                  1,500 mL
                                                                    447 mL
   Blood products:
   Total out:
                                                                  2,044 mL
                                                                    335 mL
   Urine:
                                                                  2,044 mL
                                                                    335 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -544 mL
                                                                    197 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///18/
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive, alert, appropriate,
   following commans
   Head, Ears, Nose, Throat:  face tent, breathing comfortably
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back,
   appears less erythematous than yesterday
   Neurologic: following commands and answering appropriately, can name
   [**1-2**] children
   Labs / Radiology
   73 K/uL
   11.0 g/dL
   111 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.6 mEq/L
   28 mg/dL
   109 mEq/L
   137 mEq/L
   32.2 %
   23.7 K/uL
        [image002.jpg]  Ca++:7.6 mg/dL, Mg++:1.6 mg/dL, PO4:3.2 mg/dL
   Differential-Neuts:87.0 %, Band:5.0 %, Lymph:3.0 %, Mono:1.0 %, Eos:0.0
   %,
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
   WBC
   30.3
   27.0
   32.1
   23.7
   Hct
   36.0
   29.9
   29.8
   31.3
   32.2
   Plt
   90
   75
   73
   73
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   157
   157
   137
   117
   111
   ALT: 161 AP: 455 Tbili: 1.1
   AST: 52 LDH: 721
   PT: 15.2  PTT: 34.3  INR: 1.3
   Fibrinogen: 484
   Imaging: None
   Microbiology: [**4-21**]: Cath tip culture P
   [**Date range (1) 6157**] BCx pending
   Assessment and Plan
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  She is now doing
   well and awake s/p extubation, afebrile and her WBC count is trending
   downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   despite risk of CNS penetration. No TEE performed.  Will need 4-8 weeks
   of Linezolid.
   - continue linezolid (D1=[**4-16**]), gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - ?TEE next week for r/o vegetation to determine lenghth of TX
   - f/u tigacycline sensitivities as this may be a better choice in the
   long-run
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia, c. diff, ALL.
   Diff not consistent with return of ALL. C diff negative x 2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid
   # RESPIRATORY FAILURE:  Now extubated, oxygenating well on face tent
   and with improvement in respiratory alkalosis.
   Likely has some volume overload as seen on cxr but making good urine.
   - allow auto-diuresis, aim for net even to negative.
   # DRUH RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.
   -Trend LFTs and INR
   # S/P ASYSTOLIC ARREST:  temporally related to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 20 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU/Potential floor transfer<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 60-year-old woman with recurrent acute lymphoblastic leukemia (ALL) and central nervous system (CNS) involvement, who has undergone Omaya removal due to VRE contamination and SDH evacuation. She is currently awake and extubated, afebrile, and her white blood cell count is trending downward.

The patient has several medical complications, including:

1. Leukocytosis: The patient has a high white blood cell count, which is not consistent with the return of ALL. The cause of leukocytosis is unknown and requires further investigation.
2. C. difficile colitis: The patient has tested negative for C. difficile twice, but the diagnosis is still pending.
3. ALL: The patient is currently on day +43 of hyper-CVAD chemotherapy and has undergone intrathecal methotrexate and donor lymphocyte infusion (DLI) this admission. She will require further treatment for CNS lymphoma in the future.
4. Respiratory failure: The patient has been extubated and is oxygenating well on a face tent, but has some volume overload as seen on chest X-ray. She is making good urine output and will be allowed to auto-diurese with a goal of net even to negative fluid balance.
5. Drug rash: The patient has developed a rash, which is likely due to meropenem, and has improved today.
6. Elevated liver enzymes: The patient has elevated liver enzymes, which are consistent with shock liver and are resolving.
7. Asystolic arrest: The patient had an asystolic arrest temporally related to calcium channel blocker (CCB) use in the setting of a heart compromised by prior cardiotoxic chemotherapy. Her recent echocardiogram showed significant interval worsening of ejection fraction (EF) from 40% to 20% over the past 2 weeks without any focal wall motion abnormalities.

The patient's current medications include:

* Linezolid for CNS penetration
* Acyclovir for viral prophylaxis
* Micafungin for fungal prophylaxis
* Pantoprazole for stress ulcer prophylaxis
* Heparin sodium for prophylaxis against deep vein thrombosis (DVT)

The patient's laboratory results include:

* White blood cell count: 30.3 x 10^9/L
* Hemoglobin: 11.0 g/dL
* Platelet count: 90 x 10^9/L
* Creatinine: 0.9 mg/dL
* Blood urea nitrogen (BUN): 18 mg/dL
* Glucose: 157 mg/dL
* Alanine aminotransferase (ALT): 161 IU/L
* Aspartate aminotransferase (AST): 52 IU/L
* Lactate dehydrogenase (LDH): 721 IU/L
* Prothrombin time (PT): 15.2 seconds
* Partial thromboplastin time (PTT): 34.3 seconds
* International normalized ratio (INR): 1.3
* Fibrinogen: 484 mg/dL

The patient's plan includes:

* Continuing linezolid for 4-8 weeks
* Following up on culture data and sensitivities
* Considering Tigacycline as a potential alternative to linezolid
* Performing a transesophageal echocardiogram (TEE) next week to rule out vegetation and determine the length of treatment
* Following up on blood and sputum cultures
* Treating C. difficile colitis if it is confirmed
* Continuing broad-spectrum antimicrobial therapy
* Monitoring liver enzymes and INR
* Avoiding nodal agents
* Repleting electrolytes aggressively, with particular attention to calcium."
112508.0,247400,2176-04-21 07:17:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   NGT placed/TF started
   Femoral line changed over wire by IR
   c diff x 2 negative, 3rd pending
   d/c'ed gentamicin per ID
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-20**] 07:35 PM
   Linezolid - [**2176-4-21**] 02:30 AM
   Acyclovir - [**2176-4-21**] 06:22 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-20**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-20**] 01:16 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-21**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 98 (82 - 105) bpm
   BP: 128/83(101) {95/60(74) - 128/83(101)} mmHg
   RR: 18 (15 - 28) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  1,500 mL
                                                                    532 mL
   PO:
             TF:
             86 mL
   IVF:
                                                                  1,500 mL
                                                                    447 mL
   Blood products:
   Total out:
                                                                  2,044 mL
                                                                    335 mL
   Urine:
                                                                  2,044 mL
                                                                    335 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -544 mL
                                                                    197 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///18/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   73 K/uL
   11.0 g/dL
   111 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.6 mEq/L
   28 mg/dL
   109 mEq/L
   137 mEq/L
   32.2 %
   23.7 K/uL
        [image002.jpg]  Ca++:7.6 mg/dL, Mg++:1.6 mg/dL, PO4:3.2 mg/dL
   Differential-Neuts:87.0 %, Band:5.0 %, Lymph:3.0 %, Mono:1.0 %, Eos:0.0
   %,
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
   WBC
   30.3
   27.0
   32.1
   23.7
   Hct
   36.0
   29.9
   29.8
   31.3
   32.2
   Plt
   90
   75
   73
   73
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   157
   157
   137
   117
   111
   ALT: 161 AP: 455 Tbili: 1.1
   AST: 52 LDH: 721
   PT: 15.2  PTT: 34.3  INR: 1.3
   Fibrinogen: 484
   Imaging: None
   Microbiology: [**4-21**]: Cath tip culture P
   [**Date range (1) 6157**] BCx pending
   Assessment and Plan
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 20 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU/Potential floor transfer
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   NGT placed/TF started
   Femoral line changed over wire by IR
   c diff x 2 negative, 3rd pending
   d/c'ed gentamicin per ID
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-20**] 07:35 PM
   Linezolid - [**2176-4-21**] 02:30 AM
   Acyclovir - [**2176-4-21**] 06:22 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-20**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-20**] 01:16 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-21**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 98 (82 - 105) bpm
   BP: 128/83(101) {95/60(74) - 128/83(101)} mmHg
   RR: 18 (15 - 28) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  1,500 mL
                                                                    532 mL
   PO:
             TF:
             86 mL
   IVF:
                                                                  1,500 mL
                                                                    447 mL
   Blood products:
   Total out:
                                                                  2,044 mL
                                                                    335 mL
   Urine:
                                                                  2,044 mL
                                                                    335 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -544 mL
                                                                    197 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///18/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   73 K/uL
   11.0 g/dL
   111 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.6 mEq/L
   28 mg/dL
   109 mEq/L
   137 mEq/L
   32.2 %
   23.7 K/uL
        [image002.jpg]  Ca++:7.6 mg/dL, Mg++:1.6 mg/dL, PO4:3.2 mg/dL
   Differential-Neuts:87.0 %, Band:5.0 %, Lymph:3.0 %, Mono:1.0 %, Eos:0.0
   %,
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
   WBC
   30.3
   27.0
   32.1
   23.7
   Hct
   36.0
   29.9
   29.8
   31.3
   32.2
   Plt
   90
   75
   73
   73
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   157
   157
   137
   117
   111
   ALT: 161 AP: 455 Tbili: 1.1
   AST: 52 LDH: 721
   PT: 15.2  PTT: 34.3  INR: 1.3
   Fibrinogen: 484
   Imaging: None
   Microbiology: [**4-21**]: Cath tip culture P
   [**Date range (1) 6157**] BCx pending
   Assessment and Plan
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 20 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU/Potential floor transfer<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 24-hour-old ICU admission with a complex medical history. The patient's chief complaint is not specified, but the note mentions the placement of a nasogastric tube (NGT), a femoral line, and the discontinuation of gentamicin due to a positive Clostridium difficile (C. diff) test.

The patient has a history of allergies to sulfa, penicillins, latex, and red dye, and has experienced adverse reactions to Darvon, Percodan, and Aspirin.

The patient's vital signs are stable, with a temperature of 36°C (96.8°F), heart rate of 98 beats per minute (bpm), blood pressure of 128/83 mmHg, respiratory rate of 18 inspirations per minute (insp/min), and oxygen saturation of 95%.

The patient's laboratory results show:

* White blood cell count (WBC): 30.3-23.7 x 10^9/L
* Hemoglobin (Hb): 11.0-10.5 g/dL
* Platelet count (Plt): 90-73 x 10^9/L
* Creatinine (Cr): 0.9-0.8 mg/dL
* Blood urea nitrogen (BUN): 18-16 mg/dL
* Glucose: 157-111 mg/dL
* Liver enzymes: ALT 161, AST 52, LDH 721
* Coagulation studies: PT 15.2, PTT 34.3, INR 1.3
* Electrolytes: Na 137, K 3.6, Cl 109, HCO3 32.2

The patient's microbiology results show a positive C. diff test, and a pending blood culture.

The patient's medications include:

* Pantoprazole (Protonix) for stress ulcer prophylaxis
* Heparin sodium for prophylaxis against deep vein thrombosis (DVT)
* Other ICU medications, including antibiotics, antifungals, and pain management medications

The patient's plan includes:

* ICU care
* Nutrition with Nutren Pulmonary (Full) at 20 mL/hour
* Glycemic control
* Prophylaxis against DVT and stress ulcer
* Monitoring for ventilator-associated pneumonia (VAP)

Potential medical complications that may arise include:

* Sepsis due to the positive C. diff test
* Infection related to the femoral line or NGT
* Bleeding due to the use of anticoagulant medications
* Respiratory failure due to VAP or other respiratory complications
* Renal failure due to inadequate fluid management or underlying kidney disease
* Hepatic failure due to underlying liver disease or medication toxicity
* Cardiovascular instability due to hypotension or arrhythmias

It is essential to monitor the patient's vital signs, laboratory results, and clinical condition closely to prevent and manage these potential complications."
112508.0,247400,2176-04-22 07:09:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 24-hour-old patient in the ICU with a significant medical history, including leukemia and a recent arterial line stop. The patient has multiple medications and infusions, including antibiotics, antifungals, and anticoagulants.

The patient's vital signs are stable, with a temperature of 35.6°C, heart rate of 106 bpm, and blood pressure of 106/73 mmHg. The patient's respiratory rate is 16 breaths per minute, and oxygen saturation is 96% on room air.

The patient's laboratory results show a white blood cell count of 27.0 x 10^9/L, hemoglobin of 10.6 g/dL, and platelet count of 75 x 10^9/L. The patient's electrolyte levels are within normal limits, with the exception of a slightly elevated potassium level.

The patient's medical conditions include sepsis without organ dysfunction, cardiac dysrhythmia, alteration in nutrition, impaired skin integrity, and altered mental status. The patient is at risk for aspiration, altered gag reflex, and airway clearance due to their inability to protect their airway.

The patient's microbiology results show a negative CDiff test and pending results for a fungal culture.

The patient's plan includes continued ICU care, including nutrition, glycemic control, and prophylaxis for deep vein thrombosis, stress ulcer, and ventilator-associated pneumonia. The patient's code status is full code, and they are being considered for transfer to the floor.

Potential medical complications that can arise from this patient's conditions include:

1. Sepsis-related organ dysfunction: The patient's sepsis could progress to organ dysfunction, including acute kidney injury, acute respiratory distress syndrome, or hepatic failure.
2. Cardiac arrhythmias: The patient's cardiac dysrhythmia could worsen, leading to arrhythmias such as atrial fibrillation or ventricular tachycardia.
3. Nutritional deficiencies: The patient's altered nutrition could lead to deficiencies in essential nutrients, including protein, vitamins, and minerals.
4. Skin integrity issues: The patient's impaired skin integrity could lead to further complications, including skin breakdown, pressure ulcers, or infections.
5. Mental status changes: The patient's altered mental status could worsen, leading to delirium, agitation, or confusion.
6. Aspiration: The patient's inability to protect their airway could lead to aspiration of food, liquids, or other materials, potentially causing respiratory complications.
7. Ventilator-associated pneumonia: The patient's use of mechanical ventilation could increase their risk of developing ventilator-associated pneumonia.

It is essential to closely monitor the patient's condition and adjust their treatment plan accordingly to prevent these potential complications and improve their overall outcome."
112508.0,247400,2176-04-22 07:09:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  She is now doing
   well and awake s/p extubation, afebrile and her WBC count is trending
   downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   despite risk of CNS penetration. No TEE performed.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks) gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia, c. diff, ALL.
   Diff not consistent with return of ALL. C diff negative x 2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.
   -Trend LFTs and INR
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  She is now doing
   well and awake s/p extubation, afebrile and her WBC count is trending
   downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   despite risk of CNS penetration. No TEE performed.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks) gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia, c. diff, ALL.
   Diff not consistent with return of ALL. C diff negative x 2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.
   -Trend LFTs and INR
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of recurrent acute lymphoblastic leukemia (ALL) with central nervous system (CNS) involvement. She was admitted to the ICU for sepsis without organ dysfunction, cardiac dysrhythmia, and altered mental status. She has undergone various treatments, including Omaya removal, SDH evacuation, and chemotherapy. The patient is currently awake and afebrile, with a trending downward white blood cell count.

Potential Medical Complications:

1. Sepsis: The patient is at risk for sepsis due to her underlying leukemia and recent chemotherapy, which may have compromised her immune system.
2. Cardiac Dysrhythmia: The patient's cardiac rhythm is abnormal, which may lead to cardiac complications if not managed properly.
3. Leukocytosis: The patient's white blood cell count is elevated, which may indicate the presence of leukemia or infection.
4. C. difficile Infection: The patient has had two negative C. difficile tests, but it is still a potential complication to consider.
5. Liver Dysfunction: The patient's liver enzymes are elevated, which may be related to shock liver or chemotherapy.
6. Nutritional Deficiency: The patient is at risk for nutritional deficiency due to her underlying condition and recent chemotherapy.
7. Ventilator-Associated Pneumonia (VAP): The patient is at risk for VAP due to her prolonged stay in the ICU and recent intubation.
8. Deep Vein Thrombosis (DVT): The patient is at risk for DVT due to her prolonged immobility and recent chemotherapy.
9. Central Nervous System (CNS) Complications: The patient's history of CNS involvement with leukemia and recent chemotherapy may lead to CNS complications, such as seizures or stroke.

Recommendations:

1. Continue linezolid therapy for CNS penetration and monitor for potential side effects.
2. Discontinue gentamicin and monitor for potential side effects.
3. Repeat C. difficile testing and monitor for potential complications.
4. Follow CBC and differential counts to monitor for potential leukemia relapse.
5. Continue acyclovir, micafungin, and linezolid to prevent opportunistic infections.
6. Monitor liver enzymes and INR to ensure resolution of liver dysfunction.
7. Monitor nutritional status and provide adequate nutrition to prevent deficiency.
8. Monitor for signs of VAP and take measures to prevent it.
9. Monitor for signs of DVT and take measures to prevent it.
10. Monitor for CNS complications and take measures to prevent them."
112508.0,247400,2176-04-22 16:23:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  Intubated for
   cardiac arrest thought to be secondary to CCB in the setting of
   hypocalcemia. She is now doing well and awake s/p extubation, afebrile
   and her WBC count is trending downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   (compared to daptomycin) despite risk of CNS penetration. No VRE in
   blood for over one week.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks); gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time given recent extubation, would pursue
   within one week.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia vs c. diff vs
   ALL.  Diff not consistent with return of ALL per BMT. C diff negative x
   3 with a fourth pending. According to ID, timing and pattern fits best
   with GCST effect.  Now trending down over last two days.
   - f/u repeat c diff
   - f/u blood and sputum cx
   - continue to trend with differential
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.  Alk
   P only marker not trending down. Abd exam benign, would continue to
   trend at this point.
   -Trend LFTs and INR
   # Elevated PTT: Isolated elevation today, [**Last Name **] problem: Likely a
   spurious lab value; will repeat, if truly high, will send mixing
   studies
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
 consider S+S
   eval
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM ***(FEMORAL)***
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  Intubated for
   cardiac arrest thought to be secondary to CCB in the setting of
   hypocalcemia. She is now doing well and awake s/p extubation, afebrile
   and her WBC count is trending downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   (compared to daptomycin) despite risk of CNS penetration. No VRE in
   blood for over one week.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks); gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time given recent extubation, would pursue
   within one week.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia vs c. diff vs
   ALL.  Diff not consistent with return of ALL per BMT. C diff negative x
   3 with a fourth pending. According to ID, timing and pattern fits best
   with GCST effect.  Now trending down over last two days.
   - f/u repeat c diff
   - f/u blood and sputum cx
   - continue to trend with differential
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.  Alk
   P only marker not trending down. Abd exam benign, would continue to
   trend at this point.
   -Trend LFTs and INR
   # Elevated PTT: Isolated elevation today, [**Last Name **] problem: Likely a
   spurious lab value; will repeat, if truly high, will send mixing
   studies
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
 consider S+S
   eval
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM ***(FEMORAL)***
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 60-year-old woman with a history of recurrent acute lymphoblastic leukemia (ALL) and central nervous system (CNS) involvement. She is currently in the ICU due to cardiac arrest thought to be secondary to calcium channel blocker (CCB) in the setting of hypocalcemia.

The patient's current condition is as follows:

* Vital signs: Tmax 35.6°C, Tcurrent 35.6°C, HR 106 bpm, BP 106/73 mmHg, RR 16 inspirations per minute, SpO2 96%.
* Hemodynamic monitoring: The patient is being closely monitored for cardiac dysrhythmia, and her cardiac rhythm is currently sinus tachycardia.
* Fluid balance: The patient has received a total of 1,817 mL of fluid over the past 24 hours, with a balance of 342 mL.
* Respiratory support: The patient is not receiving oxygen therapy, but her SpO2 is 96%.
* Laboratory results: The patient's white blood cell count is trending downward, and her liver enzymes are elevated, consistent with shock liver.

The patient's medical complications include:

* Cardiac dysrhythmia
* Sepsis without organ dysfunction
* Airway, inability to protect (risk for aspiration, altered gag, airway clearance, and cough)
* Impaired skin integrity
* Fever, unknown origin (FUO, hyperthermia, pyrexia)
* Leukocytosis (GCST effect, culture-negative bacteremia, C. diff, or ALL)
* ALL (currently in remission, but may require further treatment for CNS lymphoma)
* Elevated liver enzymes (consistent with shock liver, resolving)
* Elevated PTT (isolated elevation, likely a spurious lab value)

The patient's plan of care includes:

* Continue linezolid for 4-8 weeks, pending TEE results
* Discontinue gentamicin
* Follow up culture data and sensitivities
* Trend with differential
* Continue to monitor for C. diff
* Continue to monitor for blood and sputum cultures
* Continue to trend with differential
* Follow up BMT recommendations
* Follow up CBC/diff
* Continue acyclovir, micafungin, and linezolid
* Trend LFTs and INR
* Repeat PTT and send mixing studies if elevated
* Consider S+S eval for nutrition
* Continue glycemic control
* Monitor for DVT and stress ulcer
* Monitor for VAP

The patient's code status is full code, and she is being considered for transfer to the floor."
112508.0,247400,2176-04-22 16:23:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  Intubated for
   cardiac arrest thought to be secondary to CCB in the setting of
   hypocalcemia. She is now doing well and awake s/p extubation, afebrile
   and her WBC count is trending downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   (compared to daptomycin) despite risk of CNS penetration. No VRE in
   blood for over one week.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks); gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time given recent extubation, would pursue
   within one week.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia vs c. diff vs
   ALL.  Diff not consistent with return of ALL per BMT. C diff negative x
   3 with a fourth pending. According to ID, timing and pattern fits best
   with GCST effect.  Now trending down over last two days.
   - f/u repeat c diff
   - f/u blood and sputum cx
   - continue to trend with differential
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.  Alk
   P only marker not trending down. Abd exam benign, would continue to
   trend at this point.
   -Trend LFTs and INR
   # Elevated PTT: Isolated elevation today, [**Last Name **] problem: Likely a
   spurious lab value; will repeat, if truly high, will send mixing
   studies
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
 consider S+S
   eval
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM ***(FEMORAL)***
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR
   ------ Protected Section ------
   Physical Exam: Vitals as above:
   Clean stapled incision over right  head.
   Good arir movt bilaterally with crackles at bases and mild diffuse
   ronchi
   RRR no M/r/g
   Neuro: maintains appropriate eye contact. Intermittently conversant
   (limited to [**12-1**] word answers); moves all 4 ext, but not always to
   commands, CN2-12 intact, affect blunted
   Abd: ostomy in place, NTND +BS
   ------ Protected Section Addendum Entered By:[**Name (NI) 6135**] [**Name8 (MD) 5998**], MD
   on:[**2176-4-22**] 17:02 ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  Intubated for
   cardiac arrest thought to be secondary to CCB in the setting of
   hypocalcemia. She is now doing well and awake s/p extubation, afebrile
   and her WBC count is trending downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   (compared to daptomycin) despite risk of CNS penetration. No VRE in
   blood for over one week.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks); gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time given recent extubation, would pursue
   within one week.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia vs c. diff vs
   ALL.  Diff not consistent with return of ALL per BMT. C diff negative x
   3 with a fourth pending. According to ID, timing and pattern fits best
   with GCST effect.  Now trending down over last two days.
   - f/u repeat c diff
   - f/u blood and sputum cx
   - continue to trend with differential
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.  Alk
   P only marker not trending down. Abd exam benign, would continue to
   trend at this point.
   -Trend LFTs and INR
   # Elevated PTT: Isolated elevation today, [**Last Name **] problem: Likely a
   spurious lab value; will repeat, if truly high, will send mixing
   studies
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
 consider S+S
   eval
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM ***(FEMORAL)***
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR
   ------ Protected Section ------
   Physical Exam: Vitals as above:
   Clean stapled incision over right  head.
   Good arir movt bilaterally with crackles at bases and mild diffuse
   ronchi
   RRR no M/r/g
   Neuro: maintains appropriate eye contact. Intermittently conversant
   (limited to [**12-1**] word answers); moves all 4 ext, but not always to
   commands, CN2-12 intact, affect blunted
   Abd: ostomy in place, NTND +BS
   ------ Protected Section Addendum Entered By:[**Name (NI) 6135**] [**Name8 (MD) 5998**], MD
   on:[**2176-4-22**] 17:02 ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's health progress in the ICU as follows:

The patient, a 60-year-old woman with recurrent acute lymphoblastic leukemia (ALL) and central nervous system (CNS) involvement, has been admitted to the ICU due to cardiac arrest and hypocalcemia. She has undergone Omaya removal, SDH evacuation, and intubation. The patient is now awake and extubated, afebrile, and her WBC count is trending downward.

The patient's current conditions include:

1. Cardiac dysrhythmia: The patient has a history of cardiac arrest and hypocalcemia, which may have contributed to her cardiac dysrhythmia.
2. Sepsis without organ dysfunction: The patient has a history of sepsis, which may have been caused by her underlying leukemia and subsequent infections.
3. Airway, inability to protect: The patient is at risk for aspiration, altered gag reflex, and impaired airway clearance due to her intubation and potential respiratory compromise.
4. Impaired skin integrity: The patient has a history of skin lesions and may be at risk for further skin breakdown.
5. Leukemia: The patient has a diagnosis of acute lymphoblastic leukemia, which requires ongoing treatment and monitoring.
6. Fever, unknown origin: The patient has a fever of unknown origin, which may be related to her underlying infection or sepsis.
7. Altered mental status: The patient has altered mental status, which may be due to her underlying illness, medication, or sepsis.

The patient's laboratory results show:

* WBC count: 27.0
* Hct: 29.9
* Plt: 75
* Cr: 0.9
* TCO2: 16
* Glucose: 157
* Lactic acid: 2.5 mmol/L
* Albumin: 2.1 g/dL
* LDH: 737 IU/L
* Ca++: 7.6 mg/dL
* Mg++: 1.8 mg/dL
* PO4: 2.9 mg/dL

The patient's treatment plan includes:

1. Linezolid: To be continued for a course of 4-8 weeks.
2. Gentamicin: To be discontinued.
3. Acyclovir: To be continued.
4. Micafungin: To be continued.
5. Leukocyte growth factor: To be continued.
6. Blood and sputum cultures: To be repeated.
7. Repeat CDiff: To be performed.
8. Follow-up with BMT: To be scheduled.

The patient's potential medical complications include:

1. Cardiac arrhythmias: The patient's history of cardiac arrest and hypocalcemia may increase her risk of cardiac arrhythmias.
2. Respiratory compromise: The patient's intubation and potential respiratory compromise may increase her risk of respiratory failure.
3. Infection: The patient's history of sepsis and fever of unknown origin may increase her risk of further infection.
4. Skin breakdown: The patient's history of skin lesions and impaired skin integrity may increase her risk of further skin breakdown.
5. Leukemia progression: The patient's underlying leukemia may progress, requiring further treatment and monitoring.
6. Neurological complications: The patient's altered mental status and potential neurological compromise may increase her risk of neurological complications.

Based on this information, I recommend that the patient continue to receive close monitoring and treatment in the ICU, with regular assessments of her cardiac, respiratory, and neurological status."
